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Abstract 
 
Paclitaxel is an antitumor diterpene from Taxus spp. that binds tubulin, stabilizes 
microtubules and induces apoptosis in dividing human cells. It was originally 
isolated from the bark of Taxus brevifolia and approved for clinic uses by the FDA in 
1992. Because of its excellent activity in treatment of various cancers, a significant 
supply shortage has been created by the enormous demand for this natural product. 
Thus, researchers have been focusing on the development of effective ways to 
increase the production of paclitaxel and related bioactive molecules. This shortage 
was initially solved by over-harvesting of T. brevifolia bark; however, it is not an 
environment-friendly, effective and sustainable way to supply paclitaxel. A semi-
synthetic route was then developed to convert the more readily available and 
renewable 10-deacetylbacatin III into paclitaxel. As an alternative, plant cell cultures 
have been employed to commercially produce paclitaxel and it is a more 
environment-friendly and sustainable route to end the supply crisis. However, 
problems associated with plant cell culturing at an industrial scale, such as cell 
aggregation and variability in yield, significantly affect paclitaxel production. 
Therefore, a discovery of a better-performing Taxus cell line might be a solution to 
overcome these culturing-associated problems.  
 
A cambial meristematic cell (CMC) line of Taxus cuspidata has been isolated, 
cultured and demonstrated to be a cost-effective and environmentally friendly 
platform for the sustainable production of paclitaxel (Lee et al. 2010). Compared to 
dedifferentiated cell (DDC) lines, CMC lines are undifferentiated cells and proved to 
have stem cell-like properties. When cultured at an industrial scale, this cell line 
	   II	  
contains much smaller cell aggregates with many cells appearing as singletons, the 
biomass of which is still increasing after 22-month culturing, and has much greater 
paclitaxel production after elicitation (Lee et al. 2010).  
 
In my project, we aimed to identify the transcription factors (TFs) that regulate the 
expression of paclitaxel biosynthesis genes. We performed Illumina Solexa 
sequencing on cDNA libraries derived from methyl jasmonate (MeJA)-elicitated 
CMCs to digitally profile gene expression. Analysis of differentially expressed gene 
(DEG) abundance led to the discovery of 19 putative TFs and bioinformatic analysis 
further showed that these 19 TFs belong to 5 different TF families. Further, the DNA 
binding motifs associated with these TFs can be found in the promoters of the two 
early, taxadiene synthase (TASY) and taxadiene 5α hydroxylase (T5αH), and three 
late, 10-deacetylbaccatin III-10-O-acetyltransferase (DBAT), 
phenylpropanoyltransferase (PAM) and 3’-N-debenzoyl-2-deoxytaxol-N-
benzoyltransferase (DBTNBT), paclitaxel biosynthesis pathway genes. Then, yeast 
one-hybrid analysis, gel shifting assays and plant transient expression assays (TEA) 
were employed to assay TFs that interact with these promoters. Although Y1H 
screening did not show any convincing TF-promoter interactions, the attempted plant 
transient expression assay in the leaves of Nicotiana benthamiana might be a more 
suitable system to screen the positive regulators. Finally, the elucidation of a TF 
regulatory network that controls paclitaxel biosynthesis will guide the rational 
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Chapter 1: Introduction 
 
1.1 Natural Products of Plant Origin 
 
Historically, humans have been utilizing plants as endless sources of medicines for 
thousands of years. Approximately 25% of all drugs prescribed today are isolated 
from plants (Schmidt et al. 2007). Plants naturally produce a startling array of natural 
products, which are not required for their growth and development, but rather 
essential for plants to interact with their surrounding environment. These so-called 
plant secondary metabolites have been playing an important role in treatment of 
diseases ranging in effects from antimalarials (artemisinin), antiparasitics (quinine), 
anticholinergics (atropine) to antineoplastics (vinblastine and vincristine). In 
particular, plant natural products have made a great contribution to the area of cancer 
treatment. Approximately 155 anticancer drugs have been developed since 1940, 
about half of which are either natural products or direct derivations thereof (Schmidt 
et al. 2007). Despite the recent techniques used in the field of drug discovery by 
pharmaceutical companies, such as molecular modelling, combinatorial chemistry 
and other synthetic chemistry, plant natural products still remain an important source 
of new drugs, new drug leads and new chemical entities (NCEs)(Newman et al. 
2000). Firstly, because plant natural products form a large reservoir of natural 
chemical diversity. It has been estimated that approximately 50,000 metabolites have 
been identified in plants; in addition, it is predicted that the final number will exceed 
200,000 (Hounsome et al. 2008). Such a rich diversity partially results from an 
evolutionary process driven by natural selection; as a consequence, plants acquire 
improved defence against attacks from microbes, insect and animals (Dixon 2001). 
Secondly, natural products have naturally built-in chirality, and thus uniquely bind to 
their targets, including complex proteins and other three-dimensional biological 
receptors (Kingston 2009). Consequently, they might perform better as drugs than 
artificially synthesised compounds produced by combinatorial chemistry in the 
treatment of diseases (Yun et al. 2012), because they can treat diseases more 




	   2	  
1.2 Plant-derived antineoplastics 
 
Cancer has been one of the top causes of death worldwide. According to Global 
Cancer Facts and Figures (2nd edition) by American Cancer Society, cancer is the 
leading and second leading cause of death in developed and developing countries, 
respectively. So far, there have been a few plant-derived anticancer drugs approved 
for clinic uses. Vinca alkaloids, which were discovered by Robert Noble and Charles 
Beer in 1950’s, are isolated from the Madagascar periwinkle (Catharanthus roseus) 
and were the first approved drugs for cancer treatment (Newman et al. 2000). Two of 
the best known indole alkaloids in clinic use are vinblastine and vincristine (Noble 
1990). Camptothecin (CPT), a cytotoxic quinoline alkaloid, which was isolated from 
the Chinese ornamental tree Camptotheca acuminata, is also proven to be an 
anticancer drug. However, because of its severe bladder toxicity, the modified CPTs, 
such as topotecan (Hycampin®) and irinotecan (Camptosar®), are approved for 
clinic use in the treatment of ovarian and small cell lung cancers and colorectal 
cancers in humans, respectively (Creemers et al. 1996; Fuchs et al. 2006; Newman et 
al. 2000). Furthermore, homoharringtonine (Omapro®) isolated from the Chinese 
tree Cephalotaxus harringtonia is also a plant-derived anticancer agent for the 
treatment of acute myelogenous leukemia and chronic myelogenous leukemia 
(Kantarjian et al. 1996). Finally, Paclitaxel (Taxol®), which was initially isolated 
from the bark of Taxus brevifolia, is a complex diterpene (Wani et al. 1971). Its 
clinic use was approved in the early 1990. Paclitaxel is a broad-spectrum anticancer 
agent, because it is significantly active against various cancers, including ovarian 
cancer, advanced breast cancer, small and non-small cell lung cancer (Rowinsky et 
al. 1992). Particularly, because of its efficacy and tolerability and the lack of cross-
resistance with anthracycline, paclitaxel is an important drug in the treatment of 
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1.3 Plant Secondary Metabolites  
 
Plant secondary metabolites are a vast and diverse assortment of organic compounds 
that are not directly required for plant growth and development. Unlike plant primary 
metabolites, which are essential for nutrition and metabolic processes inside the 
plant, plant secondary metabolites participate in interactions between the plant and 
its surrounding environment, such as interactions between plants and pathogens. 
Based on their biosynthetic origin, plant secondary metabolites can be grouped into 
three classes: the terpenoids, the alkaloids, and the phenylpropanoids and allied 
phenolic compounds. Terpenoids, which are derived from the five-carbon precursor 
isopentenyl diphosphate (IPP), are a class of more than 25,000 secondary 
metabolites. Alkaloids, a group of more than 12,000 known organic compounds, are 
characterised by containing one or more nitrogen atoms. They are principally 
synthesised from amino acids.  Finally, the group of phenylpropanoids and allied 
phenolic compounds contains about 8,000 or so phenolic compounds, and are 
synthesised through either of the two metabolic pathways: shikimic acid pathway or 
the malonate/ acetate pathway (Buchanan 2000). 
 
1.3.1 Plant terpenoids  
 
Terpenoids are made up of a diverse array of structurally varied compounds, the 
building blocks of which are five-carbon units referred as isopentenyl diphosphate 
(IPP). All members of terpenoids are biosynthesised by repetitive fusion of the 
branched IPP units based on an isopentane skeleton. Therefore, terpenoids are 
classified based on the number of IPP units they contain in their molecular structures. 
The smallest terpenoids contain a single IPP (C5) unit; they are named hemiterpenes 
as a group. Isoprene is the best known example of hemiterpene, which is a volatile 
product released from photosynthetically active tissues of plants.  Terpenoids that 
contain two IPP units (C10) are called monoterpenes, from which the subsequent 
nomenclature is derived. They were the first terpenoids isolated from terpentine in 
1850s. Monoterpenes are components of volatile essence present in the essential oils 
secreted by herbs, and comprise as much as 5% of plant dry weight. Furthermore, 
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diterpenes, which have 20 carbons (4 IPP units), consist of a variety of C20-
containing organic compounds ranging from phytol, the gibberellin hormones, 
phytoalexins and paclitaxel. Triterpenes (C30) also contain a diverse array of 
structurally and functionally different types of molecules, such as the 
brassinosteroids (plant hormones), phytoalexins, toxins and components of surface 
waxes (oleanolic acid of grapes). Tetraterpenes (C40) that contain eight IPP units 
consists of the carotenoid accessory pigments, which are functionally essential 
components of photosynthesis. Finally, the polyterpenes, which contain more than 8 
IPP units, consist of the prenylated quinone electron carriers (plastoquinone), long-
chain polyprenols (dolichol) and long polymers (rubber) (Buchanan 2000).  
 
The biosynthesis of the fundamental precursor IPP is the starting point of terpenoid 
biosynthesis. Three molecules of acetyl-CoA are required for synthesis of each IPP 
in the acetate/mevalonate pathway in the cytosol. Fig 1.1 shows the basic 
enzymology of IPP biosynthesis. Then, a series of prenyl diphosphate homologs, 
which serve as the immediate precursors of the different classes of terpenoids, are 
formed through repetitive additions of IPP.  The formation of terpenoid skeletons 
from immediate prenyl diphosphates is catalysed by specific terpenoid synthases 
located in the plastid. The family of genes encoding plant terpene synthases (TPSs) is 
highly diversified throughout the plant kingdom. TPS genes can be grouped into 
seven clades (Fig 1.2), with some types of genes showing their lineage-specificity 
(Chen et al. 2011). Finally, the secondary enzymatic modification to the skeletons 
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Fig 1.1 (Buchanan 2000)  The biosynthesis pathway of isopentenyl diphosphate 
(IPP) through acetate/mevalonate pathway, the basic building block of terpenoids, in 
cytosol. 
	  




Fig 1.2 (Chen et al. 2011) Phylogeny of putative TPSs from seven sequenced plant 
genomes and TPSs from gymnosperms. Based on the phylogeny and functions of 
known TPSs, the TPSs family can be classified into seven subfamilies. Whereas the 
three subfamilies that include TPS-a, b and g are angiosperm-specific, TPS-d is 
gymnosperm-specific. TPS-a is further divided into two groups. TPS-a-1 is dicot-
specific and a-2 is monocot-specific. TPS-c is most conserved among land plants. In 
contrast, TPS-e/f is most conserved among vascular plants. The latter emerged from 
two separate TPS-e and TPS-f subfamilies. Finally, the TPS-h is Selaginella 
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In 1964, yew extract from the bark of a Pacific Yew tree (Taxus brevifolia) was first 
shown to inhibit the growth of cancer cells. In 1967, Monroe Wall confirmed that it 
was paclitaxel present in the extract that showed an anticancer activity. It was 
approved for clinic uses by the Food and Drug Administration (FAD) in 1992. The 
synthesis of paclitaxel began by extracting paclitaxel from yew trees in 1971. 
However, plant extraction is neither environment friendly nor economically 
practical. It would have taken about 360,000 yew trees to treat all the patients of 
ovarian cancer in USA for one year. In addition, it takes hundreds of years for a yew 
tree to yield a good amount of paclitaxel. In 1980, 10-deacetyl-baccatinIII (10-DAB), 
the precursor of paclitaxel, was isolated from the needles of the European yew tree 
(Taxus baccata) by a French group. Pierre Potier and Andrew Greene successfully 
converted 10-DAB into paclitaxel. Although the yield was little, it showed a better 
way to synthesise paclitaxel. Since the production of taxusin (a paclitaxel-related 
compound that occurs naturally in yew) by Robert Holton in 1988, pharmaceutical 
companies started funding research towards the chemical synthesis of paclitaxel. In 
1992, Bristol-Myers Squibb (BMS) patented a new semisynthesis set up by Holton, 
the metal alkaloid process. 10-DAB was the source in the process and supplied by 
extraction of renewable yew needle. Hence, the need to supply yew bark ended at the 
end of 1993. At the same time, Gary Strobel with his colleagues isolated a fungus 
from the bark of the Pacific yew in North West Montana named Taxo -myces 
andreanae. After analysis of the product produced by the fungus culture, a trace 
amount of paclitaxel was found. Although the production of paclitaxel by this fungus 
is very low, and therefore not competitive, it is still promising. Finally, Rainer 
Zocher at TU Berlin started isolating enzymes that catalyse the reactions needed for 
paclitaxel production from 10-DAB. As a result, 10-DAB acetyl transferase was 
successfully isolated and its expression in E. coli could lead to a toxic-free 
production of paclitaxel from 10-DAB (Renneberg 2007).  
	  
	  
	   8	  
1.3.2.2 Chemistry and biological role of paclitaxel (C47H51NO14) 
 
 
Paclitaxel is a natural occurring diterpene with a complex molecular structure (Fig 
1.3). It is based on a C20-terpenoid and belongs to the taxane family. It has a core 
ring structure, known as the taxane ring cluster, which is made up of three rings. The 
carbon-13 (C13) side chain is in extended conformation, which places the benzamide 
group farthest from the core. There are benzoate and acetate groups present on C2 
and C10, respectively. In addition, the C2 benzoate and C10 acetate groups extend 
away from the taxane ring cluster in opposite direction. Furthermore, the acetate 







Fig 1.3 (Mastropaolo et al. 1995) Molecular structure of paclitaxel. It contains a core 
ring structure and a side chain at the position of carbon-13.  
 
 
Paclitaxel inhibits cancer cell growth by promoting the assembly of microtubules. 
Microtubules are thought to be “the most strategic subcellular targets of anticancer 
chemotherapeutics” (Rowinsky 1991), as they play important roles in many aspects 
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of cellular biological processes, such as shaping the cell, positioning and 
reorganising the organelles and moving cells. Additionally, microtubules are 
absolutely necessary for cell division (Nicolaou 1994). Microtubules are built up 
from tubulin dimers. Each dimer consists of two subunits: α and β tubulins, which 
exist as α-β heterodimers. Paclitaxel binds into a pocket in the second globular 
domain of β tubulin, which is present on the microtubule’s inner surface. The amino 
acid residues in closest contact with paclitaxel are labelled (Fig 1.4). This physical 
interaction counteracts the effects of GTP hydrolysis on the other side of the 
monomer; as a consequence, the depolymerisation of microtubules is inhibited and 
cell cycle is arrested (Amos and Lowe 1999; Nicolaou 1994; Schiff et al. 1979).  





Fig 1.4 [Adapted from (Amos and Lowe 1999)]  Right panel: The structure of a 
tubulin dimer: α and β tubulin. Left panel: the amino acids that are in closest contact 
with paclitaxel.  
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1.3.2.3 Paclitaxel biosynthetic pathway 
 
In order to safeguard against potential shortages, as well as bring down the cost of 
cancer treatment, the production of a larger amount of paclitaxel would be required. 
This could be achieved by either semi-synthetic approaches or by genetically 
engineered biosynthetic methods. Nevertheless, it would be helpful to elucidate the 
complete paclitaxel biosynthetic pathway in Taxus spp.  
 
The first step of the paclitaxel biosynthetic pathway is the cyclisation of 
geranylgeranyl diphosphate (GGPP). GGPP is a universal diterpenoid progenitor, 
which also serves as starting materials for many other biosynthetic pathways 
(Guerra-Bubb et al. 2012). GGPP is a diterpene and formed by condensing three IPP 
units with dimethylallyl diphosphate (DMAPP). This takes place in plant plastids and 
geranylgeranyl diphosphate synthase (GGPPS) is responsible for this condensation 
reaction (Lange and Ahkami 2013). Its cDNA was cloned from a methyl jasmonate 
(MeJA)-induced Taxus canadensis gene library. The recombinant protein was 
expressed in yeast, and radiochromatographic analysis confirmed its catalytic 
activity. It supplies the precursor for paclitaxel synthesis in Taxus canadensis 
suspension cell cultures (Hefner et al. 1998). The enzyme taxadiene synthase 
(TASY), is responsible for converting the linear GGPP to the parent hydrocarbon 
taxa-4 (5),11(12)-diene. Along with the production of the primary product (taxa-4 
(5),11(12)-diene) of TASY, the production of taxa-4 (20),11(12)-diene and taxa-3 
(4),11(12)-diene are only 5% and less then 1% of the total products, respectively.  
This is the first committed step of paclitaxel synthesis, which is a slow, but not the 
rate-limiting step of the pathway (Hezari et al. 1997). The cDNA encoding TASY 
was cloned from a cDNA library constructed from poly (A)+ RNA extracted from 
the Pacific yew (Taxus brevifolia) stems by a homology-based PCR cloning method 
(Wildung and Croteau 1996). The recombinant protein of TASY has been 
functionally expressed in E. coli and shown to resemble the native enzyme in kinetic 
properties (Williams et al. 2000). Furthermore, the X-ray crystal structure of a 
truncated version of TASY (TXS) was elucidated by Koksal and coworkers (Fig 1.5) 
(Koksal et al. 2011). The first hydroxylation reaction in the paclitaxel pathway is the 
conversion of both taxa-4 (5), 11(12)-diene and taxa-4 (20), 11(12)-diene into taxa-4 
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(20),11(12)-dien-5α-ol by taxadiene-5α-hydroxylase (T5αH) (Jennewein et al. 
2004a). Following this hydroxylation, the next step in the pathway is the acetylation 
reaction at C5, in which taxa-4 (20), 11(12)-dien-5α-ol is converted into taxa-4 (20), 
11(12)-dien-5α-acetate. The corresponding enzyme is taxa-4 (20), 11(12)-dien-5α-
ol-O-acetyl transferase (TAT). Its cDNA was cloned from induced Taxus canadensis 
and expressed in E. coli by the Croteau lab (Walker et al. 2000; Wheeler et al. 2001). 
Two more predicted hydroxylation steps occur in the pathway: 13α- and 10β-
hydroxylations. The two corresponding enzymes, taxane 13α-hydroxylase and taxane 
10β-hydroxylase, have been fully characterised (Jennewein et al. 2001; Kaspera and 
Croteau 2006). Although taxane 13α-hydroxylase (T13αH) shares 63% identity with 
taxane 10β-hydroxylase (T10βH) in amino acid sequence, the former prefers taxa-4 
(20),11(12)-dien-5α-ol as it substrate, the latter one uses taxa-4 (20),11(12)-dien-5α-
acetate as the substrate for the production of taxa-4 (20),11(12)-dien-5α, 13α-ol and 
taxa-4 (20),11(12)-dien-5α-yl-acetate-10β-diol, respectively (Jennewein et al. 2001). 
However, the formation of 10-deacetylbaccatin III (10-DAB III) from these two 
hydroxylated products in the pathway remains unknown. Furthermore, 10-
deacetylbaccatin 10β-O-acetyltransferase (DBAT) was found to catalyse acetylation 
of 10-DAB III at C10 into baccatin III. The cDNA of DBAT was amplified from a 
cDNA library constructed from mRNA of methyl jasmonate-induced Taxus cells by 
a homology-based PCR cloning strategy. The recombinant protein was expressed in 
E. coli, and the analysis by 1H-nuclear magnetic resonance (NMR) and mass-
spectrometry (MS) verified its function (Walker and Croteau 2000). The final steps 
in the pathway include C13 side-chain construction and implementation. In the 
process of C13 construction, phenylalanine aminomutase (PAM) first converts 2S-α-
phenylalanine to 3R-β-phenylalanine, which is further linked with one molecule of 
CoA by amino phenylpropanoyl CoA ligase in the presence of ATP and CoA, 
resulting in β-phenylalanoyl CoA (Fig 1.6b). The cloning, heterologous expression 
and functional characterisation of a PAM-like enzyme from a Taxus cuspidata 
cDNA library in E. coli were accomplished by the Croteau group (Walker et al. 
2004). The constructed C13 side-chain, the acyl donor, is then fused to Baccatin III 
by taxoid C13-O-phenyl-propanoyltransferase (BAPT), forming N-debenzoyl-2’-
deoxytaxol. The function of BAPT was also verified by the Croteau lab (Walker et 
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al. 2002a). The final acylation step in paclitaxel pathway is catalysed by 3’-N-
debenzoyl-2’-deoxytaxol N-benzoyltransferase (DBTNBT), forming 2’-deoxytaxol 
from the coupling of the substrate N-debenzoyl-(3’RS)-2’-deoxytaxol with benzoyl-
CoA (Walker et al. 2002b). Finally, the benzamidation of 2’-deoxytaxol gives rise to 
paclitaxel and marks the end of the paclitaxel biosynthetic pathway (Croteau et al. 
2006; Guerra-Bubb et al. 2012).  
 
Overall, the cyclisation of GGPP to form the taxane skeleton, 8 P450-mediated 
oxygenations, three CoA-dependent acyl/aroyl transfers, oxetane ring formation to 
yield Baccatin III and five additional steps for the functional C13 side-chain 
construction and implementation constitute the biosynthetic pathway of paclitaxel in 
Taxus spp. (Fig 1.6). Furthermore, a targeted molecular approach has been the major 
method used to identify the structural genes involved in a biosynthetic pathway by 
different groups. For example, a homology-based PCR cloning strategy was used by 
the Croteau group to identify structural genes encoding enzymes functionally 
associated with cyclisation, oxygenation and acylation of GGPP to yield paclitaxel 
from a cDNA library generated from mRNA of MeJA-induced Taxus cells (Croteau 
et al. 2006; Kaspera and Croteau 2006). Table 1 summarises some functionally 
important genes involved in the paclitaxel pathway, which have been cloned, 
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Fig 1.5 (Koksal et al. 2011) X-ray crystal structure of a truncated version of 











Fig 1.6 (Croteau et al. 2006; Guerra-Bubb et al. 2012; Jennewein et al. 2004b) (a) A 
simplified paclitaxel biosynthesis pathway. (b) Synthesis of C-13 side chain, β-
phenylalanoyl CoA. Dotted lines represent unknown enzymatic steps. The brackets 
indicate a double bond between two carbon atoms. TASY: taxadiene synthase; T5αH: 
taxadiene-5α-hydroxylase; T5AH: taxa-4 (20), 11(12)-dien-5α-ol-O-acetyl 
transferase; T10βH: taxane 10β-hydroxylase; DBAT: 10-deacetylbaccatin 10β-O-
acetyltransferase; PAM: phenylalanine aminomutase; BAPT: taxoid C13-O-
phenylpropanoytransferase; DBTNBT: 3’-N-debenzoyl-2’-deoxytaxol N-
benzoyltransferase. 
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Table 1 Characterisation of functionally important structural genes involved in the 
paclitaxel biosynthesis pathway. 
 































T5αH 1509 502 Taxus cell Yeast and insects 
(Jennewein 
et al. 2004a) 
T5AT 1317 439 Taxus cell E. coli (Walker et al. 2000) 
TBT 1320 438 Taxus cell E. coli (Walker et al. 2002b) 













T13αH 1458 484 Taxus cell Yeast (Jennewein et al. 2001) 













DBTNBT 1323 441 T. cuspidata E. coli (Walker et al. 2002b) 
BAPT 1335 445 T. cuspidata E. coli (Walker et al. 2002a) 
PAM 2094 698 T. cuspidata E. coli (Walker et al. 2004) 
 
GGPPS: geranylgeranyl diphosphate synthase; TASY: taxadiene synthase; T5αH: taxadiene-
5α-hydroxylase; DBAT: 10-deacetylbaccatin 10β-O-acetyltransferase; PAM: phenylalanine 
aminomutase; BAPT: taxoid C13-O-phenylpropanoytransferase; DBTNBT: 3’-N-debenzoyl-
2’-deoxytaxol N-benzoyltransferase; T10βH: taxane 10β-hydroxylase; T13αH: taxane 13α-
hydroxylase; T2αH: taxoid 2α-hydroxylase; T7βH: taxoid 7β-hydroxylase; TBT: 2α-
hydroxytaxane 2-O-benzoyltransferase. T5AH: taxa-4(20),11(12)-dien-5α-ol-O-acetyl 
transferase.  
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1.3.2.4 Medical applications of paclitaxel 
 
Paclitaxel as a secondary metabolite has no known function in Taxus spp. However, 
it may be a defence compound inhibiting the growth of plant pathogenic fungal 
hyphae in the plant, because paclitaxel is found to inhibit the growth of several fungi, 
such as Phytophthora and Pythium species (Oomycetes) and Rhizoctonia solani 
(Basidiomycetes) (Flores 1994). Historically, it has been an important drug in the 
treatment of various cancers (Chu et al. 2005; Hammond et al. 2000; Perez 1998; 
Rowinsky et al. 1992). Evidence indicates that it kills cancer cells through the 
induction of apoptosis, and the accumulation of H2O2 is an early and crucial step in 
this induced cancer cell death (Alexandre et al. 2006; Wang et al. 2000). Apart from 
its clinic use in cancer treatment, paclitaxel is proved to function in the mature 
central nervous system (CNS) by facilitating axon regeneration (Sengottuvel et al. 
2011). In addition, it could be an adjuvant candidate in the process of promoting both 
Th1 and Th2 immune responses induced by ovalbumin in mice (Yuan et al. 2010). 
Therefore, paclitaxel has a broad-spectrum application in human disease treatment. 
Furthermore, the delivery of paclitaxel is problematic, because of lack of selective 
cytotoxicity towards cancer cells; thus, cancer cells as well as normal cells may be 
affected, and it leads to some side effects. Another major problem that affect wide 
clinic application of the drug is its poor water solubility. However, the coupling of 
paclitaxel with delivery-facilitating molecules can ease and enhance the targeted 
delivery of paclitaxel to its target cancer cells (Gibson et al. 2007) . For example, the 
glycan conjugation approach enhances the delivery of glycan-based paclitaxel into 
cancer cells that overexpress glucose transporters (GLUTs) (Lin et al. 2008).  
 
	  
1.3.2.5 Traditional strategies for paclitaxel synthesis 
 
After paclitaxel was approved for its clinic use in cancer treatment, the demand for 
this anticancer drug dramatically increased. BMS earned $1.5 billion from selling 
paclitaxel worldwide in 1999 (Malik 2011) and the total market for it was $1 billion 
per year worldwide (http://www.strategyr.com/Bulk_Paclitaxel_Market_Report.asp). 
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In particular, paclitaxel is in demand as a drug in the chemotherapy of ovarian cancer 
and its shortage can have a significant negative impact on the average cost of 
primary treatment for ovarian cancer. On average, it costs $4939 for 6 cycles of 
chemotherapy in the standard treatment, but $16,107 in the drug shortage scenario. 
So, the cost difference is $11,1168 per patient over 6 cycles of treatment (Havrilesky 
et al. 2012). There have been different strategies developed for large-scale 
production of paclitaxel, including extraction, chemical synthesis and fermentation 
of genetically modified microbials (Ajikumar et al. 2010; Wani et al. 1971; Yamin 
Wei 2012).  
 
From 1967 to 1994, the production of paclitaxel was mainly from extracts of barks of 
Taxus spp. (Renneberg 2007). However, the drawbacks of this approach are: firstly, 
it is not an environment-friendly and renewable process, because the removal of 
barks from yew trees leads to the death of the tree and it takes hundreds of years for 
yew trees to grow and accumulate a large amount of paclitaxel; secondly, the amount 
of extracted drug is only about 0.01% of the dry weight of the bark. For example, 
1200 kg of Taxus bark only yielded 10g of pure paclitaxel, which is about 8.3 mg per 
kg of bark (McCoy and O'Connor 2008). Purification steps further reduce the drug 
yield. As a consequence, the synthetic approach may be promising.  Due to 
paclitaxel’s complexity in chemical structure, the steps required in the route of its 
total chemical synthesis are 35 to 51, with a highest yield of 0.4%. Although 
paclitaxel can be chemically synthesised from its precursor, 10-DAB, which can be 
extracted from the renewable part of yew trees (needles or leaves), this semi-
synthetic approach is still not economically efficient for drug production, because of 
limitations on productivity and scalability (Denis 1988; Suffness 1995; Nicolaou et 
al. 1994; Holton 1994). Therefore, the synthetic approach is not the best alternative 
for paclitaxel production.  Furthermore, the production of antibiotics from 
genetically modified microbials on an industrial scale has been successful, for 
example, the production of artemisinic acid (the antimalarial drug precursor) in 
engineered yeast (Ro et al. 2006). This strategy could shed light on the production of 
paclitaxel by engineered microbials. Endophytic fungi isolated from the bark of 
Taxus sp. can naturally produce paclitaxel, such as EFY21 isolated from Taxus 
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chinensis var. mairei. After overexpression of TASY, the engineered EFY21 produce 
5 times as much as paclitaxel than the wildtype (Yamin Wei 2012). Another example 
of microbial engineering for paclitaxel precursor overproduction is engineered E. 
coli, from which, the titers of the first committed paclitaxel intermediate (taxadiene) 
is increased by about 15,000 fold (up to 1 gram per liter) (Ajikumar et al. 2010). 
However, the downsides of fermentation technologies, such as large, expensive 
infrastructures and low and variable yields, make it economically less favorable 
(Malik 2011). Overall, the drawbacks each of these strategies have greatly limited 
the large-scale paclitaxel production.  
 
1.3.3 Production of natural products by plant cell culture 
 
The unreliable harvesting of high-value and low-abundance natural products from 
plants has great negative impacts not only on patient treatments and clinical 
evaluation requirements, but also on the environment. This has been a key driving 
force behind efforts towards the development of renewable and environment-friendly 
production strategies.  
 
Plant cell culture, pioneered by a German botanist in 1898 (Thorpe 2012), provides a 
sustainable and environmentally friendly production platform for high-value natural 
products. It has several advantages over natural harvesting: firstly, the conditions for 
plant cell culture can be well controlled to meet the requirements for drug 
production; secondly, the culture conditions can be optimised to increase the yield of 
a given target drug. In addition, production and engineering of novel drugs can be 
achieved through synthetic biology approaches in plant cell culture (Kolewe et al. 
2008). Finally, it provides renewable source of natural products, as cell harvesting 
for drug production does not damage the environment. Therefore, production of 
natural products by plant cell culture is a promising approach to meet the demand for 
producing pharmaceutically active natural compounds. Table 2 lists natural products 
produced by plant culture with their pharmaceutical applications (Caldentey 2002). 
Most of the drugs that are produced through plant cell culture have anticancer 
properties.  
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Table 2. [Adapted from(Caldentey 2002)] List of natural products with 
pharmaceutically applications produced through industrial cell culture. 
 
Cell culture Product Application Manufacturer 
Taxus spp. paclitaxel antitumor Phyton Biotech (USA) Samyang Genex (Korea) 
Coleus blumei rosmarinic acid anti-inflammatory Nattermann (Germany) 
Panag 









spp. geraniol antitumor 
Mitsui Petrochemical 
Industries (Japan) 
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1.3.3.1 Production of paclitaxel by plant cell culture 
 
Because of the limitations of traditional methods for paclitaxel production, 
researchers have successfully conducted production of paclitaxel by plant cell 
culture. Table 3 summarises plant cell cultures of Taxus spp. used for production of 
paclitaxel. Although plant cell culture for industrial production is still somewhat 
limited, industrial production of paclitaxel and its precursor by this approach has 
been scaled up; for example, bioreactors up to 75,000 L have been used by chemical 
companies, such as ESC genetics (USA), Phyton (USA) and Samyang Genex 
(Korea), for paclitaxel production (Caldentey 2002). Furthermore, there have been 
several strategies developed to improve paclitaxel yields in Taxus spp. plant cell 
cultures, including elicitation, selection of high paclitaxel-accumulating Taxus spp. 
cell lines, culture media and environmental optimisation. These non-molecular 
approaches are collectively known as traditional strategies. On the basis of molecular 
and biochemical technologies, newer strategies have been developed and employed 
to gain a complete understanding of the paclitaxel synthesis, such as differentially 
expressed genes (DEGs) (Hao da et al. 2011).   
 
 
Table 3. [Adapted from (McCoy and O'Connor 2008)] Paclitaxel production by 
MeJA-treated plant cell culture of Taxus spp. The concentration of the extracellular 
paclitaxel is measured in mg per litre of culture media. 
 
 
Cell type Paclitaxel (mg/L) Reference 
Taxus canadensis 117 (Parsons and Shuler 2002) 
Taxus media 21 (Matsuda et al. 1991) 
Taxus media 110 (Kayser 2007) 
Taxus cuspidata 22 (Doran 2002) 
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1.3.3.2 Increased paclitaxel yield in cell culture by elicitation 
 
An elicitor is defined as any biotic or abiotic factor that leads to an increased yield of 
secondary metabolites. Fig 1.7 summarises elicitors used for increased production of 




Fig 1.7 [adapted from (Vongpaseuth and Roberts 2007)] A summary of abiotic and 
biotic elicitors used to increase paclitaxel and its precursors production in Taxus spp. 
cell suspension culture. 
 
Among these elicitors, MeJA, which has been shown to induce production of a range 
of secondary metabolites from alkaloids in Catharanthus, anthocyanins in soybean 
seedlings to rosmarinic acid in Lithospermum cell suspension cultures (Aerts 1994; 
Franceschi and Grimes 1991; Mizukami 1993), acts as key signal transducer and 
plays an important role in the production of secondary metabolites (Gundlach et al. 
1992). Furthermore, it has been revealed that MeJA can induce overproduction of 
paclitaxel and Baccatin III in Taxus cell suspension cultures; in addition, two regions 
of MeJA (C1 and C3 position) are known to be important for this induction, because 
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the promoting activity of MeJA is greatly reduced by either the reduction of the keto 
group at the C3 position or the deletion of the carboxyl group at the C1 position 
(Yukimune et al. 1996).  Interestingly, paclitaxel, the end product of paclitaxel 
biosynthetic pathway, was shown to stimulate cell-associated paclitaxel content by 
up to 32.7 fold in the presence of 200 mg/L exogenous paclitaxel in Taxus baccata 
suspension cultures (Exposito et al. 2009).  
 
Furthermore, paclitaxel yield can also be improved by treating cell suspension 
culture with more than one elicitor, which is known as combinatorial elicitation. For 
example, in studies eliciting Taxus chinensis cell culture with a combination of 50mg 
chitosan l-1, 60µM methyl jasmonate and 30µM Ag+, the paclitaxel yield was found 
to be significantly higher than that of the control (almost 40 times) and the culture 
with Ag+ (10 times), chitosan (6 times) or methyl jasmonate (twice), respectively 
(Zhang 2000).  
 
1.3.3.3 Increased paclitaxel yield in cell culture by molecular-based methods 
 
The goal of molecular investigations to globally elucidate paclitaxel metabolism and 
accumulation is to bioengineer a superior paclitaxel-producing Taxus spp. cell line 
by transforming Taxus cells with rate-limiting structural genes involved in and 
outside of paclitaxel biosynthetic pathway, such as genes involved in the paclitaxel-
accumulating process (transport and degradation). There are two different molecular 
approaches applied toward this goal: one is a targeted approach and it focuses on 
elucidating the structural genes and corresponding enzymes involved in paclitaxel 
biosynthesis in Taxus spp. A homology-based PCR cloning strategy has been used to 
identify the majority of structural genes and gene families and corresponding 
enzymes responsible for the enzymatic steps in the pathway, such as terpene 
cyclases, cytochrome P450 hydroxylases and acyl transferases; the other is a non-
targeted approach. This molecular strategy focuses on not only elucidation of 
structural genes in the pathway, but also genes responsible for the unknown 
mechanisms outside the pathway. The main idea behind this approach is to construct 
two cDNA libraries: a cDNA library of paclitaxel-accumulating and non-paclitaxel-
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accumulating state in Taxus spp. cell cultures i.e. a cDNA library of differentially 
expressed transcripts between these two libraries. In conjunction with genetic 
information obtained from traditional methods, both structural and regulatory genes 
with putative functions in and outside the paclitaxel pathway can also be identified 
(Vongpaseuth and Roberts 2007). This new strategy has been successfully employed 
in expression profiling of DEGs with Nicotiana tobaccum and Arabidopsis thaliana 
(Costa et al. 2000; Imanishi et al. 1998).  
	  
1.3.3.4 Contemporary limitations on plant cell culture for industrial utility 
 
Traditionally, the establishment of plant cell suspension cultures begins with plant 
calli. Plant calli are undifferentiated somatic cells and they are initiated from 
differentiated material (explants) and maintained in a dedifferentiated state by 
exogenous phytohormones (auxins and cytokins) on solid medium. Plant cell 
suspension cultures are generated when calli are suspended in liquid media, in which 
the callus breaks into small cell aggregates approximately 40-200 µm in diameter. 
Compared to callus culture, cell suspension culture proliferates more rapidly, and 
therefore is suitable for large-scale industrial culture. In contrast to undifferentiated 
cells present in callus culture, hairy root cultures are established after plants infected 
with Agrobacterium rhizogenes and comprise differentiated cells.  Hairy root 
cultures are especially utilised for production of certain natural products that can 
only be robustly synthesised in differentiated tissues (Shanks and Morgan 1999).  
 
There are several challenges presented by plant cell cultures. The first obstacle 
present in the routine industrial utility of plant cell cultures for natural product 
production is the variability of natural product yield. Compared to the utility of 
microbial cultures for target compound production, where the yield is generally 
stable, large variations in product yield in plant cell culture system often limits their 
potential utility in industry. For example, paclitaxel accumulation between different 
cell lines of the same species is markedly different (Table 3) (Ketchum 1996). The 
second challenge that limits the potential commercial utility of plant cell culture is 
the existence of large cellular aggregates in suspension cultures when cultured in 
	  
	   24	  
large bioreactors. Plant cells naturally tend to aggregate, because the pectin-rich 
middle lamella bonds cell together after cell division. As a consequence, a spectrum 
of diverse heterogeneous microenvironments is established within these cellular 
aggregates that differ in size. Thus, there are metabolic and morphologic differences 
between cells at the centre and near the periphery of the aggregates (Naill and 
Roberts 2004). In addition, the formation of those cellular microenvironments may 
contribute to the striking variability often observed in natural product production 
from plant cell culture. Aggregate size affects paclitaxel accumulation in Taxus 
suspension cultures. For example, the T. cuspidata P991 culture with mean aggregate 
size of 400 µm produced 6 mg/L paclitaxel; in contrast, the same culture with mean 
aggregate size of 840 µm produced only 0.3 mg/L paclitaxel. So, there is a 20-fold 
increase in paclitaxel production in smaller aggregates (Kolewe et al. 2011).  The 
third obstacle that limits the application of plant cell culture on an industrial scale is 
their sensitivity to mechanical stresses, such as sheer stress. Cell aggregation further 
intensifies this trait even in a sheer stress reducing bioreactor (stirred tank) (Joshi 
1996).  
 
1.3.3.5 Isolation and culture of plant cambial meristematic cells 
 
As the establishment of plant cell suspension culture begins with initiation of calli 
from differentiated plant material through what was believed to be a dedifferentiation 
process, the type of cells proliferating in the resulting cell suspension culture is a 
dedifferentiated cell line (DDC) (Thorpe 2007). The differentiated plant cell is 
reversed into a “stem cell”-like state in this process when exposed to plant hormones 
auxin and cytokinin. The “stem cell”-like (dedifferentiated) state makes it easy for 
the dedifferentiated cells to re-enter into cell cycle and subsequent cell proliferation. 
Ultimately, a multicellular mixture of proliferating cells is generated from 
dedifferentiation of specialised cell types (Grafi et al. 2007). Cell suspension cultures 
established from such cellular assortments often show some deficient traits, such as 
poor growth properties, low and variable yields of natural products (Roberts 2007), 
this might be because of deleterious genetic and epigenetic changes that happen 
during the dedifferentiation process (Fereol et al. 2005). So, the dedifferentiated cell 
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line has not been a good source for the establishment of plant cell cultures on an 
industrial scale (Yun et al. 2012).   
 
Recently, an innately undifferentiated cell line derived from cambium cells has been 
isolated and known as cambial meristematic cells (CMCs). This actively 
proliferating cambium cells can be naturally separated from phloem, cortex and 
epidermis (Fig 1.8). The cambium cells, from which CMCs are derived, function as 
vascular stem cells, and differentiate to form secondary xylem and phloem on the 
inside and outside of the ring, respectively. CMCs were first isolated from T. 
cuspidata, and the antineoplastic agent paclitaxel is most abundant within the region 
containing the CMCs (Stierle et al. 1993). This novel procedure for isolation of 
CMCs is described in Fig. 8 (Yun et al. 2012). Apart from CMCs of T. cuspidata, 
CMCs from a variety of plant species were also isolated, including ginseng (Panax 
ginseng), ginkgo (Ginkgo biloba) and tomato (Solanum lycopersicon). This suggests 
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Fig 1.8 (Yun et al. 2012) The procedures for isolating and culturing CMCs.  
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1.3.3.6 CMCs versus DDCs in performance during small and large-scale culture 
 
It has been shown that the growth of CMCs in suspension cultures is far superior to 
DDCs in several aspects. The dry cell weight (d.c.w) of CMCs derived from either 
needles or embryo of T. cuspidata was greater than that of standard T. cuspidata 
DDCs by a magnitude of 105 after subculturing both cell types every two weeks for 
22 months. In addition, after 22 months of culturing, CMCs were still growing 
rapidly; in contrast, DDCs developed prominent necrotic patches and showed signs 
of a rapid decrease in their biomass. Secondly, DDC suspension culture often 
produces pronounced cell aggregates, which is a common feature of DDC containing 
suspension culture. This can lead to the formation of different microenvironments 
between cells within these aggregates. Ultimately, DDC cultures show reduced 
growth rates and variable and decreased natural product production (Lee et al. 2010). 
Typically, in CMC cultures, there is a large majority (93%) of cell aggregates having 
a diameter of <0.5 mm and many cells exist as singletons. Conversely, in DDC 
cultures derived either from needles or embryo of T. cuspidata, the proportion of cell 
aggregates with a diameter less than 0.5 mm was only 2% or 5%, respectively. 
Thirdly, on a large scale culturing, the growth of plant cells is limited by shear stress 
and cell aggregation further potentiates this problem. It has been shown that T. 
cuspidata CMCs in cultures grow significantly faster than DDCs in a 10 L stirred 
tank bioreactor. In response to shear stress, the survival rate of CMCs is much 
greater than that of DDCs. Further, the growth of CMCs in a 20 L air-lift bioreactor, 
which is often used for production of natural products on an industrial scale, is also 
found to be noticeably greater than that of DDCs, in contrast to CMCs, DDCs fail to 
grow. Due to the unique physiological and molecular characteristics of CMCs, 
including small and abundant vacuoles, reduced aggregation and thin cell walls, 
CMCs can tolerate greater shear stress than DDCs(Lee et al. 2010). Therefore, 
CMCs is a superior cell line to DDCs when utilised for natural product biosynthesis. 
Finally, on an industrial scale, the stability of cell growth in culture is often an 
important trait for the exploitation of plant suspension cells. Over the time of cell 
culturing, CMCs showed a relatively constant growth rate, whereas the growth rate 
of DDCs widely fluctuated (Lee et al. 2010; Yun et al. 2012).  
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1.3.3.7 Utility of CMCs for production of natural products 
 
T. cuspidata CMC line has been proved to perform much better than its DDC line 
when cultured on a large scale. So, the utility of CMCs for natural product 
biosynthesis on an industrial scale could be established. A promising example is the 
use of CMCs for paclitaxel production.  
 
When T. cuspidata cells are treated with fungal elicitor or MeJA, the plant immune 
activator, it induces the synthesis of paclitaxel. It has been reported that the addition 
of fungal elicitor can induce an increase in paclitaxel production by 14,000 fold in 
CMCs cultured in a 3 L air-lift bioreactor. In contrast, the fold induction of paclitaxel 
production for elicited cultures of DDCs derived from needle and embryo is only 220 
and 433, respectively.  Further, paclitaxel can be secreted into the culture media, and 
the amount of paclitaxel secreted from the cultured cells varies significantly between 
Taxus species and also depends on culture conditions. Therefore, culture conditions 
are often optimised to maximize the secretion of natural products synthesised in 
cultured plant cells into culture media. For example, perfusion culture (Lee et al. 
2010), in general, promotes the secretion of natural products into culture media so 
that those compounds can be relatively easily purified. Because some natural 
compounds may be toxic to the cells when accumulated to a certain threshold inside 
the cell, the secretion into culture media can promote cell survival. After CMCs were 
grown in perfusion culture for 45 days, a total of 264 mg of paclitaxel per kg of cells 
was produced and 74% of this was secreted directly into the medium. In contrast, 
there was only 2-3 mg of paclitaxel secreted by DDCs derived from needle and 
embryo of T. cuspidata. Therefore, culturing CMCs with optimised conditions would 
aid the purification of paclitaxel, hence improve product yield (Yun et al. 2012). In 
addition to the diterpenoid, paclitaxel, Taxus species can also produce abietane 
tricyclic diterpenoid derivatives, such as taxamairin A and C. Both have been shown 
to have anti-cancer properties (Yang 1999). It was found that elicited CMCs 
produced 4983 and 521mg/kg/fresh cell weight (f.c.w) of taxamairin A and C in a 3 
L air-lift bioreactor, respectively. Conversely, only trace of both was produced in 
DDCs. As might be expected, CMCs is a better source for production of these 
abietanes than DDCs.  
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More broadly, like T. cuspidata CMCs, CMCs can also be isolated from other 
medical plants. For example, Panax ginseng CMCs have been shown to synthesis a 
significant amount of ginsenosides, which are a class of triterpenoid saponins and 
produced exclusively by the plant genus Panax. This class of compounds has been 
shown to have medical values, such as neuroprotection and antioxidant effects 
(Leung and Wong 2010). When cultured in a 3 L air-lift bioreactor, CMCs derived 
from Panax ginseng performed much better than DDCs as expected in terms of 
production of ginsenosides F2 and gypenoside XVII. Strikingly, it was reported that 
CMCs produced 23.8- and 24.1-fold more ginsenosides F2 and gypenoside XVII 
than DDCs, respectively. As a consequence, CMCs potentially might be a good 
source for other medically important natural products (Yun et al. 2012). 
 
In summary, the isolation of CMCs and their subsequent culture on an industrial 
scale could provide an improved source for not only biomedical drugs, but also plant 
natural products that are used as pigments, insecticides and antimicrobials (Schmidt 
et al. 2007). More importantly, this technique may also offer a sustainable, cost-
effective and environmentally friendly way to produce important natural products for 
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1.4 Taxus species 
 
1.4.1 Botany of Taxus 
 
Taxus is commonly known as yew and is a genus of gymonosperms, as its seeds do 
not develop in an ovary. There are 24 species and 55 varieties in the genus Taxus. 
They are distributed across the northern temperate and subtropical regions as far 
south as El Salvador in Central America and Sumatra in Southeast Asia.  Based on 
the leaf epidermal and stomatal features, the species in the genus Taxus are divided 
into three groups: the Wallichiana, the Baccata Group and the Sumatrana Group. 
Table 4 summarises the information about species included in each group and their 
geographic distributions. Furthermore, the Wallichiana group is divided into two 
subgroups: Wallichiana and Chinensis, and Baccata group is divided into 
the Baccata and Cuspidata species alliances (Spjut 2010).  
 
Table 4 (Spjut 2010) Number of species and their geographic distributions of three 
groups of the Taxus genus  
 
Groups of Taxus 
genus 








Central Himalayas, Indonesia (Sumatera, 
Sulawesi), the Philippines, North 
America in the Pacific Northwest, 
Mexico, central America and an isolated 





Temperate Eurasia, northern Africa and 











The name Taxus is derived from the Greek word for yew, toxos, which is thought to 
be originally from the combination of the Greek words toxicon and toxon with the 
meaning of poison and bow, respectively. Taxus belongs to the yew family Taxaceae 
which are coniferous trees, as their leaves are similar to that of conifers (pines). The 
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heights of mature trees range from 1 to 40 m, with trunks up to 4 m in diameter. The 
leaves of yew are dark-green and their barks are reddish. Yew trees are slow 
growing, and it takes about 200 years for yew to reach their nature maximum height 
(Suffness 1995).  
 
1.4.2 Taxus cuspidata 
 
Taxus cuspidata (Fig 1.9), also known as the Japanese yew, is within the genus 
Taxus, the family Taxaceae and the order Taxales. It is native to Asian countries, 
including Japan and China, in addition to North and South Korea and the Russian 
Federation (Kuril, Primorye, Sakhalin) (IUC 2010, http://www.iucnredlist.org/). It is 
a small coniferous tree with a pyramidal shape, and it can grow up to 16 m tall 
(Hartzell 1991). Its shoots are red-brown, leaves are dark green and spirally arranged 
and cones are aril red when ripen (Ohwi 1965). In Japan, it was formerly valued for 
piles and foundations, water tank and chopsticks and was also medically used as an 
antidiabetic. Due to overexploitation, its commercial use has declined in recent 
decades (http://www.conifers.org/ta/Taxus_cuspidata.php). In 1998, Taxus cuspidata 
was reported to be in a lower risk status in the IUCN Red List of threatened species 
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1.5 MeJA-induced gene expression 
 
MeJA and its derivatives (jasmonates) are plant hormones derived from fatty acids 
(Creelman and Mullet 1997; Wasternack 2007). They have been found to play 
important roles in many developmental processes, including root elongation, fertility 
and sex determination (Acosta et al. 2009; Wasternack 2007). In addition, they can 
also activate plant defence systems to defend against both biotic (pathogens, insects 
and herbivores) and abiotic stresses (UV and drought) (Balbi and Devoto 2008; 
Browse and Howe 2008; Farmer et al. 2003). Transcriptional profiling of MeJA-
treated cultured Arabidospsis cells suggested that MeJA transcriptionally 
reprogrammes cells to activate defence systems and, at the same time, arrest the cell 
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1.5.1 Jasmonate biosynthesis, activation and deactivation 
 
The molecule, α-linolenic acid (18: 3) (α-LeA), which is released by lipase activity 
on chloroplast membranes, is the precursor for jasmonates. In fact, it is the precursor 
for a group of oxygenated compounds, collectively named oxylipins, including 
jasmonates. The initial step in the generation of MeJA is the formation of (13S)-
hydroperoxyoctadecadienoic acid (13-HPOT) from α-linolenic acid by 13-
lipoxygenase (13-LOX). Then, the conversion of 13-HPOT carried by 13-allene 
oxide synthase (13-AOS) results in an unstable allene oxide, 12,13-epoxylinolenic 
acid (12, 13-EOT). The subsequent enzyme, the allene oxide cyclase (AOC), 
catalyses the final chloroplast-located reaction in the pathway and leads to the AOC 
product cis (+)-12-oxophytodienoic acid (OPDA). Then, the OPDA is released from 
the chloroplast and transported into peroxisomes by an unknown mechanism, where 
OPDA is specifically reduced into OPC-8:0 by OPDA reductase 3 (OPR3). Through 
three steps of β-oxidation by acyl-CoA oxidase (ACX), a multifunctional protein 
(MFP) and a L-3-ketoacyl CoA thiolase 2 (KAT2), the unstable JA, (+)-7-iso-JA is 
formed, which is rapidly epimerised to stable epimer (-)-JA (JA) in peroxisomes (Fig 
1.10a) (Wasternack 2007).  
 
However, the stable JA is not biologically active in terms of promoting interaction 
between COI1 and JAZ proteins (section 1.5.2). It is further converted into a variety 
of biologically active derivatives through conjugation with amino acids (Fig 1.10b). 
In particular, JA conjugation with amino acid isoleucine (Ile) by Jasmonate Resistant 
1 (JAR1) gives rise to the molecularly active hormone, (+)-7-iso-JA-L-Ile (Fonseca et 
al. 2009b; Guranowski et al. 2007; Staswick and Tiryaki 2004) (Fig 1.10b). 
Furthermore, JA conjugation with other amino acids by JAR1, including Leu, Val 
and Phe, has also been reported to exist in other plant species (Wasternack 2007). In 
Arabidopsis, however, those amino acid conjugates are not biologically active 
molecules, because there is no detectable interaction between COI1 and JAZs 
promoted by any of those conjugates, and further none of them is able to rescue the 
JA-insensitivity of jar1 mutants (Staswick and Tiryaki 2004). In vitro, the interaction 
between tomato homologues COI1 and JAZs has been shown to be promoted by JA-
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Leu, JA-Val and JA-Ala, although their functionality remains to be shown in vivo 
(Thines et al. 2007). Overall, these data suggest that there are differences in 
specificities of hormone perception in different plant species. 
 
In addition, the active JA hormones can be inactivated through different hormone 
inactivation mechanisms. For example, the active form of JA, (+)-7-iso-JA-L-Ile, is 
reversibly epimerised into the inactive (-)-JA-L-Ile through alkali treatment. Further, 
its capacity is found to be reversibly reduced by methyl-esterification of (+)-7-iso-
JA-L-Ile (Fonseca et al. 2009b) (Fig 1.10b). Recently, JA hydroxylation and 
subsequent sulfonation and glycosylation have been reported to partially switch off 
JA signalling (Miersch et al. 2008). So, both activation and inactivation of JA work 
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Fig 1.10a (Avanci et al. 2010; Wasternack 2007) JA biosynthetic pathway. The 
pathway first starts in chloroplast, in which α-linolenic acid is converted into cis (+)-
12-oxophytodienoic acid (OPDA) through a series of enzymatic steps. In 
peroxisomes, cis (+)-12-oxophytodienoic acid is firstly reduced to OPC-8:0 by 
OPDA reductase 3 (OPR3). After three steps of β-oxidation by acyl-CoA oxidase 
(ACX), a multifunctional protein (MFP) and a L-3-ketoacyl CoA thiolase 2 (KAT2), 
the unstable JA, (+)-7-iso-JA is formed, which is rapidly epimerised to stable epimer 
(-)-JA (JA) in peroxisomes. 13-LOX: 13-lipoxygenase; AOS: allene oxide synthase; 
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Fig 1.10b (Fonseca et al. 2009a) JA activation and deactivation. The stable JA can 
conjugate with amino acids to form a variety of derivatives. For example, JA 
conjugation with amino acid isoleucine (Ile) by Jasmonate Resistant 1 (JAR1) gives 
rise to the molecularly active hormone, (+)-7-iso-JA-L-Ile (grey box). However, JA 
conjugation with other amino acids (leucine, valine and phenylalanine) is inactive. 
The active JA hormones can be inactivated through different hormone inactivation 
mechanisms. For example, the active form of JA, (+)-7-iso-JA-L-Ile, is reversibly 
epimerised into the inactive (-)-JA-L-Ile through methylation or in vitro alkali 
treatment. JAR1: jasmonate resistant 1; JMT: Jasmonic acid carboxyl 
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1.5.2 JA signalling pathway 
 
JA signalling plays an important role during plant development and response to 
environmental stresses. The overview of the signalling pathway is illustrated in Fig 
1.11A. The pathway comprises two important components: one is COI 1, which 
encodes an F-box protein as a component of a SKP1, Cullin, F-box protein E3 
ubiquitin ligase (SCFCOI 1) (Xie et al. 1998).  COI 1 has been known as a specificity 
factor that targets other proteins for degradation via the 26S proteasome (Devoto and 
Turner 2003); the other is the JAZ proteins, which are the targets of the SCFCOI 1 
complex (Thines et al. 2007). In basal conditions, JAZs, which exist in the form of 
either homomeric or hetromeric complexes, interact with transcription factors (TFs) 
through the Jas domain and prevent TFs from activating JA-inducible genes. Under 
stress conditions, the active form of JA, (+)-7-iso-JA-L-Ile, promotes the interaction 
between SCFCOI 1 and JAZs. As a consequence, JAZ proteins are ubiquitinated and 
degraded by the 26S proteasome, and TFs are released to activate transcription.   
 
A well known example of JA signalling pathway involves the MYC2 basic Helix-
Loop-Helix (bHLH) TF- based regulatory system in the JA-induced defence gene 
activation in Arabidopsis (Boter et al. 2004). In the absence of JA-Ile, MYC2, which 
binds to its target promoter through a G-box, is bound to JAZs through the Jas 
domain. The JAZ proteins inhibit the activation of MYC2 target genes by recruiting 
the corepressors TOPLESS (TPL) and TPL-related proteins through an interaction 
with an adaptor protein, known as Novel interactor of JAZ (NINJA) (Pauwels et al. 
2010). Conversely, in the presence of JA-Ile and the cofactor, inositol 
pentakisphosphate (insP5, a molecule derived from inositol tetrakisphosphate by 
adding a phosphate group) (Sheard et al. 2010), JAZs are linked to COI 1 through the 
Jas domain, ubiquitinated and degraded by the 26S proteasome. This leads to the 
switch-on of JA-responsive gene expression (Fig 1.11B) (Pauwels and Goossens 
2011).  The re-establishment of MYC2 repression and restoration of the basal 
condition are completed by de novo synthesis of JAZ proteins. Interestingly, their 
corresponding JAZ genes are the early targets of MYC2 (Chini et al. 2007). MYC2 
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has been further reported to positively regulate a variety of genes involved in other 
processes, including oxidative stress response and flavonoid synthesis. Some other 
genes are negatively regulated by MYC2, such as genes for pathogen defence and 
tryptophan metabolism (Dombrecht et al. 2007).  
 
The JA signalling pathway is regulated through both positive and negative feedback 
loops (Fig 1.12) (Farmer 2007). In the positive feedback loop (a), JA activates its 
own biosynthesis. This is supported by the fact that the genes encoding all the 
enzymes involved in JA biosynthesis are transcriptionally activated by JA 
(Wasternack 2007). Conversely, in the negative feedback loop (b), the JAZ genes are 
also transcriptionally activated through JA signalling. Therefore, JA action is down-
regulated by de novo synthesised JAZs. For example, the transcription of JAZ3, 
which is a MYC2 transcriptional target, is repressed by its own product, JAZ3. The 
switch-on of JAZ3 gene expression is mediated by JA-mediated destruction of JAZ3 
repressors, the resulting JAZ3 proteins further down-regulate JA action (Chini et al. 
2007). It seems that the JA pulsed response has to be precisely controlled to avoid 
runaway stress metabolism. Plants have developed many strategies to achieve this 
goal. The negative feedback loop could be one of the strategies. In addition, the 
inactivation of the bioactive (+)-7-iso-JA-L-Ile by epimerisation or methylation after 
JA-induced protein degradation and the dominant repression by JAZΔJas repressors 
(JAZ proteins that lack Jas domains, which is caused by alternative splicing of JAZ 
mRNAs) could also contribute to the switching-off the pathway (Chung and Howe 


























Fig 1.11 (Fonseca et al. 2009b; Pauwels et al. 2010) (A) a model for JA signalling: 
Under basal conditions, the transcriptional activity of TFs is repressed by JAZs. 
Under stress conditions, the active form of JA, (+)-7-iso-JA-L-Ile, promotes the 
interaction between SCFCOI 1 and TFs. As a consequence, JAZ proteins are 
ubiquitinated and degraded by the 26S proteasome, and TFs are released to activate 
transcription (B) a representative example of JA signalling pathway: the JAZ 
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proteins inhibit the activation of MYC2 target genes by recruiting the corepressors 
TOPLESS and TPL-related proteins through an interaction with an adaptor protein, 
NINJA. Conversely, in the presence of JA-Ile, JAZs are linked to COI 1 through the 
Jas domain, ubiquitinated and degraded by the 26S proteasome. This leads to the 









Fig 1.12 (Farmer 2007) The regulatory circuit of JA signalling that fine-tunes JA 
responses: (a) the positive feedback loop: under stress conditions, JA triggers the 
defence responses through JA signalling pathway. Meanwhile, the JA biosynthesis is 
activated and produces more JA, and therefore JA responses are enhanced.  (b) the 
negative feedback loop: the JAZ genes are also transcriptionally activated through JA 
signalling. Therefore, JA action is down-regulated by de novo synthesised JAZs.  
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1.5.3 The JAZ family 
 
JASMONATE-ZIM DOMAIN (JAZ) belongs to the TIFY family, which is 
previously known as Zinc-finger inflorescence meristem (ZIM). The renaming of the 
TIFY from ZIM is due to the inconsistency of its classification among different 
databases (Vanholme et al. 2007).  
 
1.5.3.1 The structure and function of JAZ proteins 
 
There are 12 putative JAZ proteins in the Arabidopsis JAZ protein family (JAZ1-12). 
The 28 amino acid ZIM and Jas domain are highly conserved among these 12 JAZs 
(Staswick 2008). Furthermore, the TIFY motif (TIFYAG) and the JAZ degron 
(LPIAR) are also highly conserved within the ZIM and Jas domain, respectively (Fig 
1.13) (Vanholme et al. 2007).  
 
It has been demonstrated both in vitro and in vivo that ZIM domains mediate JAZ-
JAZ interactions to form either homomeric or heteromeric proteins. For example, 
JAZ10.4, a natural splice variant of JAZ10, which contains the ZIM domain but 
lacks the Jas motif, is still able to interact with other JAZs (Chini et al. 2009). In fact, 
all the JAZ-JAZ interactions in the Arabidopsis JAZ family have been confirmed by 
Yeast two-Hybrid (Y2H) (Chini et al. 2009; Chung and Howe 2009). In addition, 
JAZ has also been shown to interact with other regulatory proteins, such as NINJA 
and TPL. (Pauwels et al. 2010; Szemenyei et al. 2008). In Y2H database, JAZ1-6 
and 9-12 are shown to interact with NINJA, whereas only JAZ 5 and 8 are shown to 
directly interact with TPL in a plant interactome project (Arabidopsis Interactome 
Mapping Consortium 2011).  
 
The Jas domain is responsible for the interaction of JAZs with TFs, as well as COI 1 
in the presence of JA-Ile and the cofactor, inositol pentakisphosphate. It contains a 
degron motif (LPIAR), which is required for its interaction with COI 1,and 
ultimately, the SCFCOI 1-meidated JAZ degradation (Sheard et al. 2010). Y2H has 
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confirmed the interaction of JAZs with different classes of TFs, including bHLH, 
R2R3 MYB and TFs involved in other hormonal signalling pathway (Pauwels and 
Goossens 2011). MYC2 was the first TF identified to be regulated by JAZ proteins  
(Chini et al. 2007). MYC2 interacts with most JAZs proteins and acts as both an 
activator and repressor in the JA signalling pathway (Dombrecht et al. 2007; Lorenzo 
et al. 2004). In addition, the closest homologs of MYC2, MYC3 and MYC4 are 
targets of JAZs and act as activators, but, additively with MYC2, regulate 
specifically different subsets of the JA responses (Cheng et al. 2011; Fernandez et al. 
2011). Furthermore, two R2R3-MYB TFs, MYB21 and MYB 24, have been reported 
to be the target of JAZs and involved in JA-regulated stamen development in 
Arabidopsis (Song et al. 2011). Finally, the interaction of JAZs with WD-
Repeat/bHLH/MYB complexes through bHLH and MYB, represses JA-regulated 
anthocyanin accumulation and trichome initiation. Upon JA-induced JAZ 
degradation, the transcription complex is released and functions to activate essential 
target genes involved in the regulatory pathway of anthocyanin accumulation and 







Fig 1.13 (Pauwels and Goossens 2011) The basic structure of JAZ proteins. It 
contains a ZIM and Jas domain. The TIFY motif (TIFYAG) and the JAZ degron 
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Fig 1.14 (Pauwels and Goossens 2011) Repression of different JA–mediated 
transcriptional responses through the interaction of JAZs with a wide array of TFs, 
including MYC2/3/4, EGL3/GL3/TT8, GL1/PAP1, MYB21/24 and EIN3/EIL1. The 
release of these TFs from JAZs-mediated transcriptional repression activates 




The third functionally important motif is the Ethylene Responsive Factor-associated 
Amphiphilic Repression (EAR) motif present in the N-terminal domain of JAZ 
proteins. There are only four JAZ proteins containing the EAR motif, including 
JAZ5/6 and JAZ 7/8. The EAR motif is responsible for the recruitment of the 
corepressors, TPL, through the direct interaction between them. JAZ5 and JAZ8 
have been confirmed to have direct interactions with TPL. In particular, JAZ8 has 
been shown to mediate transcriptional repression of JA responses through direct 
recruitment of TPL in vivo (Shyu et al. 2012). However, the interaction of JAZ6 or 
JAZ7 with TPL has not been described to date. In contrast, JAZs, which lack of the 
EAR motif, require an EAR-containing adaptor protein NINJA or heterodimerize 
with EAR-containing JAZs to recruit TPL for inhibition of JA responses (Pauwels et 
al. 2010). Fig 1.15 shows hypothetical models of inhibition of JA responses by JAZs 
(Pauwels and Goossens 2011).  
 
	  





Fig 1.15 (Pauwels and Goossens 2011) Hypothetical models of inhibition of JA 
responses by JAZs. (A) Direct repression by JAZs only; (B) Repression by JAZ-
recruited TPL through EAR-containing NINJA; (C) Repression by JAZ-recruited 
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1.6 The JA-responsive TF families involved in transcriptional 
regulation of plant secondary metabolism 
 
JA signalling has been involved in many processes in plant development and 
defence.  In the signalling pathway, the bioactive JA-Ile links the JAZ repressors 
with SCFCOI 1, which leads to that the degradation of JAZs by 26S proteasome and 
therefore the release of TFs from JAZ-mediated repression and subsequent 
transcriptional responses. TFs are proteins that regulate gene activity by binding to 
sequence-specific motifs present in gene promoters and modulate the rate of 
transcriptional initiation, which is carried out by the basal transcription machinery, 
including RNA polymerase II (Ranish and Hahn 1996). In particular, TFs and their 
corresponding promoter binding elements, which are employed for transcriptional 
gene activation in the JA signalling pathway, are said to be JA-responsive. 
Furthermore, there have been different TF families described to be involved in 
transcriptional regulation of plant secondary metabolism in JA responses, through 
which the secondary metabolites are produced in response to environmental stimuli, 
for example, pathogen attack (Schwinn 2003).   
 
1.6.1 Apetala 2/ethylene-responsive element binding factor (AP2/ERF) family 
 
The AP2/ERF family consists of a large group of plant-specific TFs, which is 
divided into four major subfamilies: the AP2, RAV, ERF and dehydration-responsive 
element-binding protein (DREB), and among which, the DREB subfamily is the 
largest subfamily (Mizoi et al. 2012). The Arabidopsis and rice contain 145 and 167 
loci encoding family members, respectively (Sakuma et al. 2002). The AP2/ERF TFs 
commonly contain an AP2/ERF-type DNA binding domain, which consists of 
approximately 60 amino acids (Weigel 1995). The name of this family was derived 
from the Arabidopsis homeotic gene APETALA 2 and tobacco (Nicotiana tabacum) 
ethylene-responsive element binding proteins (EREBPs), where this domain was first 
found (Jofuku et al. 1994; Ohme-Takagi and Shinshi 1995). The domain structure, 
which was revealed in the structure of the Arabidopsis ERF1 protein in complex with 
a target DNA by NMR, contains an N-terminal, a C-terminal α-helix and three-
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strand β-sheet that is responsible for the recognition of the cognate target DNA 





Fig 1.16 (Allen et al. 1998) The structure of AP2/ERF domain in complex with its 
target DNA sequence. It consists of a N-terminal α-helix and a three-stranded anti-
parallel β-sheet.  
 
Generally, the DNA binding element is specific to AP2/ERF subfamily proteins. 
DREB1A and DREB2A, the DREB subfamily proteins, have the highest affinity for 
the sequence A/GCCGAC, which is the core sequence of cis-acting dehydration-
responsive element (DRE) (Sakuma et al. 2002). In contrast, five ERF subfamily TFs 
have the highest affinity for the ethylene-responsive element (ERE) core sequence, 
the GCC-box (AGCCGCC) (Fujimoto et al. 2000). However, there are exceptional 
cases for the core sequences. For example, TINY, a DRE-binding protein-like TF 
from the subgroup A-4 of the DREB subfamily has been shown to bind to both the 
DRE and GCC-box sequences (Sun et al. 2008).  
 
A well-characterised example of JA-responsive AP2/ERF TFs is the Octadecanoid 
Responsive C. roseus AP2 (ORCA) TF family, including ORCA1, 2 and 3. ORCA2 
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and 3, but not ORCA1, are involved in terpenoid indole alkaloid (TIA) biosynthesis 
in Catharanthus roseus (Menke et al. 1999; van der Fits and Memelink 2000). Both 
ORCA2 and 3 bind to a jasmonate and elicitor responsive element (JERE) present in 
the promoter region of the Strictosidine synthase (Str) gene, which is involved in the 
initial step of TIA biosynthesis (Memelink 2007; Endt et al. 2007). Furthermore, 
ORCA3 has been suggested to be the central regulator of TIA biosynthesis, because 
it transcriptionally activates not only several structural genes in the TIA pathway, but 
also genes involved in the biosynthesis of TIA precursors (Memelink 2007).  A close 
homologue of ORCA3, NtORC1 from tobacco, together with NtJAP1, are also 
shown to regulate the activity of structural genes involved in JA-responsive tobacco 
alkaloid biosynthesis in transient assays in tobacco protoplasts, such as the putrescine 
N-methyltransferase encoding gene, PMT (Sutter et al. 2005; Katoh 2005). The gene 
expression of both TFs is shown to be induced by MeJA (Goossens et al. 2003).   
 
 
1.6.2 Basic Helix-loop-Helix TF family 
 
The basic/helix-loop-helix (bHLH) proteins comprise a superfamily of TFs. It has 
been estimated that the Arabidopsis bHLH family contains at least 147 members, 
which is grouped into 21 subfamilies through phylogenetic analysis (Toledo et al. 
2003). The bHLH family is characterised by the bHLH signature domain. This 
domain contains ∼60 residues, which are functionally divided into two distinct 
regions. One is the basic region located at the N-terminal end of the domain.  This 
region consists of ∼15 amino acids, most of which are basic residues. It functions to 
bind target DNA sequences. The other is the HLH region at the C-terminal end. The 
amino acids within this region are mainly hydrophobic residues that form two 
amphipathic α-helices separated by a loop region. The amino acid sequence and 
length varies in the loop region (Nair and Burley 2000). The HLH region is 
responsible for protein dimerization (Ferre et al. 1994). The crystal structure of 











Fig 1.17 (Shimizu et al. 1997) The crystal structure of bHLH PHO4-DNA complex.  
It is a dimer. Each monomer contains a basic region located at the N-terminal end of 
the domain and a HLH region at the C-terminal end. The HLH region is responsible 
for protein dimerization.  
 
 
A consensus hexanucleotide sequence, known as the E-box (5’-CANNTG-3’), is the 
core DNA sequence bound by bHLH TFs. The two central bases define the type of 
E-boxes, and the palindromic G-box (5’-CACGTG-3’) is one of the most common 
types of E-box. The core sequence is recognized by the conserved residues within the 
basic region of the protein, whereas the specific recognition of a given type of E-box 
is provided by other residues in the domain (Robinson et al. 2000). In addition, the 
binding specificity is also shown to be influenced by the flanking nucleotides outside 
the core sequence (Massari and Murre 2000).  
 
A well-studied example of bHLH TF is MYC2 that has been involved in 
differentially modulating diverse JA-dependent functions in Arabidopsis (Dombrecht 
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et al. 2007). As far as the secondary metabolites are concerned, it has been 
demonstrated that MYC2 positively regulates the JA-mediated flavonoid 
(anthocyanin or proanthocyanidin) biosynthesis by possibly modulating the 
expression of an intermediate spectrum of TFs, including MYBs (AtMYB75, 90 and 
TT2), bHLHs (TT8 and EGL3) and WD40 (TTG1) (Borevitz et al. 2000; Dombrecht 
et al. 2007; Nesi et al. 2000; Nesi et al. 2001; Walker et al. 1999). The Xie group (Qi 
et al. 2011) showed that WD-repeat, bHLH and MYB proteins form a complex to 
regulate JA-mediated anthocyanin accumulation in Arabidopsis. In addition, 
NtMYC2a and NtMYC2b have been reported to regulate the expression of JA-
inducible multiple genes involved in nicotine biosynthesis by forming nuclear 
complexes with NtJAZ1(Zhang et al. 2012). These two MYC proteins could have 
identical DNA-binding specificities for the same binding element, as they are from 
the same TF family and involved in the same JA signalling pathway. Instead of 
competing with each other for occupancy at the same location on promoters, one 
MYC protein can facilitate the binding of another (Stratmann and Schibler 2011).  
 
1.6.3 MYB TF family 
 
The MYB family consists of a large and functionally diverse number of TF proteins 
in all eukaryotes. The first identified plant TF gene is the COLORED 1 (C1) that 
encodes a MYB domain protein involved in the anthocyanins biosynthesis in the 
aleurone of maize kernels (Paz et al. 1987). MYB proteins are characterised by the 
highly conserved MYB domain that is the DNA-binding motif. This domain 
generally comprises four imperfect amino acid repeats (R), with each having ∼52 
residues and forming three α-helices. In each repeat, a helix-turn-helix (HTH) 
structure is built by the second and third helices with three regularly spaced 
tryptophan residues, and the overall structure is a hydrophobic core (Ogata et al. 
1996). In addition, it is the third helix in each repeat that recognizes DNA in the 
major groove (Jia et al. 2004).   
 
Based on the number of adjacent repeats included in MYB proteins, this protein 
family can be divided into four different classes in Arabidopsis: MYB-related (one or 
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partial repeat), R2R3-MYB (two repeats), R1R2R3-MYB (3 repeats) and 4R-MYB 
(4 R1/R2-like repeats) (Fig 1.18). In particular, R2R3-MYB subfamily, which 
contains more than 100 members (Yanhui et al. 2006), is the largest subfamily in 
MYB proteins, and 4R-MYB proteins that form the smallest subfamily with the least 
number of protein members. Furthermore, in the modular structure of R2R3-MYB 
TF, the DNA-binding domain (MYB domain) is located at the N-terminus, whereas 
the activation or repression domain is located at the C-terminus. In contrast to these 
two highly conserved domains, the other regions of R2R3-MYB are highly variable. 




                    
 
Fig 1.18 (Dubos et al. 2010) Classification of plant MYB TFs in Arabidopsis. There 
are four different classes: MYB-related (one or partial repeat), R2R3-MYB (two 
repeats), R1R2R3-MYB (3 repeats) and 4R-MYB (4 R1/R2-like repeats).  
 
The large number of members within R2R3-MYB subfamily in plants fits well with 
the observation that many proteins from this subfamily are involved in plant–specific 
processes, such as primary and secondary metabolism, development and responses to 
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biotic and abiotic responses (Martin and Paz 1997). In terms of secondary 
metabolism, the regulation of flavonoid biosynthesis has been shown to involve 
several R2R3-MYB TFs in a tissue-specific manner in Arabidopsis. For example, 
AtMYB75, AtMYB90, AtMYB113 and 114 from subgroup 6 regulate anthocyanin 
biosynthesis in vegetative tissues (Gonzalez et al. 2008), whereas AtMYB123 from 
subgroup 2 controls proanthocyanidins (PAs) biosynthesis in the seed coat 
(Routaboul et al. 2006).  
 
 
1.6.4 WRKY TF family 
 
WRKY transcription factor proteins form one of the largest families of 
transcriptional regulators in plants. The members in this family are characterised by 
the DNA binding domain, which is called the WRKY domain. The WRKY domain 
consists of about 60 residues. Apart from the WRKY signature at the N-terminus, at 
the C-terminus it also has an atypical zinc-finger structure (Eulgem et al. 2000). In 
addition, the WRKY domain amino acid sequence is almost invariant except for a 
few WRKY proteins, in which the WRKY sequence is replaced by WRRY, WSKY, 
WKRY, WVKY or WKKY (Xie et al. 2005).  
 
According to the number of WRKY domains and the structure of the zinc fingers 
(Cx4-5Cx22-23HxH/C2H2 or Cx7Cx23HxC/C2HC), the WRKY TFs can be divided into 
three groups: Group I (two WRKY domains with C2H2), Group II (one WRKY 
domain with C2H2) and Group III (one WRKY with C2HC). Group II can be further 
divided into Group IIa, b, c, d and e based on the primary amino acid sequence 
(Eulgem et al. 2000).  
 
The structure of WRKY domain revealed that there is a four-stranded-β-sheet and a 
zinc-binding pocket formed by Cys/His residues (Fig 1.19). In addition, the 
conserved WRKYGQK contained at the most N-terminal β-strand makes contacts 
with a 6-bp region in the major DNA groove (Yamasaki et al. 2005).  The 
remarkably conserved core sequence bound by almost all WRKY proteins is known 
as the W boxes (TTGACC/T). It has been confirmed that the W box is the minimal 
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consensus sequence required for DNA binding through several assays, such as gel 
shift experiment, yeast one-hybrid screens and co-transfection assays (Ciolkowski et 
al. 2008). The binding specificity of WRKY proteins for their target promoters is 
further determined by the adjacent binding sites. For example, the AtWRKY6 
preferentially binds to the core sequences that have a G base at the 5’ direction of the 
W box element, whereas AtWRKY26 has a preference to W boxes that have T, C or 
A at the 5’ direction of the core (Ciolkowski et al. 2008). However, there are a few 
exceptions that WRKY proteins bind to non-W box sequences. As well as binding to 
W box, OsWRKY13 also binds to a DNA sequence of TGCGCTT, known as the 
PRE4 element (Liu et al. 2008). A WRKY TF from barley, HvWRKY46 binds to 




Fig 1.19 (Yamasaki et al. 2005) The structure of WRKY DNA binding domain. It 




It has been evident that WRKY TFs play regulatory roles in a wide range of plant 
processes, such as abiotic and biotic stresses, plant development and senescence and 
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seed dormancy and germination (Rushton et al. 2010). Like other TFs described in 
this thesis, WRKY proteins have also been reported to be involved in biosynthesis of 
the secondary metabolites. The JA-inducible CrWRKY1 is shown to positively 
regulate the TIA (serpentine) biosynthesis in roots of C. roseus plants. Together with 
other TFs, CrWRKY1 stimulates the root-specific serpentine accumulation by 
activating several key TIA pathway genes, especially Tryptophan Decarboxylase 
(TDC) and zinc-finger C. roseus transcription repressors (ZCT1, ZCT2 and ZCT3), as 
well as repressing key transcriptional activators, including ORCA2, ORCA3 and 
CrMYC2, which directs the flux toward the vindoline and catharanthine pathways 
(Memelink 2007; Suttipanta et al. 2011; Wang et al. 2010).  
 
1.6.5 NAC TF family 
 
NAC (NAM, ATAF1, 2, CUC2) TFs constitute the NAC TF family, which is one of 
the largest of plant-specific TF families. There are more than 100 NACTF encoding 
genes found in Arabidopsis (Riechmann et al. 2000). The NAC domain at the N-
terminal region of NAC proteins is the family-defining domain(Aida et al. 1997). By 
contrast, there are no known domains found at the C-terminal region, in which the 
residues are highly diverse (Ooka et al. 2003). Through forward genetics, NAM (no 
apical meristem) was the first NAC TF encoding gene to be identified, which was 
followed by the characterization of AtCUC2 (CUP-SHAPED COTYLEDON 2) (Aida 
et al. 1997). Furthermore, NAC domains have been demonstrated to be responsible 
for both protein-DNA and protein-protein interactions (Ernst et al. 2004), and the 
core sequence they recognize in the promoter fragment is CACG (Tran et al. 2004). 
Whereas the transcription activation domains have been shown to locate at the C-
terminal regions in yeast and plant cells (Hegedus et al. 2003; Tran et al. 2004), the 
structure of NAC domain (dimer) has been elucidated by X-ray crystallography. It 
shows that the NAC domain consists of a twisted antiparallel β-sheet surrounded by 
two α-helices located on each side (Fig 1.20) (Ernst et al. 2004).   
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Fig 1.20 (Ernst et al. 2004) The dicyanoaurate derivative structure of NAC dimer. 
Each consists of a twisted antiparallel β-sheet surrounded by two α-helices located 
on each side.  
 
NAC proteins have been implicated in various plant processes, including 
development, defence and abiotic stress responses (Olsen et al. 2005). In addition, 
they have been involved in regulating secondary metabolite synthesis. Two NAC 
TFs, NAC SECONDARY WALL THICKENING PROMOTING FACTOR1 
(NST1) and NST3, have been suggested to be the key regulators of the formation of 
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1.7 Regulation of TFs controlling plant secondary metabolism 
 
A single TF alone is, often, not capable of regulating the whole biosynthetic pathway 
of secondary metabolite. They generally require cofactors, some post-translational 
modifications or other interacting proteins in order to become functionally active. 
These changes may be required to affect DNA binding activity, nuclear localization 
and protein stability. In addition, they typically work together with other TFs from 
either the same or different TF family to temporally and spatially regulate the 
biosynthesis of specific secondary metabolites in a TF regulatory network.  
 
A key post-translational modification that plays important roles in plant processes is 
protein phosphorylation. Especially, it has been reported that phosphorylation of 
WRKY TFs by a phosphorylation cascade is involved in mediating many processes 
in plants, including plant immune reponses to pathogen attacks (WRKY33), plant 
defence against herbivore attack (WRKY3 and WRKY6) and dehydration 
(WRKY1), and senescence (WRKY53) (Rushton et al. 2010). Furthermore, the 
phosphorylation of Nicotiana benthamiana WRKY8 mediated by Mitogen-activated 
protein kinase (MAPK) also plays roles in plant defence (Ishihama et al. 2011). 
Recently, it has been revealed that, in vivo, the phosphorylation of WRKY33 by two 
MAPKs, MPK3 and MPK6, which function together in the same MAPK cascade, 
reprogrammes the expression of genes encoding enzymes required for camalexin 
biosynthesis, and therefore direct the metabolic flow toward camalexin metabolism 
in Arabidopsis when challenged with Botrytis cinerea (Mao et al. 2011).  
 
Alternatively, TF activity can be regulated by protein-protein interactions. The 
stimulation of the binding activity of WRKY33 requires two nuclear-encoded 
activators, sigma factor binding protein 1(SIB1) and SIB, which recognize the C-
terminal WRKY domain in plant defence against necrotrophic pathogens. A short 
FXXXVQXXTG (X, any amino acid) motif in these two proteins is important for 
interaction with WRKY33 (Lai et al. 2011). Furthermore, in the biosynthesis of 
flavonoids, MYB and bHLH TFs may functionally and physically interact with each 
other to direct the metabolic flow in a branch-specific manner, which leads to the 
production of different flavonoids. The physical interaction between certain MYB 
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and bHLH proteins has been confirmed by Koes (Mol 1998).  In maize, C1 (MYB) 
and R (bHLH) together drive the biosynthetic pathway for the production of 
anthocyanins by activating the corresponding structural genes (Bruce et al. 2000). In 
contrast, PAP1 (MYB), a possible C1 ortholog, is able to activate anthocyanin 
production without co-expression of a bHLH TF in Arabidopsis (Borevitz et al. 
2000); however, both TT2 (MYB) and TT8 (bHLH) are required to direct the 
metabolic flux toward proanthocyanidins biosynthesis in Arabidopsis (Nesi et al. 
2000; Nesi et al. 2001). Furthermore, there is some evidence showing that JA-
regulated secondary metabolite biosynthesis can be controlled by either two TFs that 
function cooperatively, or by a transcription factor cascade that consists of a TF 
regulating a down-stream TF gene expression, which in turn regulates the expression 
of a subset of structural genes involved in metabolite biosynthesis. For example, a 
bHLH TF is required for the maximum transactivation of ORC1 in the control of JA-
elicited tobacco nicotine biosynthesis. In fact, the ORC1 (AP2) and bHLH binding 
element, GCC-motif and G-box, respectively, are both present in the promoters of 
the genes encoding enzymes involved in nicotine biosynthesis (De Boer et al. 2011). 
JA-responsive ORCA TF family (ORCA2 and ORCA3) has been shown to regulate 
alkaloid biosynthesis in C. roseus (van der Fits and Memelink 2000). Recently, the 
transcriptional regulator of these two TF-encoding genes has been identified to be a 
bHLH TF, CrMYC2. This bHLH TF up-regulates the JA-responsive ORCA gene 
expression, which in turn leads to the up-regulation of a subset of alkaloid 
biosynthesis genes and subsequent increase in alkaloid production (Figueroa and 
Browse 2012).  
 
Realistically, the complexity of the transcriptional regulation of the biosynthesis of 
secondary metabolites by TFs in planta is far beyond the scope of single- or double-
TF regulatory concept. In fact, it is more likely that the biosynthesis of secondary 
metabolites is regulated by a group of TFs that form a transcriptional network. 
Grotewold (2008) predicted a model of gene regulatory network in planta based on 
the findings in Saccharomyces cerevisiae and Escherichia coli (Yu and Gerstein 
2006). Within this network, one TF often, together with others, positively or 
negatively regulates another in a regulatory motif. Then, when assembled into 
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regulatory modules, a variety of regulatory motifs build up a gene regulatory 
network (Babu et al. 2004). Moreover, TFs are situated at various levels in the 
pyramidal hierarchical arrangement. TFs situated near the top of the pyramid are 
master TFs, and they directly control these TFs present in the middle of the pyramid. 
In contrast, TFs located at the bottom of the pyramid are responsible for the control 
of the structural genes that are required for most of cellular processes. In other 
words, the higher the TF is in the pyramid, the more genes are under its control, 
which means an alteration in the activity of this TF will affect the expression of a 
large number of downstream genes. By contrast, the TFs at the bottom of the 
pyramid only regulate a small subset of genes; therefore, the change in the TF 
activity will only affect the expression of a small number of genes (Fig 1.21). Zhao 
and Dixon (2010) proposed a simple model of the transcriptional network of 
secondary cell wall biosynthesis in Arabidopsis. In their model, the master TFs, 
including NST1/2/3, can activate secondary cell wall synthesis via the centrally 
located MYB46/MYB83. Then, MYB58/63/85, which are under the control of 
MYB46/83, in turn activate the expression of lignin biosynthesis genes through AC 
elements, therefore leading to lignin production. Meanwhile, MYB4, which is 
controlled by MYB83, acts as a repressor to inhibit lignin biosynthesis (Zhao and 
Dixon 2011). Consistent with this concept, Del and Ros1 in anthocyanin biosynthesis 
are likely located near the top of the hierarchical network so that over-expression of 
these master TFs leads to up-regulation of most of structural genes present in the 
pathway, thereby a significant increase in the production of anthocyanin in the fruit 










Fig 1.2 [Adopted from(Grotewold 2008)] A simplified diagram of a model gene 
transcriptional regulatory network involving TFs (circles) and structural genes (stars) 
arranged in a pyramidal hierarchical pattern. TFs are shown at various levels in the 
pyramidal hierarchical arrangement: top TFs (red circles), central TFs (yellow circle) 
and low TFs (green circles). Structural genes (stars) are located at the bottom of the 
pyramid. Blue lines indicate the direct interaction of one TF with another from 
different levels; horizontal blue lines at each level indicate the TF interactions at the 
same level; blue arrowed lines indicate the regulation of gene expression by TFs; 
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1.8 Bioengineering of transcription factors 
 
In the field of plant metabolic engineering to increase the production of medically 
valuable compounds, TFs have been the main targets for the manipulation of 
complex metabolic pathways in plant, because modification of TF activity has a 
dramatic effect on the transcriptome, which in turn leads to metabolic changes. 
Unlike structural genes that control individual pathway steps, TFs tend to regulate 
multiple pathway steps in metabolic pathways. Therefore, TF bioengineering would 
avoid the time-consuming steps of characterizing all the enzymes involved in a 
biosynthetic pathway. In addition, it provides powerful tools to overcome flux 
bottlenecks involving multiple enzymatic steps, or to deploy genes involved in 
metabolic pathways in specific organs, cell types and even plant where they normally 
do not express (Broun 2004; Grotewold 2008). 
 
There have been some well-known examples of TF engineering with the aim of 
increasing the production of valuable compounds, which mainly include 
pharmaceutical and health-promoting products. Terpenoid indole alkaloids (TIAs) 
have attracted many attentions from pharmaceutical companies, because several TIA 
compounds are medically valuable. For example, the monomeric alkaloids serpentine 
and ajmalicine are used as a tranquilizer and to reduce hypertension, respectively. 
Moreover, the dimeric alkaloids vincristine and vinblastine are potent anticancer 
drugs (Memelink 2007). In C. roseus, ORCA3, a JA-responsive AP2 TF, has been 
shown to be a central regulator of TIA biosynthesis, and overexpression of this TF 
results in elevated expression levels of STR (strictosidine synthase) and other TIA 
biosynthesis genes and consequently, increased production of TIAs (van der Fits and 
Memelink 2000). Moreover, anthocyanins have been known to have health-
promoting effects due to their high antioxidant activities (Chun et al. 2003). The 
upregulation of the Pr gene, which encodes a R2R3 MYB TF, specifically activates a 
bHLH TF and a subset of structural genes involved in anthocyanin biosynthesis and, 
consequently, leads to accumulation of pigments in the purple cauliflower (Chiu et 
al. 2010). Most strikingly, Butelli et al. (Butelli et al. 2008) reported that the co-
expression of two heterologous TFs (Del and Ros1) isolated from the snapdragon 
Antirrhinum majus resulted in a substantial increase in anthocyanin production in the 
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fruit of transgenic tomatoes. In fact, the ectopic expression of those two TFs up-
regulated a broad range of genes involved in the entire anthocyanin biosynthesis 
pathway, including structural genes required for anthocyanin biosynthesis, genes 
encoding enzymes for side-chain modification and two genes involved in 
transportation of the end-products into the vacuole. Sometimes, however, a target TF 
does not regulate the expression of all the structural genes involved in the metabolic 
pathway, and it needs to be co-expressed with key enzymes that are not regulated by 
this TF in order to achieve the desired flux level through a pathway (Grotewold 
2008). Proanthocyanidins (PAs) are plant antioxidants that confer multiple human 
health benefits, as they give greater and more stable protection against free-radical-
induced oxidative tissue damage than vitamins C or E (Shi et al. 2003). Moreover, 
they can also prevent pasture bloat in ruminant animals (McMahon et al. 2000). 
However, there are no PAs accumulating in vegetative tissue of tobacco. The Xie 
group developed a strategy for engineering PAs in tobacco leaves involving co-
expression of anthocyanidin reductase (ANR) and a PAP1 that encodes MYB TF. As 
a result, the anthocyanin pathway induced by PAP1 in tobacco leaves is diverted into 
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1.9 Strategies for identification and functional analysis of plant TFs  
 
1.9.1 Strategies to identify plant TFs 
 
Traditionally, there are two main routes, through which TFs that have defined 
functions in regulation of secondary metabolism can be identified. One is cloning of 
genes associated with mutations; the other is screening for proteins interacting with 
defined promoter cis-elements. The latter is often used for identification of TFs in 
non-model plants. For example, MYC2/JIN1/JAI1, which encodes a bHLH TF and 
acts as either an activator and a repressor of JA-responsive gene expression in 
Arabidopsis, was first identified by screening mutants with reduced sensitivity of its 
roots to exogenous JA (Berger et al. 1996). In addition, a homolog of AtMYC2, 
JAMYC2 was identified using yeast one-hybrid assays, in which JA-responsive T/G-
box motifs in tomato LAP and pin2 promoters were used as baits to isolate the bHLH 
DNA-binding proteins (Boter et al. 2004). Furthermore, recently, a systematic 
approach to identify plant TFs has been developed. In this approach, the sequences 
of a group of putative TFs with unknown functions are first identified and then the 
TFs are systematically characterised through subsequent analysis, such as promoter 
binding activity, functional studies and phenotypes caused by their expression in 
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1.9.2 Strategies to functionally analyze plant TFs 
 
After a high-throughout identification of sequences encoding putative TFs with 
unknown functions, several strategies have been developed to functionally analyze 
these TFs, including molecular functional analysis, expression analysis, phenotypic 
analysis, bioinformatic analysis and network analysis. These strategies are briefly 
discussed. 
 
1.9.2.1 Molecular analysis 
 
Molecular analysis of TFs is to characterize the activation or repression activities of 
TFs. It employs both reporter and effector genes. The effector gene normally 
contains a TF-coding sequence fused to a heterogeneous sequence that encodes a 
DNA binding domain (DBD), such as GAL4DB from yeast, and this chimeric 
construct is driven by a strong promoter, for example, cauliflower mosaic virus 
(CaMV) 35S. In contrast, the reporter gene is usually the E. coli β-glucuronidase 
(GUS), or HIS3 (Imidazoleglycerol-phosphate dehydratase) in Saccharomyces 
cerevisiae in the case of Y1H assay. This reporter gene is driven by a heterogeneous 
sequence, including a minimal promoter and the upstream cis-elements, which 
consists of binding sequences of GAL4DBD (Fig 4.1). In addition, a reference 
construct, which contains a constitutively expressed reporter gene, is used as a 
control. Then, all three constructs are transformed and transiently expressed in plant 
tissues, such as leaves, leaf protoplasts or cultured cells. Therefore, the TF activity 
(activator or repressor) can be indirectly examined through activity of reporter gene 
(Mitsuda and Ohme 2009). 
 
1.9.2.2 Expression analysis 
 
Expression analysis involves the identification of cells and tissues that express TF-
encoding genes and further analysis of gene expression levels and patterns under 
certain conditions and chemical treatments. Several techniques, with each having 
their advantages and drawbacks, have been developed to establish the gene 
	  
	   64	  
expression profile of a given TF gene, such as quantitative reverse transcription-PCR 
(qRT-PCR), promoter-reporter experiments, in situ RNA hybridization and 
immunohistochemistry (Mitsuda and Ohme 2009).  
 
1.9.2.3 Phenotypic analysis 
 
Phenotypic analysis aims to identify a phenotype that is associated with a TF. 
Therefore, the phenotypes observed in mutants and transgenic plants need to be 
informative so that the biological functions of a given TF can be analyzed from 
them. Usually, the phenotypic changes are induced by either ‘gain-of-function’ or 
‘loss-of-function’ strategies. In the ‘gain-of-function’ method, ectopic expression of 
a targeted TF is used to induce an informative phenotype; conversely, in the ‘loss-of-
function’ method, T-DNA tagging is commonly used to inactivate genes. More 
specifically, RNA interference (RNAi) strategies have been adopted for the 
inactivation of genes of interest (Mitsuda and Ohme 2009).  
 
1.9.2.4. Bioinformatic analysis 
 
Bioinformatic analysis aims to identify and characterise TFs by using bioinformatic 
techniques on a large scale, in which, based on certain properties the proteins have in 
common, the putative TFs are aligned by sequences, grouped and compared with TFs 
with known functions in plant TF databases. These common properties include 
evolutionally conserved domains, subcellular localization, protein-protein 
interactions, miRNAs that regulate putative TFs and spatial and temporal TF gene 
expression profile. In addition to gene expression profiling, co-expression analysis is 
a particularly important strategy used to identify co-expressed genes, and therefore 
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1.9.2.5 Network analysis 
 
The elucidation of a TF regulatory network that regulates biosynthesis of secondary 
metabolites can lead to a more effectively targeted TF bioengineering, and ultimately 
increased yield of important medical molecules. The most recent and rapidly 
emerging technology that has great potential to unravel transcriptional regulatory 
networks is a combination of chromatin immunoprecipitation (ChIP) with either 
whole genome tiling arrays or next-generation sequencing technology (ChIP-chip or 
ChIP-seq). The application of ChIP confirms that TFs bind directly to the promoter 
region of putative target genes, and sequencing technologies further identify 
comprehensively the sequences of the TF-bound regions (Mitsuda and Ohme 2009).   
 
 
Overall, with the completion of genome of model plants (Arabidopsis and rice) and 
advancements in Next-generation sequencing technology, plant TF isolation can be 
conducted more effectively and globally; as a result, many TFs that regulate 


















	   66	  
1.10 Summary 
 
Despite extensive strategies for increasing paclitaxel yield to end the shortage of 
paclitaxel supply, T. cuspidata CMC has been proved to be a better-performing line, 
and subsequent cell culturing could provide an efficient, environment-friendly and 
sustainable platform to produce paclitaxel and its related precursors. The paclitaxel 
yield could be further improved using molecular approaches. Although a few 
paclitaxel biosynthesis pathway genes have been identified through the homology-
based PCR approaches, there are still more metabolic pathway genes needed to be 
uncovered. The attempts to increase the paclitaxel yield by bioengineering a known 
rate-limiting pathway gene in heterologous microorganisms (taxadiene synthase or a 
P450-mediated 5α-oxidation of taxadiene) cannot produce a significant increase in 
paclitaxel yield (Ajikumar et al. 2010; Huang et al. 2001; Yamin Wei 2012). Hence, 
more key pathway genes need to be engineered to achieve an outstanding increase in 
paclitaxel production. In addition, the upregulation of taxane biosynthesis pathway 
gene expression is not the only contributing factor that leads to the increased 
paclitaxel accumulation, because the differences in pathway genes are minor 
between high and low paclitaxel-accumulating MeJA-elicitated cultures. This 
indicates that there are additional factors that contribute to paclitaxel accumulation 
(Patil et al. 2012).  The transcriptional regulators could be the potential targets, 
because it has been shown that overexpression of one or two master regulators can 
up-regulate most of the pathway genes and ultimately lead to a significant increase in 
the end products production (Butelli et al. 2008; Grotewold 2006). So far, there has 
been no paclitaxel pathway-specific TFs reported to up-regulate the entire pathway. 
Therefore, the prior step of my project is to identify and characterize TFs involved in 
controlling paclitaxel biosynthesis pathway, followed by elucidation of the TF 
regulatory network and targeted TF bioengineering to redirect the pathway flux 
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1.11 Aims of my PhD project 
 
A cambial meristematic cell (CMC) line of Taxus cuspidata has been isolated, 
cultured and demonstrated to be a cost-effective and environmentally friendly 
platform for the sustainable production of the key anticancer drug, paclitaxel (Lee et 
al. 2010). In my project, we aim to identify the transcription factors (TFs) that 
regulate the expression of paclitaxel biosynthetic genes using gene expression 
profiling followed by yeast one-hybrid analysis, gel shift assays and plant transient 
expression assays. The elucidation of a TF regulatory network that controls 
paclitaxel biosynthesis will guide the rational engineering of CMCs to ultimately 
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Chapter 2 MATERIALS and METHODS 
 
2.1 Cell suspension cultures of cambial meristematic cells and 
somatic cells  
 
The medium (pH 5.5) used for culturing both cambial meristematic cells (CMCs) 
and somatic cells (SCs) consists of two parts: one part, which needs to be autoclaved, 
contains1011.1 mg/L KNO3, 121.56 mg/L MgSO4.7H2O, 10 mg/L MnSO4.4H2O, 2 
mg/L ZnSO4.7H2O, 0.025 mg/L CuSO4.5H2O, 113.23 mg/L CaCl2.2H2O, 0.75 mg/L 
KI, 0.025 mg/L CoCl2.6H2O, 130.44 mg/L NaH2PO4.H2O, 3.0 mg/L H3BO3, 0.25 
mg/L Na2MoO4.2H2O, 36.7 mg/L FeNaEDTA, 100 mg/L myo-inositol, 10 mg/L 
thiamine-HCL, 1 mg/L nicotinic acid, 1 mg/L pyridoxine-HCL, 133 mg/L aspartic 
acid, 175 mg/L arginine, 75 mg/L glycine, 115 mg/L proline and 1 mg/L picloram; 
the other part contains 0.5 mg/L gibberellic acid, 100 mg/L ascorbic acid, 150 mg/L 
citric acid, and 2% sucrose, which is filtered into the first part after autoclaving it. 
All chemicals used for culturing were ordered from Duchefa. Both CMCs and SCs  
were originally cultured in Unhwa Company in South Korea, delivered and cultured 
in our lab. In the initial inoculation, 4 ml of cells was cultured in 40 ml of culturing 
medium (cell: medium volume is 1: 10) in 100 ml conical flasks. When changing 
medium for subculturing after 12 days, one quarter of the old medium (including cell 
sediment) was inoculated with three quarters of freshly prepared medium in 100 ml 
conical flasks. After subculturing, the cell suspensions were shaken at 100 rpm in 24 
hour dark at 21°C (Lee et al. 2010). The cultured CMCs and SCs were induced by 
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2.2 Gateway cloning system  
 
Gateway cloning strategy (Life technologies) is an endonuclease digestion and 
ligation-free cloning technique, and it involves site-specific recombination and is a 
powerful method for cloning of PCR products and analysis of gene function. It 
shows a rapid and efficient cloning of PCR products with >99% of positive colonies. 
This cloning system consists of two site-specific recombination reactions: BP and 
LR reactions. In BP recombination reaction, PCR products or genes of interest 
flanked by attB1 and attB2 recombination sites recombine with pDONR vectors to 
generate Entry clones (pENTR), in which, PCR products of genes of interest are 
flanked by attL1 and attL2 recombination sites. The subsequent LR recombination 
reaction involves the attL sites recombine with attR sites in Destination vector 
(pDES) to generate expression clones (Fig 2.1) (GatewayTM Cloning Technology 
Instruction Manual).  
 
In BP reactions, 3 µl of attB site-flanked PCR products of TFs was mixed with 1 µl 
of pDONR, for example, pDONRTM 221 (Fig 2.2b), in the presence of Gateway® BP 
clonase II Enzyme Mix (Life technologies). The mixture was incubated at 25°C for 1 
hour, followed by introduction into E. coli strain, XL1-blue competent cells. In LR 
reactions, 3 µl of pENTR generated from BP reaction was mixed with 1 µl of pDES 
vector (pGAD424gatelapau) (Fig 2.2c) in the presence of Gateway® LR clonase II 
Enzyme Mix (Life technologies). The mixture was incubated at 25°C for 1 hour, 
followed by introduction into E. coli strain, XL1-blue competent cells. Positive 
colonies from BP and LR reaction were selected on kanamycin and ampicillin plates, 
respectively (GatewayTM Cloning Technology Instruction Manual). This cloning 
system was used to facilitate the cloning of both TF encoding genes and promoters in 
the Y1H and plant transient expression assays. AttB and attP in BP reaction and attL 
and attR in LR reaction are two pairs of recombination sites. Site-specific 
recombination can occur between these two sites in each pair in the presence of the 








Fig 2.1 Gateway cloning system (GatewayTM Cloning Technology Instruction 
Manual). BP reaction takes place between attB-sited gene products and pDONR 
vectors in the presence of BP clonase, and pENTR vectors are the products (upper 
panel). LR reaction takes place between pENTR and pDES in the presence of LR 
clonase, and the products are expression vectors (lower panel). Knr: Kanamycin 
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2.3 Gateway-compatible Yeast one-hybrid assay 
 
Yeast one-hybrid (Y1H) assay was used to screen for interactions between 5 
paclitaxel biosynthetic gene promoters and 19 putative transcription factors in yeast 
strain, YM4271. Two vectors were made for this assay. One is the promoter-reporter 
construct, pHISi. Each of the five promoter fragments was inserted upstream of the 
His3 reporter gene at the multiple cloning site (MCS) through conventional cloning 
strategy (Fig 2.2a). All five paclitaxel biosynthesis gene promoters were amplified 
from the genomic DNA of CMCs using primers (SI table 4), which were designed 
according to the published promoter sequences on NCBI 
(http://www.ncbi.nlm.nih.gov/nuccore/?term=taxus+cuspidata). The positive colony 
was then selected on ampicillin (Amp) plates. The promoter-HIS3 vector was further 
linearized at Xho I site and integrated into yeast genome to construct HIS3 reporter 
strains. The PminHIS3 enables HIS3 to be constitutively expressed at a very low 
level in the absence of target elements; however, the level of HIS3 expression is low 
enough to allow yeast transformants integrated with HIS3 reporter vectors to grow on 
URA3 synthetic drop-out (SD/URA3-) plates when constructing reporter strains. 
Therefore, the HIS3 background can be eliminated by 3-AT. The other is the TF 
expression construct, pGADgate424 lapau. This vector was constructed by cloning a 
gateway cassette B into the pGAD424 backbone at Sma I site via blunt-end ligation 
(Fig 2.2c). This allows the cloning of TF open reading frames (ORF) downstream of 
GAL4 activation domain (AD) driven by PADH1 through the gateway cloning 
strategy (Deplancke et al. 2004; Hens et al. 2012). The resulting recombinant protein 
(GAL4-TFs) expression construct was introduced into yeast reporter strains by yeast 
transformation, and the transformants were selected on SD/Leu- plates (CLONTECH 
MATCHMAKER One-Hybrid System User Manual PT1031-1). All 19 putative TFs 
were isolated from the cDNA library of CMCs (Thomas Waibel). These primers are 
gateway-compatible and designed according to the TF sequecnes obtained from 454 
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Fig 2.2a Map of pHISi (CLONTECH MATCHMAKER One-Hybrid System User 
Manual PT1031-1). The Multiple Cloning Site (MSC) is upstream of the HIS3 
reporter, into which the promoter fragments are inserted. Xho I is the site for 
linearization, followed by integration into YM4271 genome. PminHIS3 drives 
minimal constitutive HIS3 expression. AmpR allows for E. coli selection on 
ampicillin plates when constructing HIS3 reporter vectors. URA3 is the selection 






















Fig 2.2b Map of pDONRTM 221 (Life technology). cddB is flanked by attP1 and 
attP2 and a lethal gene to E. coli. CmR: chloramphenicol resistant gene; kanamycin: 
kanamycin resistant gene; T1 and T2 are rrnB T1 and T2 transcription termination 




























 Fig 2.2c Map of pGADgate424 lapau (CLONTECH MATCHMAKER One-Hybrid 
System User Manual PT1031-1). PADH1 is a constitutive promoter and drives the 
expression of GAL4 AD-TFs fusion protein. Ampr allows for E.coli selection on 
ampicillin plates when constructing the Gal4 AD-TF expression vector. Leu2 is the 
selection marker for yeast transformation when transforming the recombinant protein 
expression vector into yeast reporter strains. AmpR: ampicillin resistance; ADH1: 
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2.3.1 Yeast transformation 
 
Yeast strain used for transformation was YM4271 (His-, Leu-). YM4271 was 
cultured in 5 ml YPDA medium overnight. Then, ~3-4 ml of the overnight culture 
was diluted in 40 ml of YPDA and further incubated for 3 to 4 hours in a 30°C 
shaker. After incubation, it was centrifuged at 1000g for 5 minutes. The supernatant 
was discarded and the pellet was washed with 40 ml H2O. Finally, the yeast pellet 
was resuspended in 600 µl of 0.5xTE/1xLiAc solution (200 µl of 3M Lithium acetate, 
100 µl of 10x TE PH 7.5 and 1.7 ml of H2O) to make yeast competent cells. 15 µl of 
plasmid DNA was mixed with 20 µl of denatured salmon sperm, 125 µl of yeast 
competent cells and 600 µl of 1xPEG/LiAC (8 ml of 50% PEG, 1ml of 10xTE PH7.5 
and 1ml of 10xLiAc PH 7.5). The transformation mixture was then incubated for 60 
minutes in a 30°C shaker. After incubation, 75 µl of DMSO was added into the 
mixture, followed by heat-shock for 40 minutes at 42°C. The heat-shocked mixture 
was incubated on ice for 2 minutes, followed by centrifugation at 14,000 rpm for 5 
seconds. Finally, the pellet was resuspended in 200 µl of autoclaved H2O and the 
whole suspended solution was plated on synthetic drop-out medium, followed by 
incubation at 30°C for 2-3 days (CLONTECH MATCHMAKER One-Hybrid 
System User Manual PT1031-1). 
 
2.3.2 Yeast spotting assay 
 
When screening the library of 19 putative TFs for their interactions with 5 promoter 
fragments, the background expression of HIS3, which is caused by the constitutive 
PminHIS3, is controlled by adding 3-Amino-1,2,4-triazole (3-AT). 3-AT is a 
competitive inhibitor of the product of the HIS3. Because it is heat-labile, it must be 
added into the autoclaved and cooled SD medium (~55°C). In this assay, the 
concentration of 3-AT used to test background HIS3 expression of HIS3 reporter 
strains is 45mM. According to the protocol, if yeast reporter strain only grows on 
SD/His- and <45 mM 3-AT, it indicates that the background HIS3 expression is low, 
and therefore, this strain can be used for the second transformation with TF 
expression vectors. A single colony of yeast reporter strain was picked up and 
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suspended in 1 ml of TE buffer, then, a series of dilutions (0, 10-1, 10-2 and 10-3) 
were made. Furthermore, 5µl of each dilution was dropped onto SD/His- and 45 mM 
3-AT plates, which were then completely dried and incubated at 30°C for 4-5 days 
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2.4 Cre/loxP recombination and gateway-based plant transient 
expression assays 
 
Cre/loxP recombination engineering is used to recombine a binary promoter-reporter 
plasmid (pMDC162) (Fig 2.3a) with a TF expression vector (pJET1.2GWTF) (SF 4) 
through the loxP site (Nagy 2000; Shigaki et al. 2005). The resulting construct 
contains two independent gateway-compatible cassettes: one is the promoter-reporter; 
the other is the protein expression cassette. First of all, a protein expression cassette 
was amplified from pMDC32 (Fig 2.3b) and cloned into pJET1.2 backbone through 
blunt-end ligation. Then, a 34-base pair loxP site was inserted into each of the two 
vectors through digestion and ligation method. A loxP site was cloned into 
pMDC162 at Pac I site (Fig 2.3a), whereas it was cloned into pJET1.2GWTF at Cla 
I site (Fig 2.3c). The loxP fragment was directly synthesized using the overlapping 
primers (SI table 4). After confirming the presence of the loxP site in each vector by 
sequencing, in order to make a positive control for the plant transient expression 
assay, the cddB gene in pMDC162 and pJET1.2GWTF was replaced by the tandem 
repeat of 3xGCCGCC and open reading frame of ORA47 through gateway cloning, 
respectively. In addition to the use of the tandem repeat of ORA47 binding motif, a 
35S minimal promoter (35Sm/-49) is required to initiate reporter gene transcription. 
Therefore, a 51-base pair DNA fragment (35Sm) was directionally inserted upstream 
of 3xGCCGCC repeat at Spe I and Hind III site (Fig 2.3a). The 35Sm fragment was 
directly synthesized using the overlapping primers (SI table 4). Finally, a mixture of 
6 µl of pJET1.2GWORA47-loxP and 2 µl of pMDC162-3xGCCGCC-35Sm-loxP 
was incubated at 37°C for 1 hour in the presence of 2 µl of Cre recombinase (New 
England Biolabs). The mixture was then introduced into E. coli XL1-blue by 
transformation, and positive colonies were selected on ampicillin and kanamycin 
double selection plates. The recombinant plasmids (Fig 2.3d) were extracted using 
GeneJET Plasmid Miniprep kit (Thermo Scientific) and introduced into 
Agrobacterium (GV3101) through Agrobacterium transformation for 











Fig 2.3a Map of pMDC162-loxP-35Sm. It contains a promoter-reporter cassette 
(attR1-cddB-attR2-gusA-nosT). loxP is inserted at Pac I site. 35Sm is cloned at Spe I 
and Hind III. nosT: nos terminator GUS: beta-glucuronidase. 35Sm: cauliflower 
mosaic virus (CaMV) 35S minimal promoter. AmpR: ampicillin resistance. KanR: 
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Fig 2.3b Map of pMDC 32 (Tair: The Arabidopsis Information Resourse). A protein 
expression cassette, 2x35S-attR1-cddB-attR2-nosT, was amplified and cloned into 
pJET1.2 backbone to give rise to pJET1.2GWTF (Fig 2.3c). nosT (highlighted in 
yellow box): nos terminator; 35S (highlighted in blue box): cauliflower mosaic virus 
(CaMV) 35S promoter. KanR: kanamycin resistant. HygR: hygromycin resistance. LB: 








	   80	  
 
 
Fig 2.3c Map of gateway-compatible protein expression plasmid. The expression 
cassette (2x35S-attR1-cddB-attR2-nosT) is cloned into the backbone of pJET1.2. 
LoxP site is inserted at Cla I. 2x35S: cauliflower mosaic virus (CaMV) 35S promoter. 
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Fig 2.3d Map of a recombinant plasmid made by fusing pMDC162-loxP-35Sm (Fig 
2.3a) with pJET1.2GWTF-loxP (Fig 2.3b) through loxP sites. It includes a TF 
expression cassette (2x35S-attR1-cddB-attR2-nosT) and promoter-reporter cassette 
(attR1-cddB-attR2-GUS-nosT). p35S: cauliflower mosaic virus (CaMV) 35S 
promoter. T35S: CaMV 35S terminator. nosT: nos terminator GUS: beta-
glucuronidase. -49: 35S minimal promoter. SpR: spectinomycin resistant. HygR: 
hygromycin resistance. AmpR: ampicillin resistance. KanR: kanamycin resistance. 
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2.5 Multi-gateway based plant transient expression assay 
 
Because the Cre/loxP recombination based construction of a recombinant plasmid 
did not work (chapter 5), a multi-gateway cloning vector was constructed by cloning 
an expression cassette into the backbone of a binary gateway vector, which already 
contains a reporter cassette. Therefore, the resulting construct contains two gateway 
cassettes, and these two cassettes are flanked by two different sets of attR sites. The 
TF expression cassette is flanked by attR4 and attR3 sites, and the reporter cassette is 
flanked by attR1 and attR2 sites (Fig 2.4c). This allows a simultaneous cloning of TF 
encoding genes and promoter fragments into their corresponding cassette in the same 
vector. A p35S-R4-cddB-R3-t35S TF expression cassette was amplified from 
pK7m34GW2-8m21GW3,0 (Fig 2.4 a) (VIB) using both F_Sac I and R_Sac I 
primers   (SI table 4) and subsequently cloned into a binary GUS reporter vector, 
pHGWFS7,0 (Fig 2.4 b) at Sac II site. As a result, the recombinant vector contains 
both p35S-R4-cddB-R3-t35S TF expression cassette and promoter fragments-R1-
cddB-R2-GUS reporter cassette (Fig 2.4 c). Therefore, each of 5 promoter fragments 
and 19 putative TFs can be simultaneously cloned into the two-gateway cloning 
pDES vector through pDONR_P4-P3 and pDONR_P2-P1 (Fig 2.2b & 2.4d) (Life 
technology). In total, there were 95 constructs made to screen for TF-DNA 
interactions in plant transient expression assays. Before screening, a positive control 





















Fig 2.4a (VIB, a life sciences research institute, based in Flanders, Belgium) Two-
gateway TF expression binary vector, pK7m34GW2-8m21GW3,0. It includes two 
TF expression cassettes: pROLD-attR1-cddB-attR2-tOCS and p35S-attR4-cddB-
attR3-t35S. p35S-R4-cddB-R3-t35S TF expression cassette is amplified and cloned 
into the backbone of pHGWFS7,0 (Fig 2.4b) to make a two-gateway construct (Fig 
2.4c). p35S: cauliflower mosaic virus (CaMV) 35S promoter. T35S: CaMV 35S 
terminator. GUS: beta-glucuronidase. SpR: spectinomycin resistance. HygR: 
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Fig 2.4b (VIB, a life sciences research institute, based in Flanders, Belgium) Map of 
gateway-compatible promoter-reporter binary vector. A gateway-compatible TF 
expression cassette is cloned at Sac I site to make a two-gateway recombinant 
construct (Fig 2.4c). T35S: cauliflower mosaic virus (CaMV) 35S terminator. GUS: 
beta-glucuronidase. SpR: spectinomycin resistance. HygR: hygromycin resistance. LB: 

















Fig 2.4c Map of two-gateway plant binary vector. It includes a TF expression 
cassette (p35S-attR4-cddB-attR3-t35S) and a promoter-reporter cassette (attR1-
cddB-attR2-gus-T35S). The ORA47 TF and tandem repeats of AP2-binding motif 
(GCCGCC) replace cddB in TF expression cassette and cddB in promoter-reporter 
cassette through gateway cloning system, respectively. p35S: cauliflower mosaic 
virus (CaMV) 35S promoter. T35S: CaMV 35S terminator. GUS: beta-glucuronidase. 
SpR: spectinomycin resistance. HygR: hygromycin resistance. LB: left border. RB: 








Fig 2.4d Map of pDONR_P3-P4 (Life technology). cddB is flanked by attP3 and 
attP4 and a lethal gene to E. coli; CmR: chloramphenicol resistant gene; Kan(R): 
kanamycin resistant gene; T1 and T2 are rrnB T1 and T2 transcription termination 
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2.6 PCR-based synthesis of tandem repeats of TF-associated DNA 
binding motifs 
 
In order to enhance the binding effect of between ORA47 (AP2 type TF) and plox3 
(promoter of lipoxygenase gene), the tandem repeats of AP2-associated motif 
(GCCGCC) (<100 base pairs) were directly synthesized from primers by PCR 
amplification (SF 1). When designing primers, it is important to have overlapping 
base pairs between the forward and reverse primer (SI Table 4). The 50 µl PCR 
mixture contained 10 µl of Phusion buffer (5x), 2 µl of dNTPs (10 µM), 2 µl of each 
forward and reverse primer (10 µM), 0.3 µl of Phusion® High-Fidelity DNA 
polymerase (New England Biolabs®) and dH2O (33.7 µl). In addition, the PCR 
condition shown in Table 5. 
. The PCR products were then purified using GeneJET PCR purification kit (Thermo 
Scientific) and run on 2% agarose gel to check the quality.  The PCR products were 
also cloned into a sequencing vector pJET1.2 using CloneJET PCR cloning kit 
(Thermo Scientific) and introduced into E. coli XL1-blue by transformation. The 
plasmids were extracted using GeneJET Plasmid Miniprep kit (Thermo Scientific) 
and sequenced using pJET1.2 Sequencing Primers (Thermo Scientific) in the Gene 
pool sequencing centre in Ashworth at King’s Buildings. Using this method, the 34-
bp loxP, 51-bp 35S minimal promoter and attB1-3xGCCGCC-35Sm were also 
synthesized and confirmed by sequencing (SF 1, 2 & 3). 
 
Table 5 PCR conditions used in PCR-based synthesis of short DNA fragments 
 
PCR conditions for synthesis of short DNA fragments 
Steps Temperatures Time  
1 98°C 1 min  
2 98°C 10 sec 
3 42°C 10 sec 
4 72°C 10 sec 
Step 2 to 4 is 
cycled for 5 
times 
5 98°C 10 sec 
6 55°C 10 sec 
7 72°C 10 sec 
Step 5 to 7 is 
cycled for 30 
cycles 
8 72°C 10 min  
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2.7 Agrobacterium-mediated plant transient expression assay  
 
 
2.7.1 Agrobacterium transformation 
 
The freeze-thaw method was used for transformation of Agrobacterium GV3101. 
Two constructs (pTEA-ORA47-3xGCCGCC-35Sm-GUS and pTEA-3xGCCGCC-
35Sm-GUS) for plant transient expression assays were introduced into GV3101 by 
this method. Firstly, the competent Agrobacterium was thawed on ice, and 10 µl of 
plasmid DNA was added to 250 µl of the thawed Agrobacterium. Secondly, the 
mixture was incubated on ice for 5 minutes, then transferred into liquid nitrogen for 
5 minutes and finally incubated in a 37°C water bath for further 5 minutes. Finally, 1 
ml of Luria broth (LB) was added into the mixture, and the whole mixture was 
incubated at 28°C fro 2-4 hours with gentle shaking. Agrobacterium cells were 
collected by spinning briefly in a microcentrifuge and spread on LB agar plates that 
contain the appropriate antibiotic. The plates were incubated at 28°C for two days. 
	  
	  
2.7.2 Preparing Agrobacterium infiltration solution 
 
The transformed Agrobacterium cells GV3101 were grown in 4-5 ml of YEP 
medium for 1-2 days until the culture became cloudy. Then, the culture was 
centrifuged at 2500 rpm for 10-15 minutes at 4°C, and the pellet was resuspended in 
1 ml of infiltration medium. The infiltration medium contains 1M MgCl2, 0.5M 
MES, and 10mM acetosyringone. The absorbance at 600 nm of a 1 in 100 dilution of 
cells was measured and the OD of the original culture was calculated by multiplying 
the OD value by 100. The working solution with OD at 600 nm equalling 0.1 was 
therefore made from the original culture by calculating the dilution factors. After 
preparing the infiltration solution with OD600=0.1, the samples were kept in dark for 
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2.7.3 Infiltrating Agrobacterium into epidermal layer of tobacco leaves 
 
Tobacco leaves were chosen from healthy plants grown for 2-3 weeks in the growth 
chamber. Before infiltrating, the leaf sector was labelled for ease of identification. 
Then, a small region on abaxial side of the leaf to be infiltrated was gently rubbed to 
remove the wax cuticle with a small needle for ease of infiltration. The suspended 
Agrobacterium solution was taken up by 1ml syringe (no needle). The tip of the 
syringe was placed against the leaf over the rubbed area. The plunger was then 
gently pressed down while the adaxial side of the leaf being supported with fingers. 
After infiltrating, the infiltrated areas were outlined. Finally, the infiltrated plants 
were incubated in a growth cabinet for 48 hours to allow GUS gene expression 




2.8 GUS staining 
 
The Agrobacterium-infiltrated tobacco leaves were first incubated with solution 1 
(0.05 M NaHPO4, 0.3% formaldehyde, 0.5 mM K3Fe(CN)6, 0.5 mM K4Fe(CN)6, 1 
mM EDTA and1% Triton X-100) at room temperature, and the solution 1 was 
removed after 1 hour. After rinsing the leaves with H2O, the leaves were then 
incubated with rinsing solution (0.05 M NaHPO4, 0.3% formaldehyde, 0.5 mM 
K3Fe(CN)6, 0.5 mM K4Fe(CN)6 and 1 mM EDTA) for 20 minutes at room 
temperature.  Finally, after removing the rinsing solution, the leaves were incubated 
in staining solution (0.05 M NaHPO4, 0.3% formaldehyde, 0.5 mM K3Fe(CN)6, 0.5 
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2.9 In vitro synthesis of transcription factors by wheat germ extract 
 
TF proteins can be used in gel shift assays to detect TF-promoter interactions. 
Therefore, TF proteins firstly need to be synthesized. However, TF protein synthesis 
in E. coli did not produce a significant amount of protein required for further 
experiments (see chapter 7). So, in vitro protein synthesis by wheat germ extract was 
employed. Compared to protein synthesis in microbial hosts, it only takes one day to 
make a sufficient amount of desired proteins.  The first step was to prepare the 
double-stranded DNA template by PCR. This amplification step consists of two 
round PCRs. The first round PCR added a linker fragment on each end of the open 
reading frame of TF encoding genes. The 50 µl PCR reaction mixture included 5x 
Phusion reaction buffer (10 µl), 4 µl of dNTP mixture (2.5 mM), 2.5 µl of each first 
round forward and reverse primer, template of TF encoding genes (2 µl), 0.5 µl of 
Phusion High Fidelity DNA polymerase (Thermo Scientific) and ddH2O (28.5 µl). 
The first round PCR condition is listed in Table 6. The second round PCR further 
added T7 promoter and flag tag upstream of the open reading frame of TF encoding 
genes. The 50 µl reaction mixtures consisted of 5xreaction buffer (10 µl), 4 µl of 
dNTP mixture (2.5 mM), 2.5 µl of each SpT7u forward (10 µM) and Sp7dFLAG 
forward (100 nM) primer, 2.5 µl of each Reverse_U (10 µM) and deReverse (100 
nM), 0.5 µ of template (PCR product from first round PCR), 0.5 µl of Phusion High 
Fidelity DNA polymerase (Thermo Scientific) and ddH2O (23.5 µl). The second 
round PCR condition is shown in Table 6. The second step was to transcribe double-
stranded DNA into sing-stranded mRNA in vitro. The 25 µl reaction mixture for in 
vitro transcription included 10x transcription buffer (2.5 µl), 2.5 µl of 25mM NTPs, 
RNase inhibitor (0.6 µl), 1.25 µl of 0.1M DTT, 1 µl of 1x T7 RNA polymerase (New 
England Biolabs), 2.5 µl of template (second round PCR product) and 14.65 µl of 
RNase free water (DEPC). The transcription reaction mixture was incubated for 3 
hours at 37°C. After it, 1 µl of the sample was run on agarose gel for checking 
mRNA quantity and quality. Then, 10 µl of 4M ammonium acetate and 100 µl of 
ethanol were added to the sample, mixed, centrifuged for a few seconds and 
incubated at -20°C for 1 hour. After incubation, the sample was centrifuged at 15,000 
rpm for 20 minutes at 4°C, followed by the removal of the supernatant. Finally, the 
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pellet was dried and dissolved in 35 µl of DEPC water. The final step was the 
translation of mRNA into proteins. The 55 µl of translation mixture consisted of 10 
µl of wheat germ extract provided by the Tata lab, 10 µl of translation mixture 
(including 4x amino acid mixture), 35 µl of mRNA. The mixture was incubated at 
16°C overnight. After it, the overnight sample was centrifuged at 15,000 rpm for 10 
minutes at 4°C. The supernatant was collected and stored at -80°C (Fig 2.5) (Tada et 
al., unpublished).  
 
Table 6 PCR conditions for synthesis of double-stranded Taxus TF encoding genes 
for in-vitro protein synthesis by wheat germ (Tada et al., unpublished).  
First round PCR conditions 
1 98°C 30 sec 
2 98°C 5 sec 
3 65°C 30 sec 
4 72°C 30 sec 
5 72°C 10 min 
6 4°C  
 
Step 2 to 4 is 
cycled for 40 
cycles 
Second round PCR conditions 
1 98°C 30 sec 
2 98°C 5 sec 
3 65°C 30 sec 
Step 1 to 3 is 
cycled for 10 
cycles 
4 72°C 30 sec 
5 98°C 5 sec 
6 65°C 30 sec 
7 72°C 30 sec 
8 72°C 10 min 
9 4°C  
 
 
Step 4 to 6 is 














Fig 2.5 (Tada et al., unpublished) A schematic representation of in vitro protein 
synthesis by wheat germ extracts.  
 
 
2.9.1 SDS-PAGE Gel and Western blots 
 
The wheat germ-synthesized proteins (20 µl for each sample contains 5µl of protein, 
4 µl of SDS, 1 µl of dithiothreitol (DTT) and 10 µl of H2O) were run on 10% SDS-
PAGE (Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis) gel in 1x 
running buffer, which is diluted from 10x stock solution (20 mM Tris from Sigma, 
200 mM glycine from Sigma and 0.1% SDS from Sigma). The method for making 
both stacking and running gel is listed in Table 7. After completion of 
electrophoresis, protein samples on the gel were transferred onto the nitrocellulose 
membrane in 1x transferring buffer (TB) (14.4g of glycine from Sigma, 3.03g of Tris 
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base from Sigma and 200ml methanol from Sigma in 1 L of distilled water). After 
transferring, the membrane was incubated in 25 ml of blocking buffer (BB) for 1 
hour at room temperature (5% w/v milk, 0.1% tween 20 from Sigma and 1x 
phosphate buffered saline (PBS) to adjust the final volume). After washing the 
membrane with BB for three times, 10 minutes each time, the membrane was 
incubated with the primary antibody (anti-FLAG from Sigma) in 1: 5000 dilutions in 
5 ml of BB for 1 hour at room temperature, followed by washing with BB for three 
time, 20 minutes each time. Then, the secondary antibody (anti-mouse IgG from 
Sigma) was applied to incubate with the membrane in 1: 1000 dilution in 10 ml BB 
for 1 hour at room temperature, followed by washing with BB for three time, 20 
minutes each time. Finally, the membrane was washed with PBS twice, 10 minutes 
each time. The membrane was then exposed for 10 seconds before development 
using Konica SRX-101A.  
 
Table 7 The protocol for making stacking/running gel 
 
Ingredients Running gel Stacking gel 
30% acrylamide mix 3.3 ml 0.33 ml 
1.5 M Tris pH8.8 2.5 ml 0.25 ml 
10% SDS 0.1 ml 0.02 ml 
10% ammonium 
persulphate (APS) 
0.1 ml 0.02 ml 
TEMED 0.004 ml 0.002 ml 
H2O 4 ml 1.4 ml 
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Chapter 3 Analysis of MeJA-elicitated transcriptome of 
CMCs 
 
3.1 Experimental design of transcriptomic profiling of MeJA 
induced CMCs 
 
The cell suspension culture (csc) of CMCs from T. cuspidata was the starting 
material for transcriptome sequencing. Prior to MeJA elicitation, the csc of T. 
cuspidata CMCs (5 days after subculturing) was adjusted with fresh medium to 100 
ml from 40 ml of CMC suspension culture and grown for 2 h in the dark to 
acclimatise. The cultures were then treated with 100 µM MeJA. The samples were 
taken in biological triplicates at three post elicitation (p.e.) time points, including 0.5 
h, 2 h and 12 h. In addition, untreated samples taken at 0 h were used as the control. 
The total RNA of each sample (12 in total) was extracted and treated with DNAse. 
These RNA samples were used for Illumina/Solexa sequencing. Furthermore, for 
Roche/454 sequencing, the equal amounts of total RNA were used for subsequent 
preparation steps, including cDNA synthesis and sample normalization (Fig 3.1) 
(Thomas Waibel). Finally, the data generated by these two sequencing technologies 
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3.2 Transcriptome of MeJA elicited CMCs  
 
Provided that contigs show differential gene expression in at least one of the three 
employed post-elicitation time points (0.5h, 2h and 12h), statistical analysis was 
carried out to compare the gene expression of MeJA-treated CMCs at each time 
point with that at 0h. This resulted in a list of 1646 differentially expressed contigs 
with a significant false discovery rate (FDR)<=0.05 (5%) (Simon Tomlison). FDR is 
a statistical method used to correct for multiple comparisons in multiple hypothesis 
testing. It represents the expected proportion of false positive among all statistically 
significant discoveries. In our Solexa data, the transcript counts for each significantly 
induced contig at one-time point are normalised and transformed to transcripts per 
million (TPM). Therefore, FDR (<=0.05) means that less than 50000 counts would 
be expected to be false positive among 1 million of transcript counts, which is 
statistically significant (Benjamini 1995). The data set of 1646 differentially 
expressed genes (DEGs) was used to perform hierarchical clustering analysis, which 
is visualised as a dendrogram and heatmap (Fig 3.2) (Florian Halbritter). Overall, 
this map shows the sample integrity of the biological triplicates, in which all 12 
samples are mapped as close to each other as possible based on the gene expression 
pattern of MeJA-regulated 1646 contigs. In cluster A, all five samples, which include 
CMC #1, #2 and #3 at 0.5h and CMC #1 and #3 at 2h, exhibit relatively similar gene 
expression pattern. In addition, in cluster B, CMC #3 at 12h exhibits the most similar 
pattern to samples in cluster A. In contrast, CMC #2 shares less similarity with 
samples in clade A. All three CMC samples at 0h in cluster C exhibit relatively 
similar gene expression pattern between each other. However, the gene expression 
pattern of CMC #2 at 2h and CMC #1 at 12h is exceptionally different from that of 













Fig. 3.2 Heatmap and dendrogram of 1646 DEGs identified in response to MeJA 
treatment in biological triplicates at three post-elicitation time points (Florian 
Halbritter). 12 MeJA-induced samples are clustered in 3 clusters based on the gene 
expression pattern of MeJA-regulated1646 contigs. Red indicates up-regulated genes; 
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3.3 MeJA-responsive putative TF encoding genes 
 
In the list of 1646 DEGs, 78 contigs were annotated as putative TF encoding genes. 
Based on the conserved domains found in their amino acid sequences by using Blast 
in NCBI, these 78 putative TFs were categorised into 19 different TF families (Fig 
3.3a). Among them, the AP2/ERF group has the largest number of members, 
followed by MYB, bHLH, C3H, NAC and LOB TF groups. TF groups that contain 
less than 5 members include WRKY, GRAS, bZIP, E2F, CCAAT, IAA13, GATA, 
Trihelix, PHD, C2H2, ARF, FHA and SBP. In addition, Fig 3.3b shows the number 
of up- or down-regulated TF members in each family. In total, there are 50 up- and 
28 down-regulated TFs, respectively. Among the up-regulated TFs, AP2/ERF (6), 
MYB (7), NAC (5), bHLH (5), LOB (6), C3H (6), WRKY (3), E2F (3) and GRAS 
(3) groups contain at least three members, whereas the rest of groups have only one 
or none.  
 
Apart from Trihelix and SBP TF family, at least one member in each family has been 
assigned with a Gene Ontology (GO) term (Fig 3.3c). In total, there are 51 TFs, each 
of which has more than one GO term assigned. On the basis of GO terms, these TFs 
are further grouped into three different but inter-connected categories: cellular 
location, molecular function and biological process (Fig 3.3d). 36 TFs belonging to 
12 different TF families are all found in these three categories (Fig 3.3e). The GO 
terms assigned to these 36 TFs show that they locate in nucleus (cellular location), 
have DNA binding and transcription factor activities (molecular function) and are 
involved in regulation of transcription (biological process). Together, these indicate 
that these proteins have TF-like properties. In 12 TF families, the AP2/ERF family 
contains 10 members, followed by NAC with 6 members, LOB with 5 members, 
bHLH and bZIP with 3 members each, MYB and WRKY with 2 members each, and 
C2H2, CCAAT, E2F, FHA and GATA with only one member each. A typical TF 
protein contains both a DNA binding and a transcriptional activation or repression 
domain. However, according to the assigned GO terms, one member in AP/ERF, 2 
members in GRAS and one member in IAA13 family show that they are present in 
the nucleus, participate in transcriptional regulation, have transcription factor activity, 
but have no DNA binding activity. Thus, it seems that these TFs contain 
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transcription domain only, and therefore, they might need to interact with other 
proteins that contain DNA binding domains in order to regulate gene expression. 
Meanwhile, these could be assembly errors of sequencing data. Fig 3.3f shows the 
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Fig 3.3a Number of TF members in each of 19 differentially regulated TF families in 





Fig 3.3b Number of up- or down-regulated TF members in each TF family (In total, 
78 putative TF encoding genes) in response to MeJA in CMCs.  
	  





Fig 3.3c Number of MeJA-responsive putative TFs assigned with GO terms in each 
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Fig 3.3d 51 putative MeJA-induced TFs assigned with GO terms are further 
classified into three different categories: (d) biological process, (e) molecular 









Fig 3.3e 36 TFs belonging to 12 TF families are predicted to be involved in MeJA-





In addition, there are 6 ZIM motif-containing proteins annotated as putative JAZ 
proteins. All 6 proteins are up-regulated upon MeJA treatment, and 4 of which are 
assigned with GO terms. As expected, these putative JAZ proteins are found in 
nucleus (Thines et al. 2007) and are able to interact with other proteins involved in 
the regulation of transcription mediated by JA signalling, such as MYC proteins 
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3.3.1 Bioinformatic analysis of MeJA up-regulated putative TFs 
 
Among 36 differentially regulated TF encoding genes by MeJA at all three time 
points (0.5, 2 and 12 h), 22 are up-regulated and 14 are down-regulated (Fig 3.3h). 
15 out of the 22 belong to 5 commonly studied TF families, which have been 
reported to be involved in the regulation of secondary metabolite biosynthesis 
(Martin and Paz-Ares 1997; Mitsuda et al. 2007; Suttipanta et al. 2011; van der Fits 
and Memelink 2000; Zhang et al. 2012). In addition, there are 4 more putative TF 
encoding genes (two AP2/ERFs and two MYBs), which are not assigned with GO 
terms but are also significantly induced by MeJA. Furthermore, these genes blasted 
using Blastp in NCBI all show high E-values (<e-04) and contain conserved DNA 
binding domains (DBD) in their amino acid sequences. Therefore, in total, there are 
19 MeJA up-regulated genes that encode putative TFs (Table 8). The Solexa data 
show the up-regulation of these genes at the early post-elicitation time points (0.5 h) 
relative to 0 h.  Contig07245 and contig09658 show down-regulated gene expression 
at 12 h, whereas the rest of all contigs show up-regulated gene expression at all three 
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Fig 3.3f Number of up- and down-regulated TF members in each family (In total, 36 
putative TF encoding genes are found in all three sub-categories based on their GO 
terms) upon MeJA treatment. 
 
 
Table 8 19 MeJA up-regulated putative Taxus TF encoding genes were selected for 
biological assays based on E-values. They are obtained using BLASTp to blast their 
amino acid sequences against GeneBank non-redundant protein sequences in 
National Centre for Biotechnology Information (NCBI). 
(http://blast.ncbi.nlm.nih.gov/). This program can find similar protein sequences to 
the target sequence. The S score is a measure of the similarity of the query to the 
sequences shown in the blasted list. The E-value is a measure of the reliability of the 
S scores, and it is defined as the probability due to chance, that there is another 
alignment having a similarity greater than the given S score. The threshold for E-
value in my analysis is e-04=(10-4) or lower. Therefore, an E<e-04  of an alignment 
means that this alignment is highly unique. The E-values for 19 putative Taxus TFs 
are equal to or less than the threshold, which indicates that the corresponding 
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03304* ethylene-responsive transcription 




04485 ethylene-responsive transcription 





07245* AP2/ERF domain-containing 























12379 Tannin-related R2R3 MYB 





10385 R2R3-MYB transcription factor 
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08058 JAMYC [Taxus cuspidata] 231 4e-68 
 
bHLH bHLH 
09595 transcription factor WRKY 








transcription factor WRKY 






＊ Indicates genes that are not assigned with GO terms.  
	  




Fig 3.4A Fold change in the expression of 19 putative TF encoding genes belonging 
to 5 different TF families in at least one of the three post elicitation time points (0.5, 
2 and 12 hour) relative to 0 hour. Log FC is the fold change on the log2-scale 
































Fig 3.4B (Rabia et al. unpublished) Confirmation of MeJA-induced expression of 19 
putative Taxus TF encoding genes by RT-PCR. Left panel: contig number of each 
gene; right panel: PCR confirms the induction of 19 putative TF genes by MeJA.  
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In order to further characterise all 19 TFs, the amino acid sequences of those TFs 
from 5 families are aligned with that of well-characterised TFs from corresponding 
TF families using the sequence aligner from Just-bio 
(http://www.justbio.com/index.php?page=aligner) (Fig 3.4C-G). 
 
AP2 TFs are characterised by the AP2 domain present in their polypeptides, and both 
YGR and RAYD elements are located in this domain (Okamuro et al. 1997). The 
amino acid sequences of 6 MeJA-induced putative AP2 TFs are aligned against that 
of the AP2 domain of AtAP2 and NtEREBP (NCBI), respectively (Fig 3.4C-a to f). 
Among them, 4 putative AP2 TFs, which include Contig00499, 22386, 01431 and 
04485, show high sequence similarity with both AtAP2 and NtEREBP in the 
conserved YGR and RAYD elements (Fig 3.4C-a to b). This could indicate that all 4 
TFs are AP2-like and EREBP-like proteins. In contrast, Contig03304 only shows 
sequence similarity in the RAYD element when aligned with AtAP2, but the YGR 
region is missing (Fig 3.4C-c). In addition, when aligned with NtEREBP, the YGR 
element in Contig03304 is highly conserved, but the RAYD element is partially 
conserved (Fig 3.4C-d). This could indicate that Contig03304 is more closely related 
to NtEREBP, and it is a more EREBP-like TF. Interestingly, when aligned with 
AtAP2, Contig07245 shows partially conserved YRG element but highly conserved 
RAYD element (Fig 3.4C-e). In contrast, it shows the opposite when aligned with 
NtEREBP (Fig 3.4C-f). Therefore, Contig07245 could be either an AP2-like or an 



































Fig 3.4C (a to f) Amino acid sequence alignment of the AP2 domain between 
AtAP2/NtEREBP and 6 putative MeJA-induced AP2 TFs. Brackets indicate the 
location of the two conserved elements in the AP2 domain: YRG and RAYD. 
Brackets indicate location of the conserved YRG and RAYD elements. Red shaded 
boxes highlight regions of sequence similarity. Yellow shaded boxes highlight the 
conserved regions that do not appear in putative AP2 TFs (Contig03304 and 07245). 
Asterisk indicates the conserved single amino acids.  
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NAC TFs are defined by the NAC DNA-binding domains located at the N-terminal 
of the peptides. When the amino acid sequences of OsNAC6, AtANAC019, AtNAM 
and AtNAC1 (NCBI) are aligned against 4 MeJA-induced putative NAC TFs, 
including Contig00172, 08447, 10855 and 05638, all these 4 TFs contain highly 
conserved regions found at the N-termini of NAC proteins (Fig 3.4D-a). Furthermore, 
these conserved regions were also found in the alignment between ANAC019, 055 
and 072 (Tran et al. 2004) and in the NAC domain of NAC proteins from a wide 
range of plant species (Olsen et al. 2005). In contrast, the C-terminal regions are 
highly variable in sequence. They are characterised by the frequent appearance of 
simple amino acid repeats and contain regions that are rich in serine (S) and 
threonine (T), proline (P) and glutamine (Q), or acidic residues (SF 10 a & b). This is 
a common feature of the C-terminal region of NAC proteins (Duval et al. 2002; 
Hegedus et al. 2003; Kikuchi et al. 2000). All these features indicate that these four 
putative TFs are NAC-like proteins. By contrast, the N-terminal region of 
Contig09658 is partially conserved (Fig 3.4D-b). This might indicate that this protein 
has diverged away from the NAC TF FAMILY through evolution.  Finally, all 5 
putative TFs possess a putative nuclear localisation signal (NLS) sequences (Tran et 
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Fig 3.4D (a to b) Amino acid sequence alignment of NAC domain between 
OsNAC6, AtANAC019, AtNAM and AtNAC1and 5 putative MeJA-induced NAC 
TFs. Red shaded boxes highlight regions of sequence similarity. Blue double-headed 
arrow below the sequence indicates putative nuclear localization signal (NLS). 
Asterisk indicates the conserved single amino acids. 
 
 
Most plant MYB genes encode the R2R2-MYB type proteins. They typically contain 
a R2R3 domain, which has an amino acid sequence of -W-(X19)-W-(X19)-W-
….F/I-(X19)-W-(X18)-W- (Dubos et al. 2010). The amino acid alignment of 4 
putative MYB TFs with that of R2R3 domain of EsR2R3-MYB2 and AtR2R3-MYB 
proteins (NCBI) shows that they all contain the conserved sequence of the R2R3 





Fig 3.4E Amino acid sequence alignment of R2R3 domain of MYB TFs between 
EsR2R3-MYB2 and AtR2R3-MYB and 4 putative MeJA-induced MYB TFs. Red 
arrows indicate the conserved amino acid sequence (-W-(X19)-W-(X19)-W-….F/I-
(X19)-W-(X18)-W-) found in R2R3 domain of R2R3-MYB TFs. Asterisk indicates 
the conserved single amino acids. 
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WRKY TFs typically consist of WRKY domains (WRKYGQK) and zinc fingers 
(C2H2 or C2HC). In the amino acid alignment between AtWRKY6, 18 and 60 
(NCBI) and Contig09595 and 19284, both a WRKY domain and a zinc finger are 
found in the two MeJA-induced putative WRKY TFs (Fig 3.4F). This feature defines 
these two proteins as group II WRKY TFs (Eulgem et al. 2000). In addition, there is 
a putative NLS (KKRK) found in the upstream of the WRKY domain in 
Contig19284, but not in Contig09595. This may indicate that it is only Contig19284 
that can be imported into the nucleus.  
 
 
Fig 3.4F Amino acid sequence alignment of WRKY TFs between AtWRKY18, 6 
and 60 and 4 putative MeJA-induced WRKY TFs. Brackets indicate both WRKY 
and C2H2 zinc finger domains. Red and blue arrows indicate C and H residue in the 
C2H2 zinc finger, respectively. Asterisk indicates the conserved single amino acids. 
 
 
bLHLH TFs are featured by a bHLH signature domain that locates at the C-terminal 
region of the peptide. It is about 60 residues long and divided into two distinct 
regions, including a basic at the N-termini and a HLH region at the C-termini. The 
amino acid sequence of the bHLH domain from two putative bHLH TFs is 58-amino 
acids long. After alignment with the bHLH domains of AtMYC2 and 4 (NCBI), they 
show high sequence similarity in the two distinct regions in bHLH domains (Toledo 
et al. 2003) (Fig 3.4G). Furthermore, the highly conserved amino acids found in 
these two TFs are also found in the sequences of a large number of AtbHLH TF 
members (Toledo et al. 2003).  
	  





Fig 3.4G Amino acid sequence alignment of bHLH domain between AtMYC2 and 4 
and 2 putative MeJA- induced bHLH TFs. Brackets indicate the basic and HLH 
regions. Asterisk indicates the conserved single amino acids.  
 
In conclusion, after the sequence alignment with well-known TFs of 5 different 
families, each of 19 MeJA-induced putative TFs has been assigned to a specific TF 
family, which is supported by the fact that the conserved signature domains are 
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3.4 MeJA up-regulated paclitaxel biosynthetic pathway genes 
 
The increased abundances for transcripts of paclitaxel biosynthesis pathway genes 
were first revealed through random sequencing of a MeJA-induced Taxus cuspidata 
cDNA library (Jennewein et al. 2004b). Consistently, the paclitaxel biosynthesis 
pathway genes are also significantly up-regulated after MeJA treatment in at least at 
one of the three post-elicitation time points in our Solexa database. The seven 
pathway genes, which include three early (GGPP, TASY and T5αH) and four late 
(DBAT, PAM, BAPT and DBTNBT) genes, are all significantly induced at least at one 
of the three time points tested (Fig 3.5). Both RNA gel blot analysis and RT-PCR 
results showed that these 7 pathway genes were all up-regulated by MeJA elicitation 
within 6 h in the Taxus cuspidata cell line P991, although the transcript level of 
BAPT and DBTNBT were much lower than that of early pathway genes (Nims et al. 
2006; Patil et al. 2012). Furthermore, the middle pathway genes involved in 
hydroxylation and acyl/benzoyltransfer are also significantly induced by MeJA, 
including T10βH, T13αH, T2αH, T7βH, T14bH and TBT (Fig 3.6). In addition, 
similar results were obtained in the transcriptional profile of Taxus chinensis cells in 
response to MeJA by RNA sequencing and the randomly sequenced cDNA library 
derived from MeJA induced Taxus cuspidata cells (Jennewein et al. 2004b; Li et al. 
2012). Finally, plant multidrug and toxic compound extrusion (MATE) transporters 
encoding genes have been reported to be involved in the transport of secondary 
metabolites. For example, a MATE transporter, which is localized in the vacuolar 
membrane, has been reported to mediate nicotine transportation in Nicotiana 
tabacum (Morita et al. 2009). Another MATE transporter, TT12 from Arabidopsis, 
and its ortholog MATE1 from Medicago truncatula have also been found to facilitate 
the uptake of epicatechin 3'-O-glucoside into the vacuole, which is the precursor for 
proanthocyanidin biosynthesis (Zhao and Dixon 2009; 2010). However, there are no 
MATE encoding genes found in our 1646 annotated contigs. This may indicate that 
MATE is not involved in paclitaxel transportation into vacuoles. Instead, two 
putative ATP binding cassettes (ABC) transporter encoding genes are found to be 
induced by MeJA at all three post-elicitation time points (Fig 3.7). This ABC 
transporter family has been shown to transport a wide range of chemical compounds, 
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including metal ions, auxins and defensive secondary metabolites (Rea 2007). For 
example, a multidrug resistance-associated protein (MRP)-type ABC transporter, 
ZmMrp3, has been reported to be involved in anthocyanin transport in Zea mays. In 
addition, the ZMMrp3 is co-expressed with other anthocyanin structural genes 
(Goodman et al. 2004). Therefore, these putative ABC transporters could be involved 
in mediating the transport of paclitaxel and its precursors, as their encoding genes are 
induced together with the paclitaxel biosynthesis structural genes. The Walker group 
has shown enrichment of not only several known paclitaxel biosynthetic pathway 
genes but also novel transcripts that may be involved in taxane modification 
(acylation and hydroxylation), transport and degradation in the MeJA up-regulated 




Fig 3.5 Fold change in the expression of the early and late paclitaxel biosynthesis 
pathway genes after MeJA treatment at three different post-elicitation time point (0.5, 
2 and 12 hour) relative to 0 hour (Fig 1.6). Log FC is the fold change on the log2-
scale between the normalised and stabilised transcript counts. GGPPS: 
geranylgeranyl diphosphate synthase; TASY: taxadiene synthase; T5αH: taxadiene-
5α-hydroxylase; DBAT: 10-deacetylbaccatin 10β-O-acetyltransferase; PAM: 
phenylalanine aminomutase; BAPT: taxoid C13-O-phenylpropanoytransferase; 
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Fig 3.6 Fold change in the expression of the middle paclitaxel pathway genes after 
MeJA treatment at three different post-elicitation time point (0.5, 2 and 12 hour) 
relative to 0 hour. Log FC is the fold change on the log2-scale between the 
normalised and stabilised transcript counts. T10βH: taxane 10β-hydroxylase; T13αH: 
taxane 13α-hydroxylase; T2αH: taxoid 2α-hydroxylase; T7βH: taxoid 7β-





Fig 3.7 Fold change in the expression of two putative ABC transporter encoding 
genes after MeJA treatment at three different post-elicitation time point (0.5, 2 and 
12 hour) relative to 0 hour. Log FC is the fold change on the log2-scale between the 
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3.5 19 putative TF-associated DNA-binding elements in paclitaxel 
biosynthesis gene promoters 
 
In order to regulate gene transcription, TFs have to interact with DNA by binding to 
the promoter of a given gene via specific binding motifs, which typically contain a 
core sequence of 4-6 nucleotides and are present within the promoter. Each TF 
family has family-specific binding motifs. For example, AP2 and WRKY TFs 
specifically bind to GCCGCC and TTGACC, respectively (Ciolkowski et al. 2008; 
Sakuma et al. 2002). The putative TF binding motifs, which are present within the 
promoters of five paclitaxel biosynthesis genes, are summarised in Table 9. The 
PAM promoter only contains 3 E-boxes. W-box, E-box and MYB binding sites 
(MYBBS) appear frequently in the promoter of TASY, T5αH，DBAT and DBTNBT. 
In contrast, the T/G-box appears only once in the four promoters except PAM and 
GCCGCC is only present in TASY, DBAT and T5αH. The core sequence of the NAC 
binding site (NACBS) is part of the E-box motif if the two middle nucleotides are 
CA (Appendix I). There are reasons that these five genes (TASY, T5αH, DBAT, PAM 
and DBTNBT) were chosen in this project.  They are involved in the early and late 
steps of the paclitaxel biosynthesis pathway (Fig 1.6) (Guerra et al. 2012). In 
particular, TASY-encoding enzyme catalyses the committed step of paclitaxel 
biosynthesis (Wildung and Croteau 1996). In addition, their expression has been 
experimentally shown to be up-regulated by MeJA (Nims et al. 2006; Patil et al. 
2012). Finally, since Taxus spp. is a non-model plant, and therefore its genome is not 
completely sequenced, the promoters of these five genes are the only ones available 
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Table 9 Summary of JA-responsive putative TF associated DNA binding motifs 
present in five paclitaxel biosynthetic gene promoters by searching promoter 
sequences in the database of Plant Cis-acting Regulatory DNA Elements (PLACE) 
(http://www.dna.affrc.go.jp/PLACE/). 
 
Motif Name T/G-box W-box MYBBS NACBS GCCGCC E-box 
Core sequence AAACGTG 
 












1 12 6 3 1 7 
T5αH 
(1611 bp) 
1 10 13 4 1 9 
PAM 
(257 bp) 
0 0 0 1 0 3 
DBAT 
(1433 bp) 







1 3 9 3 0 10 
 
 
The core sequences determine the DNA-binding selectivity of TFs from different 
families. In other words, the TF family to which the corresponding DNA-binding 
proteins for a given motif belong can be predicted. Furthermore, the surrounding 
sequences outside the core motif appear to be important, because they partially 
determine the binding site preferences of the type of TFs from the same family. For 
example, AtWRKY6 and AtWRKY11 have a binding preference to W-boxes that 
contain a G residue directly 5’ adjacent to W-box (5’AGTTGACCAA). In contrast, 
AtWRKY26, 38 and 43 prefer to bind to the same sequence that has a T, C or A in 
the place of this G residue (5’A [T/C/A] TTGACCAA) (Ciolkowski et al. 2008). 
Furthermore, the surrounding sequences also have been reported to be functionally 
important for gene transcription regulation. It has been shown that WRKY53 can 
bind to different promoters that contain W-boxes. However, it can act as either a 
transcriptional activator or repressor depending on the surrounding sequences of W-
boxes (Miao et al. 2004). Since the surrounding sequences required for efficient 
WRKY binding are shown to include 4 bp proximal to and 3 bp distal of W-boxes 
(Ciolkowski et al. 2008), there is assumption that this rule is also applied to other TF 
binding motifs in our database. After aligning all TF binding motif sequences listed 
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in Appendix I, the core sequences of W-boxes (WRKY), E-boxes (bHLH/MYC), 
NACBS (NAC) and GGCGCC (AP2/ERF) are highly conserved throughout all five 
promoters. However, the sequences that surround each core are different both within 
a promoter and between promoters. This could indicate that the DNA-binding 
selectivity of TFs from the same family depends on the surrounding sequences of 
their conserved core binding sequence. In fact, there is more than one MeJA-
responsive TF found in each TF family. For example, the AP2/ERF, NAC, bHLH, 
and WRKY family have 15, 6, 8 and 4 members, respectively (Fig 3.3b).  This might 
indicate that each member of a TF family has their specific binding motif that differs 
in surrounding sequences with each other. Furthermore, the MYBBS are found to be 
variable in both the core and surrounding sequences, which are represented by 
TAAC [T/G] G, GGATA [T/A/G/C], AAACCA, [T/C] [A/G/T/C] GT [T/A] 
[A/T/GG/TC/GT] or C [A/T] A [C/T] C [G/C] A (Appendix I). MYB TF family has 
been known to contain a large and functionally diverse number of TF proteins in all 
eukaryotes. There are 9 MeJA-responsive MYB proteins (Fig 3.3b). They might have 
their own specific DNA-binding motifs that differ with each other in surrounding 
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3.6 Discussion 
 
In conclusion, after bioinformatic analysis of the transcriptome of MeJA-elicited 
CMCs, the expression of 1646 genes is significantly induced by MeJA in at least one 
of the three post-elicitation time points. Based on the conserved TF signature 
domains, 78 genes are annotated as putative TFs. Then, 19 putative TF-encoding 
genes were chosen for further assays, because they are all induced at the early time 
point (0.5h) (Fig 3.4 A) and show high E-values (<e-04) when blasted against the 
database of non-redundant protein sequences of vascular plants (Table 3.1). RT-PCR 
further confirmed their induction by MeJA at all three time points (Fig 3.4 B). 
Finally, the amino acid sequence alignment results show all 19 TFs contain the 
signature domains when aligned with their well-characterised TF counterparts (Fig 
3.4 C-G). Furthermore, a number of known paclitaxel biosynthetic pathway genes, 
including the early, middle and late pathway genes, are also induced by MeJA at the 
early time points (Fig 3.5 & 6). The induction of the early and late pathway genes by 
MeJA was confirmed by RT-PCR in the literature, including GGPP, TASY, T5αH, 
DBAT, PAM, BAPT and DBTNBT (Nims et al. 2006; Patil et al. 2012). Finally, the 
TF associated DNA-binding motifs are found in the promoters of two early and three 
late pathway genes (Table 8 & Appendix I). Collectively, this leads to the prediction 
that these TFs could regulate the expression of these five genes as well as other 
known and unknown paclitaxel biosynthesis pathway genes. Biological assays are 
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Chapter 4 Gateway compatible Yeast One-Hybrid Assay  
 
 
4.1 Experimental design  
 
The Yeast One-Hybrid (Y1H) assay has been widely used as a straightforward 
technique for detecting interactions between DNA fragments and proteins. It has 
been shown to be a rapid and efficient method to screen for transcription factor-DNA 
interactions (Ouwerkerk and Meijer 2011). Therefore, this method was employed to 
detect interactions between 19 putative TFs and five paclitaxel biosynthesis gene 
promoters. Fig 4.1 illustrates the experimental design of Y1H used in my project. 
There were two constructs introduced into the yeast nucleus by transformation. One 
is reporter vector (Ppromoter: His), which is integrated into the yeast genome (Fig 
2.2a); the other is effector vector (PADH1: GAL4AD-TF), which is used to express 
the fusion proteins of GAL4 activation domain and putative TFs (Fig 2.2c). The 
interactions between DNA fragments (promoters) and putative TFs are detected as a 
result of His expression, which enables the yeast to grow on SD/His- medium. In 
addition to the effector construct, the cloning of TFs into this construct is facilitated 
by gateway cloning technology. The TFs are cloned downstream of and in-frame 
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Fig 4.1 Experimental design of Y1H. A linearized Ppromoter: His reporter construct is 
integrated into the yeast genome to make a His reporter strain (1). An effector vector 
(PADH1: GAL4AD-TF) is introduced into the reporter strain (2). If TF proteins bind 
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4.2 Y1H positive control 
 
In order to test if Y1H is a suitable assay to detect protein-DNA interactions, a 
positive control was established for Y1H assay before screening interactions between 
19 putative TFs and paclitaxel biosynthesis promoters. A known interaction between 
AtSTZ/ZAT10 (a C2H2 zinc finger TF of Arabidopsis) and plox3 (the promoter of 
Lipoxygenase 3 in JA biosynthesis) was used as the positive control in Y1H assay 
(Pauwels et al. 2008). 
 
4.2.1 Construction of plox3: His reporter and pADH1: GAL4-STZ/ZAT10 
effector  
 
The construction of Plox3: His reporter vector began with PCR amplification of lox3 
promoter, followed by cloning into pHISi at MCS (Fig 4.2). The size of PCR- 
amplified fragment shown on gel agreed with the 1997 bp-long plox3. The 
enzymatic digestions further confirmed the insertion of plox3 into pHISi. As 
expected, both Xba I and Xho I gave rise to linearized plox3: His. By contrast, Hind 
III digestion resulted in three fragments: 5.6 kb, 3.0 kb and 187 bp. As the smallest 
Hind III fragment is much smaller than the lowest marker (500 bp), which run off the 
gel. Furthermore, the amplification of attB1- and attB2-sited STZ/ZAT10 was 
carried out by a nested PCR (Fig 4.3). Two sets of primers were used to successfully 
amplify the attB1-STZ/ZAT10-attB2 fragment (~0.75 kb). Finally, the STZ/ZAT10 
was cloned into pGADgate424 through gateway cloning.  The insertion of it into 
both pDONR 221 and pGADgate424 (pDES) was detected by PCR (Fig 4.4). As 
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Fig 4.2 PCR amplification and cloning of Plox3 into pHISi. Left panel, PCR 
amplification of ~2.0 kb lox3 promoter (indicated by red arrow); right panel, 
confirmation of cloning of plox3 into pHISi by enzymatic digestion. The red circle 









Fig 4.3 Nested PCR amplification of attB1-STZ/ZAT10-attB2 fragment. Left panel, 
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Fig 4.4 Gateway cloning of STZ/ZAT10 into pGADgate424 (pDES). Temperature 
gradient PCR confirmed the insertion of it into both pDONR 221 (pENTY) and 
pGADgate424 (pDES). 
 
4.2.2 Yeast genomic integration of plox3: His reporter 
 
The YM 4271 yeast strain cannot grow on SD/URA-, LEU- or HIS- plates, as the 
genotype of this strain is Ura-52, His3-200, and Leu2-3. Before transformation of 
plox3: His reporter, the strain can only grow on YPDA plates (Fig 4.5a), but not on 
SD/URA- plates (Fig 4.5b). After transformation, the strain transformed with plox3: 
His reporter can grow on SD/URA- plates (Fig 4.5c). However, it still cannot grow 
on SD/HIS-plates (Fig 4.5d). This indicated that plox3: His reporter was integrated 
into yeast genome, which was further confirmed by PCR amplification of plox3 from 
the genomic DNA extracted from these transformants. Plox3 insertion was detected 
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Fig 4.5 (a-d) Genomic integration of Plox3: His reporter into YM4271. Before 
integration, yeast strain can grow on YPDA (a), but not on SD/URA- (b); after 




   
Fig 4.6 PCR confirmation of genomic integration of Plox3: His reporter into 
YM4271 using extracted genomic DNA from 8 transformants that were selected 
from the SD/URA- plate in Fig 4.5c. 
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4.2.3 Yeast spotting assays 
 
Because of the minimal promoter of HIS3 (PminHIS3) present downstream of plox3, 
which is used for transcriptional initiation, there is a basal His expression after 
genomic integration of plox3. 3-Amino-1,2,4-triazole (3-AT), a competitive inhibitor 
of HIS3 gene products, was used to eliminate the background His expression on 
SD/His- plates before the transformation of the effector vectors. Five plox3: His 
yeast colonies (colony 1, 2, 4, 6 and 8), which were selected from the SD/URA- plate 
in Fig 3.14c, were subject to spotting assays. As a result, colony 1, 4 and 8 showed 
reduced growth as [3-AT] increased from 0 to 30mM.  No growth was found when it 
reached both 45 and 60mM (Fig 4.7). So, all these three colonies showed low 
background of His expression upon inhibition by 3-AT, and therefore, they were 





Fig 4.7 Yeast spotting assay of the positive control on SD/His- plates. Colony 1, 4 
and 8 showed low background of His expression as [3-AT] increased from 0 to 
60mM. 3-AT: 3-amino-1,2,4-triazole.  
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After the selection of Plox3: His reporter transformants that had low background His 
expression, the reporter transformant 1 was transformed with the effector construct 
(pADH1: GAL4AD-STZ/ZAT10) and selected on SD/Leu- plates. 4 colonies from 
SD/Leu- plates were further spotted on SD/His-/60mM [3-AT] plates. As expected, 
the negative controls, which include His-, YM4271 and plox3: His strains, did not 
show any growth. By contrast, like the positive control (His+ strain), all 4 
transformants showed strong growth at three series of dilutions. This indicates that 






Fig 4.8 Spotting assay of yeast strains containing both plox3: His and pADH1: 
GAL4AD-STZ/ZAT10 on SD/His-/60mM [3-AT] plates. As expected, like His+, 
yeast transformants with both constructs grew on SD/His-/60mM [3-AT] plates. In 
contrast, the controls, including His-, YM4271 and YM4271 transformants 
containing only plox3: His, did not grow. 10: 1 is 1 in 10 dilution of yeast strain 
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4.3 Screening for interactions between 19 putative TFs and 5 
paclitaxel biosynthesis gene promoters 
 
 
Following the establishment of the positive control of Y1H, all 5 promoters were 
amplified from the genomic DNA of CMCs and cloned into pHISi reporter vectors to 
make Ppromoter: His reporter constructs (Fig 4.9). There were two DNA fragments 
amplified for the DBAT promoter, because the forward primer sequence was also 
found in the middle of the promoter sequence (Fig 4.9 E). Fig 4.10 shows the 
confirmation of promoter insertions into pHISi through enzymatic digestion of either 
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Fig 4.9 (A-E) PCR amplification of 5 paclitaxel biosynthetic gene promoters. (A): 
PAM (257 bp), (B): TASY (1433 bp), (C): DBTNBT (1665 bp), (D): T5αH (1611 bp), 












Fig 4.10 Confirmation of the insertion of paclitaxel biosynthesis gene promoters into 
pHISi. (a): Hind III-PDBTNBT: His reporter, (b): Hind III-PTASY: His reporter, (c): 
Hind III & Xho I-PPAM: His reporter and Hind III & Xho I-PT5αH: His reporter, (d): 
Hind III & Xho I-PDBAT: His reporter.  
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Five different Ppromoter: His reporter yeast transformants were obtained and 
selected on SD/URA- plates after integrating each of five reporter vectors into 
YM4271 genome. The promoter integration was confirmed by PCR using genomic 
DNA extracted from the five reporter transformants (Fig 4.11). The PCR-confirmed 
positive transformants of each Ppromoter: His reporter were spotted on SD/His-
/various [3-AT] plates to select for transformants with lowest His expression. As a 
result, the growth of the five reporter transformants was suppressed at 0.5mM [3-
TA]. Furthermore, those five promoter-reporter transformants were each transformed 
with PADH1: GAL4-TFs effectors and selected on SD/Leu- plates. PCR further 
confirmed the existence of TFs in each reporter strain (Fig 4.12). Then, the positive 
strains were spotted on SD/His-/0.5, 1.0, 3.0, 5.0, 15, 30 to 45mM [3-AT] plates. 
However, there was no convincing yeast growth on any of the plates with an 
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Fig 4.11 (a-e) Confirmation of integration of five paclitaxel biosynthetic gene 
promoters into the yeast genomic DNA of YM4271 strain by PCR. Five paclitaxel 
biosynthetic gene promoters, including TASY, T5αH, PAM, DBAT and DBTNBT, 
were cloned into pHISi (Fig 4.10). The Ppromoter: His was then linearized by Xho I and 
integrated into YM4271 genome by transformation. Promoter-specific primiers (SI 
Table 4) were used in PCR to confirm the genomic intergration of PTASY: His (a), 





































Fig 4.12 (a-d) Confirmation of introduction of PADH1: GAL4-TFs into each of four 
Ppromoter: His reporter strains by PCR. The effector constructs, PADH1: GAL4-
TFs, were introduced into each of the four different YM4271 promoter reporter 
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strains (Fig 4.11) by transformation. TF-specific primers (SI Table 4) were used in 
PCR to confirm that 13 different PADH1: GAL4-TF effector constructs were 
successfully introduced into PT5αH: His (a), 9 different PADH1: GAL4-TF effector 
constructs were successfully introduced into PPAM: His (b), 12 different PADH1: 
GAL4-TF effector constructs were successfully introduced into PDBAT: His (c) and 8 
different PADH1: GAL4-TF effector constructs were successfully introduced into 
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4.4 Discussion 
 
In conclusion, the positive control of this assay was established; however, this 
system could not be successfully deployed to screen TF-promoter interactions (Fig 
4.10). There was no convincing yeast growth shown for any of the 95 putative TF 
protein-DNA interactions (5 promoters against 19 TFs). One reason could be that 
plant-specific post-translational modifications, such as phosphorylation, are required 
for TF protein binding activity (Ishihama et al. 2011). Some of Taxus TF proteins 
might not be post-translationally modified (PTM) in the yeast system due to the lack 
of plant PTM machineries. Therefore, their DNA binding activity is not activated. 
Another possible reason is that some TFs might require a TF dimer (either 
homodimer or heterodimer) or cofactor to form a higher order protein complex for 
protein-DNA interactions (Bruce et al. 2000; Lai et al. 2011; Xu et al. 2006). As a 
result, false negatives, which cannot be detected in the yeast system, can be 
produced. Because there was only one TF expressed in each promoter-reporter strain, 
a protein-DNA interaction might not be detected in the absence of another one or a 
cofactor. Hence, it might be necessary to co-express two TFs in one type of 
promoter-report strain. A candidate TF dimer, which could be co-expressed, is a 
MYB/bHLH heterodimer or WRKY/WRKY homodimer (Bruce et al. 2000; Xu et al. 
2006). However, a Taxus chinensis WRKY (TcWRKY) has been shown to interact 
with cis-elements present in DBAT promoter by Y1H assay and regulate its 
expression in T. chinensis suspension cells (Li et al. 2013). There could be a 
technical issue that led to the results that no TF-promoter interactions were detected 
in Y1H assay. One possible problem could be that the protein expression vector 
(pGADgate424 lapau), which is designed to express the recombinant proteins, was 
not able to express Taxus TF-GAL4AD recombinant proteins. The evidence for this 
was that only GAL4AD, but not GAL4AD-TF recombinant proteins, was detected 
by western blots (Eunjung et al., unpublished data). Prior to detection of TF proteins, 
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Chapter 5 Gateway-compatible and Agrobacterium-
mediated Plant Transient Expression Assays   
 
Plant transient expression assays (TEAs) have been used to study gene function, such 
as protein-DNA interactions, in planta (Yang et al. 2000). It is a rapid screening 
system for assigning gene function. In addition, this method is frequently used when 
there is a difficulty in producing stably transformed transgenic plants for analysis of 
gene function in planta (Shang et al. 2007). An Agrobacterium-mediated transient 
gene expression assay has been developed for the rapid study of interactions between 
plant transcription factors and promoters in vivo (Yang et al. 2000). Therefore, this 
method might be suitable for screening interactions between 5 paclitaxel biosynthetic 






















	   144	  
5.1 Experimental design 
 
Two gateway-compatible vectors were initially constructed. One was a gateway-
compatible plant promoter-reporter (GUS) binary vector using either the whole 
promoter or tandem repeats of isolated TF binding motifs as the bait, such as repeats 
of the AP2/ERF TF binding sequence (GCCGCC). In the case of tandem repeats, a 
minimal promoter is needed for transcriptional initiation of the GUS reporter gene 
(Fig 5.1b). Another construct is the effector vector for expression of TFs driven by a 
35S promoter. Cre/lox recombination is a site-specific recombination technology. 
The Cre recombinase recombines a pair of target sequences, which is known as the 
Lox sequences (loxP site). The Cre recombinase and loxP sites are originally derived 
from a bacteriophage P1 (Sauer and Henderson 1988). Both constructs in this plant 
TEA contain a loxP site. They were therefore recombined into a single recombinant 
construct through Cre/loxP recombination. The recombinant plasmid was introduced 
into Agrobacterium and then infiltrated into tobacco leaves by Agrobacterium-
infiltration (Fig 5.1a) (Yang et al. 2000). GUS, which encodes the beta-glucuronidase 
from E. coli, is often used in a reporter gene system in transgenic plants (Jefferson 
1989). This enzyme catalyses the hydrolysis of a wide range of glucuronides. In the 
case of 5-bromo-4-chloro-3-indolyl glucuronide (X-Gluc), the product of the reaction 
gives rise to a clear blue colour. GUS is very stable and still active after prolonged 
storage. Plants that express GUS are healthy and fertile (Jefferson et al. 1987). The 
GUS reporter gene system can be used to study in vivo protein-DNA interactions in 
tobacco leaves (Fan and Dong 2002; Yang et al. 2000). Upon GUS expression, which 
can be either visualised or quantitatively analysed (Jyoti Kapila 1997; Yang et al. 
2000), it indicates not only the interaction between plant promoters and TFs, but also 
that the candidate TF is a positive regulator in the regulation of gene expression.
	  




                                                   




Fig 5.1 a: Construction of a plant gateway-compatible recombinant plasmid and 
Agrobacterium-mediated infiltration: a gateway-compatible promoter-reporter 
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(GUS) plasmid is fused with a gateway-compatible TF expression plasmid via the 
loxP site through Cre/loxP recombination. The resulting two-gateway recombinant 
plasmid is introduced into tobacco leaves through Agrobacterium-mediated 
infiltration. b: the construction of the promoter-reporter plasmid in the case of using 
tandem repeats of TF binding motif as the bait. GUS: beta- glucuronidase gene; 35S: 
cauliflower mosaic virus (CaMV) 35S promoter; nosT: nos terminator; -49: 
cauliflower mosaic virus (CaMV) 35S minimal promoter; B1: attB1site (Fig 2.1); B2: 
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5.2 Positive control for plant transient expression assay 
 
The positive control for plant TEA is the already known interaction between ORA47 
(AP2 TF) and plox3 in Arabidopsis (Pauwels et al. 2008). Instead of using the whole 
lox3 promoter, the tandem repeat of AP2 DNA binding motif (GCCGCC) was used 






Fig. 5.2 Construction of the binary vectors for the positive control of plant TEA. The 
two internal control constructs (a & b) and the target construct (c). Two internal 
controls (a & b) are used to eliminate the possibility that the endogenous AP2 TFs 
bind to GCCGCC motif, which results in false positive results. -49: the 35S minimal 
promoter. ORA47: AP2/ERF domain TF protein; GCCGCC: AP2/ERF associated 
DNA binding motif; GUS: beta- glucuronidase gene; 35S: cauliflower mosaic virus 
(CaMV) 35S promoter; nosT: nos terminator; -49: cauliflower mosaic virus (CaMV) 
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5.2.1 Cre/loxP mediated plasmid recombination  
 
Before cloning the ORF of putative TFs and GCC tandem repeats into pJET1.2-GW-
loxP (ampicillin selection) (SF 5) and pMDC162-GW-35Sm-loxP (kanamycin 
selection) (SF 6) through the gateway system, respectively, these two backbones 
were first mixed together to see whether the recombination would occur in the 
presence of Cre recombinase. After Cre recombination, there were a small number of 
colonies growing on both ampicillin and kanamycin double selection plates (Fig 5.3 
c & f), compared to the number of colonies growing on single selection plates (either 
ampicillin or kanamycin) before Cre recombination (Fig 5.3 a & b). This was 
probably because of the low recombinant efficiency (20%-30%). Furthermore, as 
expected, there was no colony growth on double selection plates when only one of 
the plasmids was introduced into the relevant E. coli strain by transformation (Fig 




Fig 5.3 Introduction of pJET1.2-GW-loxP, pMDC162-GW-35Sm-loxP and putative 
recombinant plasmid into DB3.1 E.coli strain, and selection on ampicillin (A), 
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kanamycin (K) and ampicillin and kanamycin (A+K). As expected, transformants 
with pJET1.2-GW-loxP grew on ampicillin plates, but not on ampicillin and 
kanamycin plates (a & d), and transformants with pMDC162-GW-35Sm-loxP grew 
on kanamycin plates, but not on ampicillin and kanamycin plates (b & e). 
Transformants with putative recombinant plasmid of both pJET1.2-GW-loxP and 
pMDC162-GW-35Sm-loxP grew on ampicillin and kanamycin plates (c & f).  
 
 
5.2.2 Evidence for co-existence of two incompatible plasmids within the same 
host  
 
There are three possibilities that would enable the transformants to grow on double 
selection plates after Cre recombination. The first one is that the two plasmids are 
fused into one recombinant plasmid and the recombined plasmid replicates within 
the host. The second is that the two plasmids are not fused together, instead that they 
co-exist and independently replicate within the same host. The third reason is that 
either of the two plasmids or both of them co-exists with the recombinant plasmid 










Fig 5.4 The possible plasmid combinations that exist within the same host after Cre 
recombination, which allows the transformants to grow on kanamycin and ampicillin 
double selection plates. 1=the first possibility; 2=the second possibility; 3=the third 
possibility. 
 
In order to show which of the possible plasmid combinations exists inside the host, 
the putative recombinant plasmids were extracted and digested with Pac I enzyme. 
In theory, Pac I digestion of putative recombinant plasmids (Fig 5.5c), pJET1.2-GW-
loxP (Fig 2.3b) and pMDC162-GW-35Sm-loxP (Fig 2.3a) is supposed to give rise to 
three Pac I fragments (∼13.0, ∼3.1 and ∼2.9 kb) (Fig 5.5c), a single large fragment of 
linearized pJET1.2-GW-loxP (∼6.0 kb) and pMDC162-GW-35Sm-loxP (∼13.0 kb), 
respectively. However, there were two Pac I fragments shown after Pac I digestion 
in 12 samples: the upper band had the same size as the linearized pMDC162-GW-
35Sm-loxP (control 2b Fig 5.5a); the lower band was at the same level as the 
linearized pJET1.2-GW-loxP (control 1b Fig 5.5a). Furthermore, Asc I was also used 
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to digest the putative recombinant plasmids. The result was the same as that of Pac I 
digestion (Fig 5.5c & 5.6). Therefore, it is most likely that the majority of 
transformants had two plasmids co-existing and independently replicating within the 
same host. In addition, both plasmids contain the same replication origins, pBR322. 
Therefore, they are incompatible to each other when replicating in the same host. 
However, it has been shown that two incompatible plasmids are not rapidly lost, but 
are able to persistently replicate for multiple overnight growth cycles (Velappan et 
al. 2007). Furthermore, the small plasmids showed much stronger bands than the 
large ones on a gel; this could be due to the fact that the replication of the small 
plasmid gradually outcompetes the large one (Fig 5.5 a & b). In other words, the 





Fig 5.5 a & b: Pac I-digestion of putative recombinant plasmids, pJET1.2-GW-loxP 
and pMDC162-GW-35Sm-loxP. Control 1a: Uncut pJET1.2-GW-loxP; Control 1b: 
PacI- pJET1.2-GW-loxP; Control 2a: Uncut pMDC162-GW-35Sm-loxP; Control 3b: 
PacI- pMDC162-GW-35Sm-loxP; Control 3: Uncut putative recombinant plasmid. 
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Fig 5.5 c: Map of the recombinant plasmid. Three Pac I sites are highlighted in red 
dotted box; three Asc I sites are highlighted in blue dotted box. The size of three 




Fig 5.6 Asc I-digestion of putative recombinant plasmids and pMDC162-GW-35Sm-
loxP. Control 1: uncut putative recombinant plasmid; Control 2a: uncut pMDC162-
GW-35Sm-loxP; Control 2b: AscI- pMDC162-GW-35Sm-loxP.  
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The co-existence of two independent plasmids within the same host could be firstly 
explained by the fact that the recombination reaction did not take place before 
transformation so that two plasmids were independently co-introduced into the same 
E. coli host. This might be due to that the Cre/loxP recombination system did not 
work at all. Regarding this possible explanation, the insertions of loxP sites into both 
binary vectors were confirmed by analytic digestion as well as sequencing results 
(SF 4 & 5). Furthermore, in order to test whether the inserted loxP site functioned to 
recombine another loxP-containing plasmid in the presence of Cre recombinase, the 
pJET1.2-GW-loxP (AmpR) was chosen to react with pUNI 51 (KanR) through 
Cre/loxP recombination. This was followed by introduction into DB3.1 E. coli 
strains through transformation. pUNI 51 vectors also contain loxP sites and are 
commonly used as shuttle vectors to construct a recombinant DNA without 
restriction enzymes (Liu et al. 1998). As expected, there was no colony growth for 
the introduction of either pUNI 51 or pJET1.2-GW-loxP into DB3.1 on double 
selection plates before Cre/loxP recombination (Fig 5.7 a, b, c & d).  pUNI 51 can 
only be propagated in BW cells (Pir+), but not in DB3.1 (Pir-). Because E. coli needs 
to express the P protein (the pir gene product) for replication of plasmids containing 
the R6kr origin of replication (Yang et al. 2000) and pJET1.2-GW-loxP can only be 
selected on ampicillin selection plates but not on kanamycin selection plates. After 
recombination, the DB3.1 transformants were able to grow on double selection plates 
(Fig 5.7 e). This indicates that the plasmid recombination occurred between the 
inserted loxP site in pJET1.2-GW-loxP and that in pUNI 51 in the presence of Cre 
recombinase. As a result, the fused pUNI 51 was replicated under the replication 
origin contained in pJET1.2-GW-loxP in DB 3.1 cells. Meanwhile, the kanamycin 
resistant gene on pUNI 51 was activated, which allowed the transformants to be 
selected on kanamycin and ampicillin double selection plates. In addition, the 
sequencing results confirmed the appearance of loxP site in both vectors. So, the 
recombination between pJET1.2-GW-loxP and pUNI 51 further confirmed that the 
Cre/loxP recombination system works when a loxP site is inserted into a plasmid. 
Therefore, these observations prove that the inserted loxP allows the recombination 
reaction to take place in the presence of Cre recombinase before transformation.  
 
	  






Fig 5.7 Cre/loxP recombination of pUNI 51 with pJET1.2-GW-loxP. The controls: a, 
b, c & d. e, the growth of DB 3.1 transformed with recombinant plasmid on 
ampicillin (A) and kanamycin (K) double selection plates. As expected, compared to 
the controls, the transformants with recombinant plasmids grew on ampicillin and 




The co-existence of two independent plasmids within the same host could also be 
explained by the fact that the recombination reaction occurred before transformation, 
the recombinant plasmid, however, was not able to replicate itself inside the host. 
This could be caused by the presence of two identical replication origins (pBR322) 
in one recombinant plasmid. However, it has been suggested that in ColE1 plasmid, 
replication initiates at a single pBR322 replication origin even when there are several 
identical potential origins present in the same plasmid. In other words, only one 
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pBR322 replication origin is active per plasmid (Martin et al. 1992).  Therefore, the 
recombinant plasmid (pTEA) might be able to replicate inside the host. 
 
Finally, because the recombinant plasmid contains two identical cddB genes (Fig 5.5 
c), the third explanation could be that homologous recombination most likely 
happened between these two identical sequences; as a result, the recombinant DNA 
was split into two separate plasmids once introduced into DB3.1 competent cells and 
these two dependent plasmids co-existed in the same host. However, the genotype of 
DB3.1 shows this strain is Δ (sr1-recA). Therefore, it has reduced occurrence of 
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5.3 Discussion 
 
Through the Cre/loxP recombination, a recombinant binary vector was constructed 
by recombining a TF expression vector with a promoter-GUS reporter vector in vitro. 
However, instead of the existence of a recombinant vector inside the E. coli after 
transformation, these two plasmids independently co-existed (Fig 5.5 a & b). After 
two possible reasons were eliminated, one possible explanation for this is that there 
could still be a recombination event occurring between two cddB genes present in 
each gateway cassette after introducing the recombined plasmid into DB 3.1 E. coli 
strain, although the genotype of DB 3.1 shows that this strain has reduced occurrence 
of DNA recombination. As a result, two independent plasmids co-existed and 
independently replicated inside the host. Another possible explanation is that there 
were only a tiny minority of cells transformed with recombinant plasmids because of 
a low recombinant efficiency (20%-30%). The transformation efficiency became 
even lower when transforming a large sized vector (the recombinant vector is ~19 
kb) (SI Table 1). Altogether, this resulted in a low possibility of successfully 
screening for colonies that contain the desired recombinant plasmid. Since there were 
16 colonies picked up for extraction of recombinant plasmids, and none of them was 
found to contain the desired recombinant plasmid (Fig 5.5 a & b). Therefore, a 
positive colony could possibly be selected if a large number of colonies were 
screened.  
 
In short, this plasmid construction has two drawbacks: one is the occurrence of 
recombination events; the other is that the size of the recombinant is too large to be 
effectively introduced into Agrobacterium by transformation. Therefore, a more 
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Chapter 6 Technically improved plant transient expression 
assays   
 
The Cre/loxP-mediated plasmid recombination between a gateway-compatible TF 
expression vector (pJET.12GWTF) and promoter-reporter vector (pMDC162-GW-
35Sm) did not work. This might be caused by technical issues, for example, low 
recombination efficiency and homologous recombination. In addition, provided that 
the recombinant could be constructed, the size of which (~ 19 kb) would be too large 
to be efficiently transformed. Therefore, in order to overcome these problems, a 
relatively small sized construct needs to be made, which itself contains both 
gateway-compatible TF expression and promoter-reporter cassettes. In addition, both 
TF-encoding genes and target promoters can be cloned simultaneously, because of 
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6.1 Experimental design 
 
In this technically improved plant TEA, a two-gateway cloning system is formed by 
cloning the entire TF expression gateway cassette, which is amplified from 
pK7m34GW2-8m21GW3,0 (Fig 2.4a), into the backbone of a promoter-reporter 
binary vector, pHGWFS7,0. Therefore, the resulting plasmid contains two gateway 
cassettes. The TF expression cassette, which is driven by a 35S promoter, contains 
attB4 at the left end and attB3 at the right end of a TF ORF sequence. The bait-
reporter cassette contains attB1 at one end and attB2 at the other end of the bait 
sequence (Fig 2.4c and 6.1A). As a result, the cloning of TFs and baits can be carried 
out simultaneously. In the case of using tandem repeats of TF binding motifs as the 
bait, a 35S minimal promoter downstream of the bait is needed to initiate the 
expression of GUS genes. In addition, there is one control construct, which contains 
the bait-reporter cassette (Fig 6.1B). Finally, these two constructs are introduced into 
Agrobacteria by transformation, and the transformed Agrobacteria are infiltrated 




















Fig 6.1 Constructs of Agrobacterium-mediated plant TEA. A: A two-gateway target 
construct. This construct was made by inserting a gateway-compatible TF expression 
cassette (p35S-B4-cddB-B3-t35S) into the backbone of pHGWFS7,0. TF encoding 
genes are cloned through B4 and B3-mediated gateway cloning system, while either 
promoters or tandem repeats is cloned through B1 and B2-mediated gateway cloning 
system. These two reactions can occur simultaneously. B: the internal control, 
pHGWFS7,0. Both constructs are infiltrated into tobacco leaves through 
Agrobacterium-mediated infiltration. -49: 35S minimal promoter; GUS: beta- 
glucuronidase gene. Pr: promoters; TR: tandem repeats; B4: attB4; B3: attB3; B2: 
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6.2 Positive controls for improved plant TEA 
 
The interaction between Plox3 and ORA47 was used as a positive control of plant 
TEA. A tandem repeat of a TF binding motif was used as bait, because tandem 
repeats of a given cis motif result in an increased chance of TF occupancy relative to 
a single motif and hence result in increased reporter gene expression (Yang et al. 
2000). Therefore, three tandem repeats of GCCGCC, the AP2 TF-associated binding 
motif, were used in conjunction with ORA47 as a positive control in the plant TEA. 
There were two constructs in the positive control, including the target construct and 
one internal control (Fig 6.2). The Agrobacteria strain GV3101 transformants of 
these two plasmids were selected on spectinomycin plates and further confirmed by 
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Fig 6.2 The constructs for positive control of plant transient expression assay. Upper 
panel: the target construct. This construct contains a TF expression cassette (p35S-
attB4-ORA47-attB3-t35S), from which ORA47 is expressed, and a GCCGCC 
tandem repeat-GUS reporter cassette (attB1-3xGCCGCC-attB2). Lower panel: the 
internal control. This construct only contains a GCCGCC tandem repeat-GUS 
reporter cassette. ORA47: AP2/ERF domain TF protein; GCCGCC: AP2/ERF 
associated DNA binding motif; GUS: beta- glucuronidase gene; 35S: cauliflower 
mosaic virus (CaMV) 35S promoter; nosT: nos terminator; 35Sm: cauliflower mosaic 
virus (CaMV) 35S minimal promoter; B4: attB4; B3: attB3; B1: attB1; B2: attB2; 
LB: left border; RB: right border. Hyg: hygromycin resistance; Sm/SpR: 











Fig 6.3 Confirmation of Agrobacteria GV3101 transformants of pTEA-ORA47-
3xGCCGCC-35Sm-GUS and pTEA-3xGCCGCC-35Sm-GUS by amplifying ORA47 
(yellow arrow) and 3xGCCGCC-35Sm (blue arrow) by PCR using gene-specific 
primers (SI Table 4). Upper panel, both ORA47 and 3xGCCGCC-35Sm were 
confirmed to introduced into Agrobacterium transformants; lower panel, 
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The PCR-confirmed positive Agrobacterium transformants for each construct were 
infiltrated into tobacco leaves. As expected, the control, which was infiltrated with 
infiltration buffer only, did not show blue colour (Fig 6.4 C). Furthermore, the 
internal control, pTEA-3xGCCGCC-35Sm-GUS showed little background (Fig 6.4 
B). Finally, the transformants with pTEA-ORA47-3xGCCGCC-35Sm-GUS showed 






Fig 6.4 Agro-infiltration of GV3101 transformants in tobacco leaves at OD600=0.1. 
A: pTEA-ORA47-3xGCCGCC-35Sm-GUS; B: pTEA-3xGCCGCC-35Sm-GUS; C: 
infiltration buffer only. As expected, the target construct A showed GUS expression, 
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6.3 Discussion 
 
In this improved plant TEA, a TF expression cassette was cloned into a promoter-
GUS reporter backbone to form a pTEA destination binary vector. The size of this 
plasmid is ~13 kb, which facilitates its introduction into Agrobacterium by 
transformation. After confirming the presence of pTEA-ORA47-3xGCCGCC-35Sm-
GUS in Agrobacterium (GV3101) by PCR (Fig 6.3), the results from three replicates 
of Agro-mediated infiltration showed GUS expression (Fig 6.4 A) for this positive 
control but little or no GUS expression for the two negative controls (Fig 6.4 B & C). 
This indicates that there is an interaction between ORA47 and its associated DNA-
binding motifs present in plox3, and ORA47 is an activator. This assay was therefore 
validated as a suitable system to screen plant TFs for binding to their cognate 
promoter sequences. This system will be used to identify putative Taxus TFs (19) 
that bind to the promoters (5) of paclitaxel biosynthesis pathway genes and activate 
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Chapter 7 Synthesis of TF proteins by in vitro transcription 
and translation using wheat germ 
 
Regarding the rapid progress in the area of proteomics, the production of sufficient 
amount of protein becomes crucial. Therefore, the development of a protein 
synthesis system is an important endeavour in biotechnology. There are three 
systems currently used to synthesize desired proteins: chemical synthesis, in vivo 
expression and cell-free protein synthesis. The first two strategies each have their 
drawbacks: chemical synthesis is not suitable for synthesis of long peptides because 
of low yield (Blaschke et al. 2000), and in vivo expression can only synthesize 
proteins that would not interfere with the physiology of the host cells (Chrunyk et al. 
1993; Goff and Goldberg 1987). In contrast, cell-free protein synthesis can produce 
large peptides as accurately as ones synthesized by in vivo translation (Kurland 1982; 
Pavlov and Ehrenberg 1996). In addition, this system can express proteins that have 
a significant effect on the physiology of the host cells. One of the most convenient 
eukaryotic cell-free protein synthesis systems is based on the wheat germ extracts. 
This cell-free protein synthesis system, which is prepared from wheat embryos, is 
highly efficient and robust (Madin et al. 2000). The wheat germ-based cell-free 
system has several advantages such as low cost, capacity to synthesize large proteins 
and easy availability in large amounts. Furthermore, it is more suitable for 
synthesizing eukaryotic proteins, as it is a eukaryotic system. However, a study has 
shown that this system is not generally stable and thus insufficient to synthesize 
proteins because of the presence of endogenous ribosome-inactivating proteins 
(RIPs). RIPs are N-glycosidases and can inhibit protein synthesis by removing a 
single adenine residue present in a stem-loop structure of 28S ribosomal RNA 
through the cleavage of the N-glycosidic bond (Stirpe et al. 1992). Most commonly 
RIPs are single-chain proteins (Type I RIPs) such as tritin, colocin 1/2, mapalmin 
and asparin 1/2 (Bolognesi et al. 1990; Madin et al. 2000). Therefore, the elimination 
of these translation inhibitors by extensive washing gives rise to wheat germ extracts 
that contain stable and highly active translational apparatuses. With such an extract, 
translation proceeded for more than 60 hours when performed in a dialysis bag, 
which enables the continuous supply of substrates as well as the continuous removal 
of small byproducts. It has been claimed that 1-4 milligram (mg) of enzymatically 
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active proteins, for example, 1.2 mg of green fluoresce protein (45 kDa), and 0.6 mg 
of a 126 kilodalton (kDa) tobacco mosaic virus protein per millilitre of reaction 
volume were produced (Madin et al. 2000).  
 
 
Electrophoretic mobility-shift assay (EMSA) is a commonly used in vitro assay to 
detect protein-DNA interactions. When the target protein is bound to 32P 
radioactively labelled probes (TF-associated DNA binding motifs or DNA fragments 
that contain TF-associated DNA binding motifs), a protein-DNA complex forms, 
thus it migrates more slowly than the free probes (unbound 32P radioactively labelled 
TF-associated DNA binding motifs or DNA fragments that contain TF-associated 
DNA binding motifs) (Carey et al. 2012; Garner and Revzin 1981). This technique 
was therefore chosen to detect interactions between the promoters of five paclitaxel 
biosynthesis pathway genes and 19 Taxus TF candidate proteins. Prior to EMSA, 19 
Taxus TF candidate proteins need to be synthesized. In vivo protein expression in E. 
coli was initially chosen. However, the synthesized proteins could be not detected. 
This could be due to the fact that expression of these Taxus proteins interferes with 
the physiology of the E. coli host, and therefore insoluble inclusion bodies form 
(Chrunyk et al. 1993). In addition, it is also likely that because of significant levels of 
mRNA degradation by endogenous E. coli ribonucleases, large mRNAs are more 
likely to be degraded than small ones, and therefore this system is not suitable for 
producing proteins translated from large mRNAs (Madin et al. 2000). The molecular 
weights (MW) of these 19 Taxus TFs (SI Table 2) range from ~8 to 51 kDa. 10 of 
them have MW greater than 30 kDa, and the rest has MW below 20 kDa. So, these 
proteins (MW>30 kDa) might not be synthesized in the E. coli host because of their 
corresponding mRNA degradation. As a consequence, wheat germ cell-free protein 
synthesis was deployed to synthesize these 19 Taxus TF candidate proteins because 
of its numerous advantages.  
 
The in vitro synthesis of Taxus TF candidate proteins started with first round PCR, in 
which linker sequences were first added to both 5’ and 3’ end of the open reading 
frame (ORF) of these TFs. In total, 18 out of 19 TF encoding sequences each were 
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amplified with linker sequences added except contig 07425. This exception could be 
caused by technical problems such as PCR reaction conditions (Fig 7.1 and 7.2). The 
DNA sequences of the T7 promoter and FLAG-tag were subsequently added to the 
5’ end of the first round PCR products through the linker sequences in the second 
round PCR (Fig 7.2). FLAG-tag is a polypeptide protein tag and has an amino acid 
sequence of DYKDDDDK. It can be added to a target protein using recombinant 
DNA technology. This allows one to detect the FLAG-tagged protein with an anti-
FLAG antibody when there is no antibody against the target protein. Then, the 
second round PCR products were used to generate mRNA by in vitro transcription, 
from which Flag tagged TF proteins were produced by in vitro translation in wheat 
germ extract (Dr. Yasuomi Tada at Kagawa University, Japan). In total, 15 proteins 
were produced, including 14 Taxus TF candidates and the ORA47 (Fig 7.3). The 
synthesis of the other 4 candidates (contig 07425, 05638, 15401 and 22386) was 
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Fig 7.1 First round PCR in the process of synthesizing TFs by wheat germ cell-free 
system. In total, 19 (16 shown in Fig 7.1 and 3 shown in Fig 7.2) out of 20 TF 
encoding sequences were amplified with linker sequences added on both 5’ and 3’ 
end of the ORF of each TF. These 19 genes include 18 Taxus TF candidates and the 
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Fig 7.2 Second round PCR in the process of synthesizing TFs by wheat germ cell-
free system. Based on the first round PCR products, the second round PCR products 
were subsequently amplified with the T7 promoter and Flag tag added to the 5’ end 
the through the linker sequences. In total, all 19 TF encoding sequences from the first 
round PCR were amplified, including 18 Taxus TF candidates and the ORA47 that 





Fig 7.3 Western blots of synthesized FLAG-tagged Taxus TF candidate proteins and 
ORA47 using wheat germ cell-free system. In total, 14 FLAG-tagged Taxus TF 
candidates and ORA47 were synthesized. The primary antibody against 15 FLAG-
tagged proteins was anti-FLAG in 1 in 5000 dilution. The secondary antibody 
agaisnt the primary antibody was anti-mouse (IgG) in 1 in 1000 dilution. The 
exposure time was 10 seconds.  
 
In conclusion, because these 19 Taxus TF candidate proteins might interfere with E. 
coli physiology,  it was difficult to express these proteins  and  the amount of 
recombinant proteins could not even be visualized (Rabia et al. unpublished). In 
contrast, the  in vitro protein synthesis by wheat germ is a simple, quick and efficent 
way to synthesize these Taxus TF proteins. As shown in Fig 7.4, 14 putative 
candidate Taxus TF proteins and one AP2/ERF TF (ORA47) were produced using 
this system and visualized. Because EMSA only requires ~2 to 20 µl of crude protein 
solutions (wheat germ extracts) for detecting protein-DNA binding, in which  target 
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proteins are synthsized, the amount of synthesized proteins in the wheat extract does 
not need to be determined (Carey et al. 2012).  However, it has been experimentally 
proved that the specific Taxus TF candidate protein-DNA interactions were clearly 
detected using the wheat germ extracts that contain the desired Taxus protiens (Rabia 
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Chapter 8 General discussion 
 
8.1 Summary of my project 
 
In this project, Illumina Solexa was first performed to digitally profile differently 
expressed genes at the early time points from the cDNA library of MeJA-elicitated 
CMCs. Consequently, this led to the discovery of 1646 significantly differently 
expressed genes, and further annotation showed that there were 78 MeJA-induced 
putative TF-encoding genes. Based on the E-values, 19 TF-encoding genes all have 
high E-values (<e-04) when blasted against the non-redundant protein sequences in 
the vascular database. In addition, they were all significantly induced at 0.5 h time 
point after MeJA treatment (Fig 3.4 A & B). These 19 genes were therefore selected 
for further characterisation. Finally, the bioinformatic analysis showed that all 19 
TFs contain the conserved signature domains (CSDs) when aligned with their well-
known counterparts. Based on the CSDs (Fig 3.4 C to G), these 19 TFs were 
therefore grouped into 5 different TF families, including AP2/ERF, NAC, MYB, 
WRKY and bHLH. The promoter analysis by PLACE 
(http://www.dna.affrc.go.jp/PLACE/) shows that these five TF families-associated 
DNA-binding motifs are present in the promoters of five paclitaxel biosynthesis 
pathway genes, including TASY, T5αH, DBAT, PAM and DBTNBT (Appendix I). All 
together, it indicates that these 19 TFs could regulate the expression of these five 
pathway genes as well as other known and unknown pathway genes.  
 
The Y1H assay was firstly deployed to screen interactions between 19 TFs and 5 
promoters (95 combinations). The positive control for Y1H showed that ZAT10 
interacted with plox3; however, no convincing interactions were detected among 95 
TF-promoter combinations. This was most likely caused by some technical issues 
such as protein expression vectors used to express the recombinant GAL4AD-TF 
proteins, as only the GAL4AD, but not the recombinant proteins, was detected 
(Eunjung et al., unpublished data) (chapter 4). Because of the numerous advantages 
the plant transient expression assay has, such as expression of plant proteins in 
planta system, thus, it was chosen to screen Taxus protein-promoter interactions in 
the leaves of Nicotiana benthamiana. However, the positive control for the assay was 
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not successfully established. Because the recombinant plasmid, which contains both 
TF expression cassette and promoter-reporter cassette, was not successfully 
constructed through Cre/loxP-mediated recombination of two dependent vectors. 
Evidence showed that the recombination event could happen between two separate 
loxP-containing vectors (pJET1.2-GW-loxP and pMDC162-GW-35Sm-loxP). 
However, the probability of selecting a positive colony that contains the recombinant 
plasmid is very low. This is most likely caused by low recombination efficiency, 
difficulty in transforming E. coli with large vectors (~ 19 kb) and occurrence of 
reverse recombination event between two cddB genes present in each gateway 
cassette. On the other hand, the interaction between ORA47 (AP2 TF) and its 
associated GCCGCC binding motif was confirmed through the expression of the 
GUS reporter in the technically improved plant assay (Fig 6.4 A). This indicates that 
this re-designed plant transient expression assay is therefore validated as a suitable 
system to detect interactions between plant proteins and promoters. 
It would be more informative to validate Taxus TF-promoter interactions using an in 
planta system, if a list of interactions between 19 TFs and their family associated 
binding motifs found in each of five pathway gene promoters is quickly produced 
and used as a guide.  An in vitro gel shift assay, which can quickly and efficiently 
detect interactions between proteins and DNA fragments, was therefore undertaken 
by a lab colleague, Rabia Amir. As a positive control, ORA47 was first shown to 
bind to the AP2/ERF associated GCCGCC motif present in plox3. Furthermore, two 
bHLH TFs (Ct11748 and 08058) were shown to bind to the promoter of TASY, PAM, 
DBAT and T5αH. A WRKY TF Ct09595 was shown to bind to all 4 promoters 
except PAM, because PAM does not contain any WRKY-binding sites. In contrast, 
another WRKY TF, Ct19284, interacted with DBAT, DBTNBT and T5αH. Finally, 
three AP2 TFs (Ct03304, 01431 and 04485) were found to bind with the GCCGCC-
containing promoters, including TASY and T5αH (Rabia Amir and Gary Loake, 
unpublished data).  
 
The gel shift assay is not able to distinguish between positive and negative 
regulators. Therefore, the interactions obtained in a gel shift assay are typically 
further validated by another in-vivo transient expression, for example utilising 
	  
	   173	  
protoplasts of Arabidospsis. Instead of using TF-associated DNA-binding motifs, 
whole promoters or multimers of cis-elements are used to identify positive 
transcriptional regulators that activate lucifrase gene expression when binding to 
their associated DNA-binding motifs present in the promoters (Pauwels et al. 2008). 
As a positive control, ORA47 was shown to bind the plox3 promoter and activate 
lucifrase gene expression. This interaction was also confirmed by Goossens group 
(Pauwels et al. 2008). We have identified a number of positive regulators through 
this assay, including MYB (Ct10855), AP2 (Ct22386) and bHLH (Ct08058) 
interacting with the TASY promoter and WRKY (Ct19284) and MYB (Ct15401) 
interacting with the DBAT promoter (Howat and Gary Loake, unpublished data).  
 
In conclusion, the plant transient expression assay in tobacco leaves was found to be 
a suitable system to validate plant TF-promoter interactions. In parallel, gel shifting 
and plant transient expression assays have been shown to work well and are 
identifying positive transcriptional regulators controlling the expression of five 
paclitaxel biosynthesis pathway genes.   
 
 
8.2 CMCs: culturing and potential in plant natural product production 
 
In terms of plant cell culturing at an industrial scale, CMCs have several advantages 
over DDCs, such as greatly reduced cell aggregate size (<0.5 mm in diameter), 
relatively fast and constant growth rate and significantly increased production of 
secondary metabolites. Therefore, this superior cell line could be potentially used for 
production of medically and economically important natural products. The increased 
production of paclitaxel from CMCs of Taxus cuspidata has shown that the use of 
CMCs has great potential in natural drug production (Lee et al. 2010). Apart from 
anticancer drugs (paclitaxel, taxamairin A and taxamairin C) produced from Taxus 
cuspidata CMCs, ginsenosides (F2 and XVII), medically valuable natural products, 
have also been produced through CMC culturing technology (Yun et al. 2012). 
Furthermore, CMCs have been isolated from other plant species, including ginseng 
(Panax ginseng), ginkgo (Ginkgo biloba) and tomato (Solanum lycopersicon). This 
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further indicates that this plant cell isolating technique could be potentially used to 
isolate CMCs from a wide range of selected plant species for production of natural 
products that are used as antimicrobials, perfumes, pigments and insecticides. 
Overall, culturing of CMCs may therefore provide a cost-effective and sustainable 




8.3 Employment of advanced techniques in my project 
 
In terms of efficiency in time, the use of advanced biological techniques throughout 
my project has greatly facilitated the profiling of gene expression of MeJA-elicited 
CMCs, Y1H, gel shift and plant transient expression assay.  
 
8.3.1 Next Generation sequencing  
 
Next Generation sequencing technology was employed to help determine MeJA-
induced TFs in T. cuspidata. In this context, 454 pyrosequencing sequencing was 
employed to determine the T. cuspidata transcriptome producing a total of 860,800 
reads of 351 bp average length (Lee et al. 2010). These reads were assembled into 
longer reads (isotigs), which were blasted against available sequence databases. In 
addition, Illumina Solexa digital gene expression (DEG) profiling was used to 
identify MeJA-elicitated transcripts in CMCs. Thus, 1646 differentially expressed 
genes were uncovered as being significantly up-regulated (Fig 3.2). After annotation 
of these 1646 DEGs, 78 contigs were annotated as putative TF encoding genes (Fig 
3.3a). Furthermore, according to the E-values (<e-04) (Table 8), 19 putative TFs, 
which are induced at 0.5 h time point by MeJA, were selected and assayed for their 
interactions with the promoters of five paclitaxel biosynthesis pathway genes. These 
promoters were analyzed in PLACE and found to be rich in the cognate binding 
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8.3.2 Gateway cloning technology 
 
When screening interactions between 5 Taxus promoters and 19 putative TFs, 
gateway cloning technology was used to clone all 19 TFs into pGADgate424 lapau 
destination vector (Fig 2.2c) in Y1H assays. Furthermore, in the two-component 
system cloning, both promoters and TFs were spontaneously cloned into pTEA 
destination vector through two different gateway cassettes, attR1-cddB-attR2 and 
attR3-cddB-attR4 (Fig 2.4c). Compared to the conventional cloning technology 
(ligation-directed cloning), gateway cloning has several advantages such as rapid, 
directional and efficient cloning and expression of PCR products with a wide rang of 
size and high percentage of positive colonies. Therefore, the deployment of this 
technology in Y1H and plant transient expression assays has greatly increased the 
efficiency of transferring a large number of genes between different vectors. In 
addition, it is a versatile cloning system; any standard vector can be converted into a 
gateway-compatible vector through the insertion of gateway cassettes. For example, 
after inserting a gateway cassette, pGAD424 is converted into pGADgate424 lapau 
(Fig 2.2c), into which all 19 TF-encoding genes are spontaneously cloned through 
the gateway cloning system. 
 
8.3.3 In-vitro transcription and translation using wheat germ extracts 
 
In order to screen TF protein-DNA interactions by gel shift assay, Taxus TF proteins 
first need to be synthesized. It was found difficult to express these TF proteins in E. 
coli, which is probably due to the fact that these proteins interfere with E. coli 
physiology. In contrast, they were synthesized successfully by a wheat germ-based 
cell free protein synthesis system (Fig 7.4) (Tada et al. unpublished). This in-vitro 
system is an efficient and cost-effective way to produce enough protein for EMSA. 
14 Taxus TF candidate proteins were synthesized through this method and they were 
used to detect TF associated DNA-binding motif interactions in gel shift assays 
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8.4 Further work 
 
8.4.1 Transcriptional regulation network for paclitaxel synthesis 
 
A gene regulation network (GRN) is the understanding of transcriptional regulatory 
networks at a genome-wide scale, and it can be constructed by working out 
interactions between regulators (TFs) and with their targets through different 
approaches. Y1H assays have been used as an approach to identify upstream TFs that 
bind to promoters or DNA fragments of interest (target-centered approach) and 
systematically map GRNs. In this assay, a collection of TF proteins or a cDNA 
library of TFs (prey proteins) needs to be developed, and it will be assayed against 
target promoters or DNA fragments of interest (baits). In addition, the gateway-
compatible Y1H allows a high-throughput screening of protein-DNA interactions 
(Deplancke et al. 2006; Hens et al. 2012). This technique could be further enhanced 
when coupled with a robot, the BioRad VersArray, which is known as enhanced 
Y1H (eY1H) (Gaudinier et al. 2011). By contrast, Chromatin immunoprecipitation 
(ChIP) coupled with microarrays (ChIP-chip) or Next-Generation sequencing (ChIP-
seq), on the other hand, are TF protein-centered approaches to identify downstream 
targets of given TFs and subsequently map GRNs. In this approach, together with 
their bound target DNA (promoters), the given TFs are immunoprecipitated, which is 
followed by subsequent identification of the bound target DNA. Therefore, ChIP-
chip or ChIP-seq can construct a GRN that describes the in vivo interactions between 
given TFs and their targets. However, there are some drawbacks in these two 
approaches. The in-planta TF-DNA binding can be easily missed in yeast system, 
because of the heterologous nature of Y1H assay. As a result, there will be TF-DNA 
interactions that cannot be detected in yeast, but can be detected if assayed in planta. 
In contrast, although the ChIP approach can show in vivo planta TF-DNA binding, 
high-quality antibodies against the TFs are required to perform specific and 
sufficient immunoprecipitation. In common, both do not provide information about 
the regulatory effect of TFs after binding with their targets. To circumvent this 
problem, an in vivo planta system is needed to show the effect of TFs upon binding. 
The transient expression assay performed in either protoplasts or leaves can provide 
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information about the TF’s effects on the expression of target genes (Lau et al. 2011; 
Yang et al. 2000). Furthermore, comprehensive data on transcript abundance and on 
TF-DNA interactions could be generated by RNA sequencing (RNA-seq) and ChIP-
seq (Ouyang et al. 2009).  
 
 
So, based on the data from screening interactions between 19 Taxus TF candidates 
and 5 promoters using both gel shift and protoplast transient expression approaches, 
a GRN for paclitaxel biosynthesis can be mapped. For example, it has been found 
that AP2 (Contig03304) simultaneously interacts with DBAT, TASY and T5αH 
promoters in TEA (Howat et al. unpublished). It indicates that this AP2 could act as 
a master TF that regulates the expression of three paclitaxel biosynthesis pathway 
genes. However, this mini GNR only shows the regulatory relationship between a 
limited number of TFs and 5 paclitaxel biosynthesis structural genes, but no 
information about TF-TF interactions and microRNA-mediated regulation of gene 
expression. Therefore, a more comprehensive GRN could be constructed, if 
including more TFs and their regulated paclitaxel biosynthesis pathway genes and 
combining other approaches, such as Y2H and computationally and experimentally 
derived microRNA-mRNA interactions (Brady et al. 2011).  
	  
	  
8.4.2 Establishment of a superior paclitaxel-producing CMC line 
 
The identification of TFs controlling the expression of paclitaxel biosynthesis genes 
and further unravelling of a TF regulatory network for paclitaxel biosynthesis would 
enable bioengineering of CMC to establish a superior paclitaxel-producing line. It 
has been established that a non-embryonic Taxus cuspidata cell line is stably 
transformed with two GUS reporter binary vectors (pCAMBIA1301 and 
pCAMBIA1305.2) through the Agrobacterium-mediated transformation and these 
two resulting transgenic Taxus cuspidata cell lines showed GUS activity. In addition, 
both transgenic cell lines have been maintained in suspension cultures for more than 
20 months without the loss of GUS gene expression and antibiotic resistance 
(Ketchum et al. 2007). The transformation of CMCs with TF expression binary 
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vectors is currently ongoing. The over-expression of key TFs in CMCs, which 
control the expression of rate-limiting paclitaxel biosynthesis pathway genes could 
lead to a significant increase in paclitaxel production. In addition, the silencing of 
TF-encoding genes, which regulate the expression of branched pathway genes, could 
further enhance paclitaxel production.  
 
Together with the advantages CMCs have over DDCs in large-scale culturing, the 
cell culturing of this superior paclitaxel-producing CMC line could significantly 
enhance paclitaxel production.  
 
8.4.3 Identification of unknown genes involved in paclitaxel metabolism  
 
Based on the assumption that genes sharing a common function or being involved in 
a given biological process are most likely transcriptionally co-regulated (the ‘guilt-
by-association’ principle), the co-expression approaches aim to construct 
coexpression networks, from which biologically relevant information can be 
extracted (Usadel et al. 2009). For example, identification of unknown structural 
genes involved in various biological processes (Bassel et al. 2011). Ectopic 
overexpression of a TF in plants is one of the common means to identify the 
remaining structural genes that constitute metabolic networks. For example, in 
combination with microarray analysis, a suite of co-regulated genes, which are 
involved in synthesis and further metabolism of phenylalanine, were identified in 
transgenic tomato overexpressing a MYB TF, Petunia hybrida ODORANT1. Among 
these co-expressed genes, a gene encoding prephenate aminotransferase was 
discovered, which converts prephenate to arogenate (Dal et al. 2011). Therefore, 
after identifying Taxus TFs, one or more TFs could be ectopically expressed in 
CMCs, and subsequently, the unknown structural genes involved in paclitaxel 
metabolism, including unknown pathway genes and genes involved in paclitaxel 
transport and storage, could be discovered through the analysis of coregulated genes 
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8.4.4 Gene-to-metabolite network  
 
Furthermore, by extending the concept of the ‘guilt-by-association’ principle, a co-
expressed relationship between the pathway genes involved in synthesis of secondary 
metabolites and secondary metabolite accumulation patterns could also be 
established, from which, the function of genes involved in secondary metabolic 
pathways can be decoded, and therefore, a gene-to-metabolite network can be 
elucidated.  For example, through the BL-SOM (Batch-learning self-organizing map) 
analysis of the combined time-series data of the transcriptome and of the 
metabolome obtained after sulfur deprivation, which causes changes in gene 
expression and metabolite accumulation patterns in Arabidopsis, two gene clusters 
for synthesis of glucosinolate and anthocyanin were found, respectively. In addition, 
a set of genes involved in glucosinolate biosynthesis was found to encode 
sulfotransferases and R2R3-MYB transcription factors (Hirai et al. 2005; Hirai et al. 
2007). Another example of assigning functions to genes through the correlation of 
transcripts and metabolites is the identification of genes involved in the late step of 
anthocyanin biosynthesis in the background of MYB-overexpressing transgenic 
Arabidopsis, including genes that encode two flavonoid glysosyltransferases and two 
acyltransferases (Tohge et al. 2005). In this project, an in-house time-series (0.5, 2 
and 12 hour samples) of the transcriptome was obtained from the MeJA-elicitated 
CMC line, in which, a set of pathway genes involved in the paclitaxel biosynthesis 
are co-upregulated at all three time points (Fig 3.5, 6 &7). Collaboraions have been 
established to generate metabolomic data from a MeJA-elicited T. cuspidata CMC 
line using mass spectrometry-based techniques (Kueger et al. 2012) and this will be 
combined with the in-house transcriptomic data. The function of pathway genes 
involved in paclitaxel biosynthesis and gene-metabolite correlation can then be 
predicted by combining both transcriptome and metabolome data of the MeJA-
elicited CMC line. The function of identified genes could then be validated using 
reverse genetics (e.g. RNAi knockout) and biochemical approaches (e.g. analysis of 
recombinant protein activity). Finally, molecular networks of gene-to-metabolite for 
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paclitaxel biosynthesis can be constructed through a comprehensive identification of 
function of paclitaxel pathway genes. 
8.4.5 Gene clusters for paclitaxel synthesis  
 
Operon-like gene clusters for secondary metabolic pathways are commonly found in 
bacteria and filamentous fungi, but not in planta, in which functionally related genes 
are co-ordinated (Osbourn 2010b). However, recent studies have discovered a small 
number of plant secondary metabolic gene clusters in different plant species, which 
are mainly implicated for the biosynthesis of defence compounds, for example, the 
avenacin clusters in Avena spp. (oat) (Qi et al. 2004), the momilactone clusters for 
the synthesis of diterpenes in Oryza sativa (rice) (Sakamoto et al. 2004), the cluster 
for the synthesis of 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) in 
maize (Jonczyk et al. 2008) and the cluster for the synthesis of the anticancer 
alkaloid noscapine (Winzer et al. 2012). In addition, TFs, in turn, are found to be key 
regulators of plant secondary metabolic gene clusters. For example, OsTGAP1, a 
basic leucine-zipper TF, is found to positively regulate both momilactone and 
phytocassane synthesis in rice (Okada et al. 2009). Interestingly, there are more than 
one TF found to regulate a plant secondary metabolic gene cluster, and the regulatory 
genes that encode these TFs also tend to cluster together. For example, at least seven 
ERF (Ethylene Response Factor) encoding genes were found to cluster at the NIC2 
locus (locus B), which positively regulates nicotine biosynthesis. Furthermore, these 
seven genes were experimentally proven to show unequal effectiveness in promoting 
nicotine biosynthesis (Legg 1971; Shoji et al. 2010). This finding might provide new 
insights into how regulatory genes for biosynthesis of secondary metabolites are 
organized, and further shed light on the studies on how a downstream transcriptional 
network for synthesis of secondary metabolites is effectively activated through the 
jasmonate signalling pathway (Shoji et al. 2010). In our MeJA-upregulated TF 
database, more than one member of each TF family shows up-regulation after MeJA 
elicitation. These families include AP2/ERF (6), MYB (7), NAC (5), bHLH (5), 
WRKY (3), GRAS (3), E2F (3), LOB (6) and C3H (6) (Fig 3.3b). As these 
regulatory genes are all activated upon MeJA elicitation, it is likely that these TFs 
from the same TF family are organized in a clustered manner, which could be tested 
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using fluorescence in situ hybridisation (FISH) (Trask 1991), and that each of these 
TFs shows differences in effectiveness in promoting paclitaxel biosynthesis.  
 
Furthermore, paclitaxel is a defence compound against plant pathogenic fungi 
(Flores 1994). In our MeJA-responsive paclitaxel biosynthetic gene database, genes 
involved in the early, middle and late paclitaxel biosynthetic pathway and 
transportation of paclitaxel into vacuoles are all co-upregulated at three different 
time points (Fig 3.5, 6 & 7). So, there could be a gene cluster for the synthesis of 
paclitaxel in Taxus cuspidata.  A striking example to support this hypothesis is the 
discovery of a 10-gene cluster for synthesis of noscapine, an anticancer alkaloid from 
Papaver somniferum (opium poppy). Unlike paclitaxel, which functions to promote 
tubulin polymerization, this anticancer drug binds to tubulin and inhibits its 
polymerization, and thereby arrests cell division and induces apoptosis (Winzer et al. 
2012). Furthermore, an upstream regulatory gene cluster could regulate this 
downstream structural gene cluster for synthesis of paclitaxel, and in turn, the 
jasmonate signalling pathway could regulate the whole transcriptional cascade for 
paclitaxel biosynthesis, because the production of paclitaxel is significantly increased 
in CMC suspension cultures after MeJA treatment (Lee et al. 2010).  
 
Gene clusters of plant secondary metabolites are thought to form through gene 
duplication events, followed by independent evolutionary events, which leads to 
subsequent establishment of two dependent clusters for synthesis of two different 
end products. For example, the Field group proposed that both thalianol and mameral 
cluster formed after the α whole-genome duplication event within the Brassicales 
(Chu et al. 2011; Field et al. 2011). There are two primary advantages of gene 
clustering: one is co-inheritance; the other is co-regulation (Osbourn 2010a; b). 
Firstly, co-inheritance prevents the disruption of the most effective and beneficial 
gene sets, such as plant secondary metabolic gene clusters for synthesis of defence 
compounds. As a result, the pathway genes are maintained in a clustered manner, and 
subsequently the selection for clustering might be further enhanced. The disruption 
of secondary metabolic gene clusters can result in not only the loss of the beneficial 
end products, but also the accumulation of harmful intermediates, such as toxic or 
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bioactive compounds that have negative effects on plant growth and development 
(Mylona et al. 2008). Secondly, co-regulation allows the pathway genes to be 
expressed in a similar pattern because they share similar promoters. In addition, it 
may facilitate the processing of transcripts, including chromatin remodelling as well 
as export from nucleus to cytoplasm for protein synthesis (Chu et al. 2011). For 
example, the histone modification, H3 lysine 27 (H3K27), has been marked in the 




8.5 Obstacles and solutions in my research  
 
The first obstacle in my research was the unsequenced genome of Taxus spp. This 
makes it difficult to carry out the molecular research on unravelling the paclitaxel 
metabolism with the ultimate goal to improve paclitaxel production. The solution to 
this was to establish a transcriptomic database of MeJA-elicitated CMCs. We 
performed Solexa sequencing to digitally profile DEGs from the cDNA library of the 
MeJA-elicitated CMCs of Taxus cuspidata. Meanwhile, 454 pyrosequencing further 
sequenced the DNA sequences of these DEGs so that we were able to isolate and 
characterise candidate genes annotated as putative TFs.  
 
The second obstacle is the use of Cre/loxP recombination to create a recombinant 
binary vector by combining two separate ones for Agrobacterium-mediated 
infiltration in transient expression assays in tobacco leaves. However, it was found 
that the recombinant plasmid could not be replicated; instead, these two separate 
vectors independently replicate inside E. coli. Therefore, a two-component gateway 
binary vector was constructed by cloning a TF-expression cassette into another 
vector that already contains a promoter-reporter cassette in its backbone. Through 
this method, the pTEA-ORA47-3xGCCGCC-35Sm-GUS was made and tested for 
GUS activity in tobacco leaves.  
 
The third obstacle is that there was no colony growth when introducing a two-
component gateway binary vector, which contains two cddB genes in each of two 
gateway cassettes it contains, into either DB3.1 or 2T1 cddB-resistant E. coli. 
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However, when replacing one of the cddB with a different DNA sequence, such as 
ORA47, the resulting construct was successfully introduced into both strains. This 
finding is not expected, because a commercial two-component gateway vector 
(pK7m34GW2-8m21GW3,0) (Fig 2.4), which contains two cddB genes, was 
extracted from 2T1 strain. However, when it was re-introduced into the same strain, 
no colony grew. As a result, both cddB genes had to be replaced by the DNA 
sequence of TF and promoters, respectively, prior to cloning the cddB-containing TF 
expression cassette into the backbone of cddB-containing reporter vector (SF 8). 
However, this cloning strategy is not what is expected from using two-component 
gateway cloning. Because both TF-encoding gene and TF-associated promoter 
sequences are supposed to simultaneously replace each cddB gene present in TF 
expression and promoter-reporter cassette, respectively, in the strategy of two-
component gateway cloning. Therefore, the attempted two-component gateway 
system did not work as planned. In order to avoid the labour-intensive cloning steps, 
TF-promoter interactions were first screened by gel shift assays (Amir et al. 
unpublished); then, the TF-promoter pairs that show interactions will be validated by 
the plant assay. 
 
Finally, there was difficulty in cloning small DNA fragments into large-sized vectors, 
such as the cloning of loxP (34 bp) into pMDC162 (~13 kb). The solution to this was 
to amplify a loxP-containing fragment (300 bp) from pUNI 51, and clone this 
fragment into pMDC163 by conventional cloning (SF 6). Another difficulty was the 
directional cloning of 35Sm upstream of the GUS reporter in pMDC162, because 
there is only one site (Asc I) available for the insertion of this 51 bp-long fragment. 
Therefore, two sites (Spe I and Hind III) were added in the place of Asc I, and the 
amplified SpeI-35Sm-Hind III was directionally inserted upstream of GUS gene (SF 
7). In addition, it was also difficult to amply short DNA fragments such as loxP site 
(34 bp), 35Sm (51 bp), B1-GCCGCC tandem repeats-B2, B1-35Sm-B2 (120 bp) and 
B1-3xGCCGCC-35Sm (~125 bp) by PCR, because of difficulties in designing 
primers for such short DNA sequences (loxP) and the absence of the DNA templates 
for PCR amplification of 35Sm, B1-GCCGCC tandem repeats-B2, B1-35Sm-B2 and 
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B1-3xGCCGCC-35Sm. They were synthesized by directly annealing both forward 




8.6 Overview of paclitaxel project  
 
My project can be summarized in Fig 8.1 Our current aim is to identify TFs 
controlling the expression of paclitaxel biosynthesis pathway genes among the 19 
putative Taxus TF candidates and produce high paclitaxel-producing transgenic 
Taxus cuspidata CMC lines. Further work could be the elucidation of a gene-to-
metabolite network of paclitaxel and transcription regulatory network of paclitaxel 
biosynthesis and the discovery of unknown paclitaxel pathway genes and a gene 
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Fig 8.1 An overview of paclitaxel project. The isolation and culture of Taxus 
cuspidata CMCs (TcCMCs) provide a platform for industrial paclitaxel production. 
After profiling differentially expressed genes (DEGs) in MeJA-induced TcCMCs 
using Next Generation sequencing technology, early induced putative TF encoding 
genes are annotated. Then, different binding assays, such as gel shift assay, Y1H and 
plant transient expression assays, are used to verify interactions between these Taxus 
TFs and promoters of paclitaxel biosynthesis genes (solid black arrows). Provided 
TFs that regulate the paclitaxel biosynthetic pathway have been identified, 
overexpression (OE) of key regulators would lead to the identification of previously 
unknown pathway genes. Meanwhile, if the metabolome of MeJA induced TcCMCs 
could have been profiled using mass-spectrometry (MS), taxanes and their precursors 
could be identified. Therefore, this could lead to a construction of gene-to-metabolite 
networks by the concept of the ‘guilt-by-association’ principle, and ultimately the 
elucidation of paclitaxel biosynthesis pathway. On the other hand, gene clusters for 
paclitaxel synthesis could be discovered through mapping co-expressed pathway 
genes on the genome of TcCMCs. Finally, based on the discovery of TFs and 
pathway genes, a transcription regulatory network of paclitaxel biosynthesis could be 
constructed using a combination of techniques, including RNAi, microarray, 
chromatin immunoprecipitation sequencing (ChIP-seq) and computational 
modelling. This gene transcriptional network not only shows both TF-TF and TF-
structural gene interactions, but also indicates the hierarchical relationships between 
regulatory genes (TF-TFs) and between TFs and structural genes. Therefore, 
TcCMCs could be engineered to over-express the most centred TFs that regulate the 
entire paclitaxel biosynthesis pathway. In addition, paclitaxel production could be 
further enhanced by silencing TFs that control branched pathways. In other words, 
all the branched pathways could be re-directed toward paclitaxel synthesis. Solid 
black arrows indicate work that has been done or in the process. Dotted black arrows 
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Chapter 9 Supplementary Information 
 
SI. 1 PCR-based synthesis of short DNA fragments 
 
It was difficult to amplify short DNA fragments, including loxP (34 bp), cauliflower 
mosaic virus (CaMV) 35S minimal promoter (35Sm) (51 bp), attB1-35Sm-attB2 
(~100 bp), attB sited -3xGCCGCC tandem repeats (~100 bp) and attB1-
3xGCCGCC-35Sm (~120 bp). Because the DNA templates were not available, and it 
was difficult to design amplifying primers for such short DNA sequences. Therefore, 
these fragments were directly synthesized by annealing both forward and reverse 






SF 1 PCR-based synthesis of GCCGCC tandem repeats flanked by attB sites. The 
PCR products were purified from agarose gel and cloned into sequencing vector 
(pJET1.2) for sequencing. Each GCCGCC repeat is 17-bp long, including 6 and 5 
bases on the left-hand side and on the right-hand side of GCCGCC core, 
respectively. Both attB1 and attB2 site contain 25 base pairs.  
 
 
SF 2 PCR-based synthesis of loxP 35S minimal (35Sm) promoter shown on 1.8% 
agarose gel. The loxP site and 35Sm is 34-bp and 51-bp long, respectively. 35Sm: 
cauliflower mosaic virus (CaMV) 35S minimal promoter.  
	  








SF 3 PCR-based synthesis of attB1-35Sm-attB2 and attB1-3xGCCGCC-35Sm-attB2 
shown on 1.8% agarose gel. As expected, the synthesized B1-35Sm-B2 is about 120 
bp long (Upper panel). In the synthesis of B1-3xGCCGCC-35Sm-B2, the fragment 
B1-3xGCCGCC-35Sm was firstly synthesized by primer annealing. Then, B1-
3xGCCGCC-35Sm-B2 was synthesized using the B1-3xGCCGCC-35Sm as 
templates (Middle and lower panel). 35Sm: cauliflower mosaic virus (CaMV) 35S 
minimal promoter.  
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SI. 2 Construction of pJET1.2GWTF expression vector 
 
A gateway-adapted TF expression cassette was amplified from pMDC32 and clone 
into pJET1.2 by blunt-end ligation to form pJET1.2GWTF. Xho I digestion further 








SF 4 Construction of pJET1.2GWTF expression vector. Left panel: PCR 
amplification of gateway-adapted TF expression cassette (2x35S-R1-cddB-R2-
nosT); right panel: Xho I digestion of pJET1.2GWTF. As expected, it is cut into two 
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SI. 3 Cloning of loxP site and 35S minimal promoter 
 
In order to combine pJET1.2GWTF and pMDC162 through Cre/loxP recombination, 
a loxP site was cloned into each of the backbones. The loxP was inserted into 
pJET1.2GW at Cla I. However, it was difficult to clone loxP into pMDC162. This 
might be due to the fact that it is not easy to clone a very small fragment (34 bp) into 
a large backbone (~13 kb), and the transformation efficiency of large vectors is 
relatively low. As a result, a ~300 bp loxP-containing fragment was amplified from 




SF 5 Cloning of loxP site into pJET1.2GWTF at Cla I site. Cla I digestion of 
Miniprep products of pJET1.2GWTF-loxP showed the bands at the expected size 
(~34 bp) shown on 1.8% agarose gel. Ctrl: PCR product of synthesized loxP was 
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SF 6 Cloning of loxP site-containing fragment into pMDC162-35Sm at Pac I site. 
The loxP-containing fragment (~300 bp) was amplified from pUNI 51 (Upper 
panel); Pac I-digestion of Miniprep products of pMDC162-35Sm-loxP showed the 
bands at the expected size (lower panel). Ctrl: un-cut plasmids. 35Sm: cauliflower 
mosaic virus (CaMV) 35S minimal promoter.  
 
In order to initiate GUS expression in the case of using AP2-associated TF DNA 
binding motifs (GCCGCC), the 35Sm must be directionally cloned into pMDC162 
backbone. However, there was only one site (Asc I) available for the insertion of 
35Sm upstream of GUS. As a result, two unique sites (Spe I and Hind III) were 
introduced by cloning ~300 bp fragment into pMDC162 at Asc I site, which contains 
both sites. Then, 35Sm was directionally inserted upstream of GUS at these two sites 





















SF 7 Directional Cloning of 35Sm into pMDC162. A DNA fragment, which contains 
two unique sites (Spe I and Hind III), was amplified and subsequently cloned into 
pMDC162-loxP at Asc I site (Upper panel); Spe I-35Sm-Hind III was synthesized 
(Middle panel) and cloned into Spe I and Hind III-linearized pMDC162-loxP, which 
is further proved by Spe I and Hind III double-digestion of Miniprep products of 
pMDC162-35Sm shown on 1.8% agarose gel (lower panel). 35Sm: cauliflower 
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SI. 4 The correlation between plasmid size and E. coli 
transformation efficiency  
 
In order to test the hypothesis that the plasmid size affects transformation efficiency 
of E. coli, a large and small sized plasmid were introduced into E. coli (XL1-blue) by 
transformation. The transformation of pMDC162 (~13 kb), which is more than 4 
times larger than pJET1.2 (~3 kb), showed much less number of colony, when 
compared to the number of colony in the transformation of pJET1.2 (SI table 1). So, 
the larger the plasmid is, the less efficient its transformation with E. coli becomes.  
 
 
SI table 1 E. coli transformation efficiency. The transformation for each plasmid was 
repeated three times. 
 
Plasmids Size (kb) Selection markers Number of colony  
pJET1.2 ~3.0 ampicillin Full of plates 
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SI. 5 Construction of pTEA-ORA47-3xGCCGCC-35Sm-GUS for the 
positive control of transient expression assay in tobacco leaves 
 
The ORA47 expression cassette (p35S-ORA47-t35S) was firstly amplified and 
ligated into the backbone of pHGWFS7,0 at Sac I site to give rise to pTEA-ORA47-
cddB-GUS (SF 8 & 9). Then, the attB-sited 3xGCCGCC-35Sm fragment was cloned 






SF 8 Construction of pTEA-ORA47-3xGCCGCC-35Sm-GUS. Left panel: PCR 
amplification of p35S-ORA47-t35S; right panel: Sac I digestion of pTEA-ORA47-













SF 9 The pTEA-ORA47-cddB-GUS construct. The p35S-ORA47-t35s cassette was 
inserted at Sac I site. cddB is replaced by 3xGCCGCC-35Sm through gateway 
cloning at the attR1 and ttR2 site. ORA47 encodes a AP2/ERF TF. p35S: cauliflower 
mosaic virus (CaMV) 35S promoter. T35S: CaMV 35S terminator. GUS: beta-
glucuronidase. SpR: spectinomycin resistance. HygR: hygromycin resistance. LB: left 
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SI. 6 Five paclitaxel biosynthetic gene promoter sequences amplified 
from our Taxus cuspidata CMCs 
 
Five paclitaxel biosynthesis gene promoters were amplified from the genomic DNA 
of our Taxus cuspidata CMCs, and sequenced in the GenePool centre at Kings’ 
Buildings. There were three replicates sequenced for each promoter. After comparing 
the sequences of each promoter with the corresponding one published on NCBI 
(http://www.ncbi.nlm.nih.gov/nuccore/?term=taxus+cuspidata), some minor 
differences in the promoter length were found between our and on-line database 
except the PAM promoter. 
 
 
SI table 2 Minor differences in promoter length between our database and NCBI 
 
Promoter length (bp)  
Promoters Our database NCBI 
PAM 257 257 
TASY 1408 1405 
T5αH 1433 1436 
DBAT 1611 1610 
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SI.7 The common feature of the C-terminal region of NAC proteins 
 
The C-terminal regions are highly variable in sequence. They are characterised by 
the frequent appearance of simple amino acid repeats and contain regions that are 
rich in serine (S) and threonine (T), proline (P) and glutamine (Q), or acidic residues 





SF 10a Sequence alignment of the C-terminal regions of NACs between well-
characterised (ANAC019, OsNAC6, NAM and AtNAC1) and putative Taxus NACs 
(Contig 00172, 08447, 10855 and 05638).  The C-terminal regions are highly 
variable in sequences. Regions that that are rich in serine (S) and threonine (T), 
proline (P) and glutamine (Q), or acidic residues such as aspartic acid (D), 
asparagine (N) and glutamic acid (E), are underlined in blue.  
 
	  





SF 10b Sequence alignment of the C-terminal regions of NACs between well-
characterised (ANAC019, OsNAC6, NAM and AtNAC1) and putative Taxus NACs 
(Contig 09658).  The C-terminal regions are highly variable in sequences. Regions 
that that are rich in serine (S) and threonine (T), proline (P) and glutamine (Q), or 
acidic residues such as aspartic acid (D), asparagine (N) and glutamic acid (E), are 
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SI table 3 Molecular characterisation of 19 MeJA induced putative Taxus 
transcription factors. 
 
Contig number TF class ORF (bp) Protein (aa) Protein MW 
(kDa) 
03304 AP2 210 69 7.89 
04485 AP2 537 178 19.87 
07245 AP2 375 124 14.69 
01431 AP2 759 252 28.65 
00499 AP2 528 175 19.75 
22386 AP2 1392 463 50.85 
12379 MYB 867 288 33.64 
10385 MYB 936 311 35.21 
10855 MYB 1332 443 49.36 
15401 MYB 870 289 32.7 
06771 NAC 963 320 36.5 
09658 NAC 501 166 18.42 
00172 NAC 1233 410 45.85 
05638 NAC 1260 419 47.22 
08447 NAC 1140 379 9.14 
11748 bHLH 630 209 23.42 
08058 bHLH 678 225 25.01 
09595 WRKY 801 266 15.38 
19284 WRKY 1029 341 38.47 
 
The open reading frames (ORFs) were determined using Expert Protein Analysis 
System (ExPASy) (http://web.expasy.org/translate/). Then, according to the amino 
acis sequences, the molecular weight (MW) of each protein was calculated using 
ProtCalc in JustBio (http://www.justbio.com/index.php?page=protcalc). These 
proteins were classified using a specialized BALST tool that identifies the conserved 
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SI table 4 Primers used in PCR amplification of DNA fragments 
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Appendix I: TFs associated DNA binding motifs on 
paclitaxel biosynthesis pathway gene promoters 
 
 
The TFs associated DNA binding cis-elements are analysed by searching promoter 
sequences in the database of Plant Cis-acting Regulatory DNA Elements (PLACE) 
[http://www.dna.affrc.go.jp/PLACE/]. The sequences of five paclitaxel biosynthesis 
pathway gene promoters were analysed. The TF family-associated DNA binding 
motifs are shown for the 19 MeJA induced putative Taxus TFs grouped into five 
different TF families. GCC-box (GCCGCC) is bound by AP2/ERF TFs, E-box 
(CANNTG) and T/G-box (AACGTG) are bound by bHLH TFs, W-box (TGAC) is 
bound by WRKY TFs, NAC binding site (NACBS) (CACG) is bound by NAC TFs 
and MYB binding sites (MYBBS) are variable in core sequences (Ciolkowski et al. 
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